Sentence,class,file
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Experimental Pharmacology Journal of Experimental Pharmacology 2016:8 1–10Dove press submit your manuscript | www.dovepress.co m Dove press  REviEwopen access to scientific and medical research Open Access Full T ext Article 1 http: //dx.doi.org/10.2147/JEP .S6355 3Experimental treatment of antipsychotic-induced  movement disorders Erum Shireen Department of Biochemistry,   Neurochemistry and Biochemical  Neuropharmacology Research  Laboratory, University of Karachi,   Karachi, Pakistan Correspondence: Erum Shireen   Department of Biochemistry,  Neurochemistry and Biochemical  Neuropharmacology Research  Laboratory, University of Karachi, Main  University Road, Karachi 75270, Pakistan   T el +92 21 9926 1313 Ext 2289   Email eshireen@uok.edu.p kAbstract:  Antipsychotic drugs are extensively prescribed for the treatment of schizophrenia  and other related psychiatric disorders.",Non-OADS,/arxiv_data1/oa_pdf/e6/60/jep-8-001.PMC4982503.pdf
"Journal of Experimental Pharmacology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-experimental-pharmacology-journa lThe Journal of Experimental Pharmacology is an international, peer- reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of laboratory and experimental  pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/e6/60/jep-8-001.PMC4982503.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/60/jep-8-001.PMC4982503.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 377–385ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  377 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S106769Financial and feasibility implications of the  treatment of hepatitis C virus in Italy: scenarios  and perspectives Davide Croce1,2 Marzia Bonfanti1 Umberto Restelli1,2 1Center for Research on Health  Economics, Social and Health Care  Management, Università Cattaneo,  Castellanza, Italy;  2School of Public  Health, Faculty of Health Sciences,  University of the Witwatersrand,  Johannesburg, South AfricaBackground: Hepatitis C virus (HCV) affects an estimated number of people between 130  million and 210 million worldwide.",Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
"2 Cirrhotic subjects have a yearly prob- ability between 1% and 3% to develop HCC.3Correspondence: Davide Croce Center for Research on Health Economics, Social and Health Care Management, Università Cattaneo, Corso Matteotti 22, 21053 Castellanza VA, ItalyTel +39 0331 572 424Fax +39 0331 572 513Email dcroce@liuc.itJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Croce et alRunning head recto: Hepatitis C virus in Italy: scenarios and perspectivesDOI: http://dx.doi.org/10.2147/CEOR.S106769",Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: http://www.ecdc.europa.eu/en/publications/Publications/TER_100914_Hep_B_C%20_EU_neighbourhood.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: http://www.agen-ziafarmaco.gov.it/it/content/pubblicato-il-nuovo-algoritmo-la-terapia-dell%E2%80%99epatite-c-cronica.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: http://www.agenziafarmaco.gov.it/sites/default/files/Aggiornamento_dati_Registri_AIFA_DAAs_   28.12.2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: http://www.iss.it/piter/?lang= 1&id= 163&tipo= 3.,OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: http://demo.istat.it/pop2015/index.html.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: http://careonline.it/wp-content/uploads/2015/12/Gardini_Care_6_2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: https://www.ars.toscana.it/files/pubblicazioni/V olumi/2015/carcere_2015_definitivo.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: http://www.agenziafarmaco.gov.it/it/content/lista-centri-autorizzati-alla-prescrizione-dei-farmaci-antivirali-   l%E2%80%99epatite-c-aggiornamento-.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available at: http://www.ispor.org/research_pdfs/49/pdffiles/PIN73.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
"Available from: http://webtv.camera.it/evento/8620.Accessed April 16, 2016.",Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: http://www.gazzettauf   ficiale.it/atto/serie_generale/caricaDettaglioAtto/originario?atto.dataPubblicazioneGazzetta= 2014-12-05&atto.codiceRedazionale= 14 A09382&elenco30giorni= false.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 385 Hepatitis C virus in Italy: scenarios and perspectives  28.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: http://www.gazzettaufficiale.it/eli/id/2015/05/13/15A03674/sg%20;jsessionid=DZfSl94qS9LREa1djBOfvQ__.ntc-as1-guri2b.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: http://www.imf.org/external/pubs/ft/weo/2015/02/weodata/index.aspx.,OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available at: https://www.simg.it/Documenti/Rivista/2009/04_2009/4.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: http://www.webaisf.org/media/4415/silla   bus2008.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: https://www.aiom.it/C_Common/Download.asp?file= /$Site$/files/doc/ lg/2015_lg_aiom_epatocarcinoma.pdf.,OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: http://www.webaisf.org/media/8065/documento_trapianto.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: http://www.trapianti.salute.gov.it/imgs/C_17_pubblicazioni_2316_allegato.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: http://www.gazzettaufficiale.biz/atti/2011/20110285/11A15734.htm.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: http://www.gazzettauf-ficiale.it/eli/id/2013/02/05/13A00836/sg.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
Available from: http://www.regione.calabria.it/sanita/allegati/deceti_2015/farmaci_del_pht_-12_aggiorna-mento_tabella_prezzi_-.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/42/ceor-8-377.PMC4982504.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4b/2a/ott-9-4887.PMC4982505.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4887–4899OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4887Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10159 4 high expression of S100A8  gene is associated  with drug resistance to etoposide and poor  prognosis in acute myeloid leukemia through  influencing the apoptosis pathway Xiao-yan Yang,1,* Ming-ying  Zhang,1,* Qi Zhou,1 shui-yan  Wu,1 Ye Zhao,2 Wei-ying gu,3  Jian Pan,1 Jian-nong cen,2  Zi-xing chen,2 Wen-ge guo,4  chien-shing chen,5 Wen-hua  Yan,6 shao-yan hu1 1Department of haematology and  Oncology, children’s hospital of soochow  University, 2Department of haematology,  The First affiliated hospital of soochow  University, suzhou, 3Department of  haematology, The Third affiliated hospital  of soochow University, changzhou,  People’s republic of china; 4Department  of Mathematical sciences, new Jersey  institute of T echnology, newark, nJ,  5Department of internal Medicine,  Division of hematology and Medical  Oncology and Biospecimen laboratory,  loma linda University, loma linda,  ca, Usa; 6Department of cardiology,  children’s hospital of soochow University,  suzhou, People’s republic of china *These authors contributed equally  to this workAbstract:  S100A8 has been increasingly recognized as a biomarker in multiple solid tumors  and has played pivotal roles in hematological malignancies.",Non-OADS,/arxiv_data1/oa_pdf/4b/2a/ott-9-4887.PMC4982505.pdf
"As a result, there is an accumulation of leukemic blasts,  resulting in variable myelosuppression manifested as pancytopenia.2 Clinically, a  combination of conventional karyotypic analysis plus reverse transcriptase poly - merase chain reaction (RT-PCR) or fluorescent in situ hybridization for specific  abnormalities can aid in the diagnosis, treatment, and posttreatment monitoring  of patients with AML.3 However, despite continuous improvements and refine - ment in laboratory tests, ~50% of AML patients have a normal or noninformative correspondence: shao-yan hu Department of haematology and  Oncology, children’s hospital of soochow  University, 92 Zhongnan street, suzhou  industry garden, suzhou 215025,  People’s republic of china Tel +86 512 6778 8409 Fax +86 512 6778 6206 email hsy139126@163.co m  Wen-hua Yan Department of cardiology, children’s  hospital of soochow University, 92  Zhongnan street, suzhou industry garden,  suzhou 215025, People’s republic of china Tel +86 512 6778 8203 Fax +86 512 6778 6206 email whyan328@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Y ang et al Running head recto: High expression of S100A8  gene in AML DOI: http://dx.doi.org/10.2147/OTT.S101594",Non-OADS,/arxiv_data1/oa_pdf/4b/2a/ott-9-4887.PMC4982505.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/4b/2a/ott-9-4887.PMC4982505.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/2a/ott-9-4887.PMC4982505.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/9f/b4/bctt-8-149.PMC4982506.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9f/b4/bctt-8-149.PMC4982506.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9f/b4/bctt-8-149.PMC4982506.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2016:8 149–155Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 149 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S105563 Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10,  and CYP3A5*3 in Thai breast cancer patients  undergoing tamoxifen treatment Wanaporn  Charoenchokthavee1 Duangchit Panomvana1 Virote Sriuranpong2 Nutthada Areepium1 1Department of Pharmacy Practice,   Faculty of Pharmaceutical Science,   2Medical Oncology Unit, Department  of Medicine, Faculty of Medicine,   Chulalongkorn University, Bangkok,  ThailandBackground: Tamoxifen (TAM) is used in breast cancer treatment, but interindividual vari- abilities in TAM-metabolizing enzymes exist and have been linked to single nucleotide poly- morphisms in the respective encoding genes.",Non-OADS,/arxiv_data1/oa_pdf/9f/b4/bctt-8-149.PMC4982506.pdf
"Despite the fact that TAM provides significant clinical benefit, interindividual variability in its metabolism and effectiveness has been linked to single Correspondence: Nutthada Areepium Department of Pharmacy Practice, Faculty of Pharmaceutical Science, Chulalongkorn University, 254 Phayathai Road, Pathumwan, Bangkok 10330, ThailandEmail Nutthada.a@pharm.chula.ac.thJournal name: Breast Cancer - Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Charoenchokthavee et alRunning head recto: CYP2D6 and CYP3A5 polymorphisms in Thai breast cancer patientsDOI: http://dx.doi.org/10.2147/BCTT.S105563",Non-OADS,/arxiv_data1/oa_pdf/9f/b4/bctt-8-149.PMC4982506.pdf
"Breast Cancer - Targets and Therapy 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/9f/b4/bctt-8-149.PMC4982506.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 155 CYP2D6 and CYP3A5 polymorphisms in Thai breast cancer patients 2.,Non-OADS,/arxiv_data1/oa_pdf/9f/b4/bctt-8-149.PMC4982506.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/51/ijn-11-3801.PMC4982507.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3801–3811International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3801OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10958 2 Using ferromagnetic nanoparticles with low curie  temperature for magnetic resonance imaging- guided thermoablation Vít herynek1 Karolína T urnovcová2 Pavel Veverka3 T ereza Dědourková4,5 Pavel Žvátora6 Pavla Jendelová2 andrea gálisová1 lucie Kosinová7 Klára Jiráková2 eva syková2 1Mr-Unit, radiodiagnostic and  Interventional radiology Department,   Institute for clinical and experimental  Medicine, Prague, 2Department  of Neuroscience, Institute of  experimental Medicine, 3Department  of Magnetics and superconductors,   Institute of Physics, czech academy  of sciences, Prague, 4Department  of Inorganic Technology, Faculty of  chemical Technology, University  of Pardubice, 5sYNPO, akciová  společnost, Pardubice, 6Department  of analytical chemistry, Institute  of chemical T echnology, 7Diabetes  center, Institute for clinical and  experimental Medicine, Prague,   czech republic Introduction:  Magnetic nanoparticles (NPs) represent a tool for use in magnetic resonance  imaging (MRI)-guided thermoablation of tumors using an external high-frequency (HF) mag - netic field.",Non-OADS,/arxiv_data1/oa_pdf/af/51/ijn-11-3801.PMC4982507.pdf
"The concept of the treatment is based on depositing magnetic NPs in the vicinity  of the tumor and their subsequent heating by an external alternating magnetic field.4–7correspondence: Vít herynek Mr-Unit, radiodiagnostic and  Interventional radiology Department,  Institute for clinical and experimental  Medicine, Vídeňská 1958/9,  14021 Prague 4, czech republic Tel +420 261 362 703 Fax +420 241 728 224 email vit.herynek@medicon.c z Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Herynek et al Running head recto: Ferromagnetic NPs for MRI-guided thermoablation DOI: http://dx.doi.org/10.2147/IJN.S109582",Non-OADS,/arxiv_data1/oa_pdf/af/51/ijn-11-3801.PMC4982507.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/af/51/ijn-11-3801.PMC4982507.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/51/ijn-11-3801.PMC4982507.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/aa/d9/ott-9-4867.PMC4982508.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4867–4878OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4867Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10692 6 Modulation of expression of the nuclear receptor  nr0B2 (small heterodimer partner 1) and its  impact on proliferation of renal carcinoma cells Katharina Prestin1,* Maria Olbert2,* Janine hussner1 Tamara l isenegger1 Daniel g gliesche1 Kerstin Böttcher2 Uwe Zimmermann3 henriette e Meyer zu  schwabedissen1 1Department of Pharmaceutical  sciences, Biopharmacy, University  of Basel, Basel, switzerland;   2center of Drug absorption and  Transport, institute of Pharmacology,   3Department of Urology,   University Medicine greifswald,   greifswald, germany *These authors contributed equally to  this workAbstract:  Mammalian nuclear receptors (NRs) are transcription factors regulating the expres ‑ sion of target genes that play an important role in drug metabolism, transport, and cellular  signaling pathways.",Non-OADS,/arxiv_data1/oa_pdf/aa/d9/ott-9-4867.PMC4982508.pdf
"However, when talking about NRs, one has  to consider an extraordinary member of this protein superfamily, which is the small correspondence: henriette e Meyer zu  schwabedissen Department of Pharmaceutical sciences,  Biopharmacy, University of Basel,  Klingelbergstrasse 50, ch-4056 Basel,  switzerland Tel +41 61 267 1495 Fax +41 61 267 1498 email h.meyerzuschwabedissen@unibas.c h Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Prestin et al Running head recto: Impact of NR0B2 on proliferation of renal carcinoma cells DOI: http://dx.doi.org/10.2147/OTT.S106926",Non-OADS,/arxiv_data1/oa_pdf/aa/d9/ott-9-4867.PMC4982508.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer ‑reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/aa/d9/ott-9-4867.PMC4982508.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/d9/ott-9-4867.PMC4982508.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ef/9a/ijn-11-3813.PMC4982511.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3813–3824International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3813OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10956 5 Improved skin permeation of methotrexate via  nanosized ultradeformable liposomes alam Zeb Omer salman Qureshi hyung-seo Kim Ji-hye cha hoo-seong Kim Jin-Ki Kim college of Pharmacy, Institute  of Pharmaceutical science and  T echnology, hanyang University,   ansan, gyeonggi, republic of KoreaAbstract:  The aim of this study is to investigate methotrexate-entrapped ultradeformable  liposomes (MTX-UDLs) for potential transdermal application.",Non-OADS,/arxiv_data1/oa_pdf/ef/9a/ijn-11-3813.PMC4982511.pdf
"Keywords:  ultradeformable liposomes, deformability, methotrexate, skin permeation,  transdermal delivery Introduction Transdermal drug delivery has been extensively studied for the past few decades as  an attractive and valuable alternative for oral and parenteral administration.1,2 The  major advantages of transdermal delivery are convenience, noninvasiveness, improved  patient compliance, avoidance of first-pass metabolism, avoiding some serious side  effects, and bypassing the variables affecting the drug absorption in the gastrointestinal  tract.3 Despite these obvious advantages of transdermal delivery, the number of drug  molecules administered via this route is quite limited due to the barrier function of  stratum corneum, the outermost layer of the epidermis of skin.4 Various approaches  including the use of permeation enhancers, microneedles, iontophoresis, electropora - tion, jet injection, and nanocarriers have been applied to increase drug penetration by  overcoming the barrier function of skin.5 Liposomes as nanosized carriers are promising transdermal drug delivery systems  since they are biocompatible and can carry both water-soluble and lipid-soluble drugs.6  Even though conventional liposomes (CLs), typically consisting of phospholipid and  cholesterol (CH), have been investigated, their effectiveness in delivering a therapeuti - cally significant amount of drug across skin is still a question mark.2 It was reported that  liposomes with lower elastic modulus and higher deformability could be driven deep  into the skin by hydration gradient when applied nonocclusively.7 Deformability was correspondence: Jin-Ki Kim college of Pharmacy, Institute  of Pharmaceutical science and  Technology, hanyang University,  55 hanyangdaehak-ro, sangnok-gu, ansan,  gyeonggi 426-791, republic of Korea Tel +82 31 400 5808 Fax +82 31 400 5958 email jinkikim@hanyang.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zeb et al Running head recto: Improved skin permeation of methotrexate via ultradeformable liposomes DOI: http://dx.doi.org/10.2147/IJN.S109565",Non-OADS,/arxiv_data1/oa_pdf/ef/9a/ijn-11-3813.PMC4982511.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ef/9a/ijn-11-3813.PMC4982511.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/9a/ijn-11-3813.PMC4982511.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/79/db/ijn-11-3731.PMC4982524.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3731–3736International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3731OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10628 9 Inhibition of E. coli and S. aureus  with selenium  nanoparticles synthesized by pulsed laser ablation  in deionized water g guisbiers1 Q Wang2 e Khachatryan1 lc Mimun1 r Mendoza-cruz1 P larese-casanova3 TJ Webster2,4,5 Kl Nash1 1Department of Physics and  astronomy, The University of  Texas at san antonio, san  antonio, TX, 2Department of  Bioengineering, 3Department of  civil and environmental engineering,   4Department of chemical engineering,   Northeastern University, Boston,   Ma, Usa; 5center of excellence  for advanced Materials research,   King abdulaziz University, Jeddah,   saudi arabiaAbstract:  Nosocomial diseases are mainly caused by two common pathogens, Escherichia  coli and Staphylococcus aureus , which are becoming more and more resistant to conventional  antibiotics.",Non-OADS,/arxiv_data1/oa_pdf/79/db/ijn-11-3731.PMC4982524.pdf
"Pulsed laser  ablation in liquids (PLAL) has several advantages compared to the other conventional  methods such as wet chemistry routes, physical vapor deposition, or chemical vapor  deposition to synthesize selenium.11 Indeed, the surface of the synthesized nanopar - ticles is absent of unnecessary adducts and byproducts, and the produced nanoparticles correspondence: grégory guisbiers Department of Physics and astronomy,  The University of Texas at san antonio,  One UTsa circle, san antonio,  TX 78249, Usa Tel +1 210 458 8672 email gregory.guisbiers@physics.or gJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Guisbiers et al Running head recto: Inhibition of E. coli and S. aureus  with selenium nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S106289",Non-OADS,/arxiv_data1/oa_pdf/79/db/ijn-11-3731.PMC4982524.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/79/db/ijn-11-3731.PMC4982524.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/79/db/ijn-11-3731.PMC4982524.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/88/ehw172.PMC4982535.pdf
"http://www.thl.ﬁ/publications/morgam/ manual/contents.htm (July 28, 2015) .",Non-OADS,/arxiv_data1/oa_pdf/f9/88/ehw172.PMC4982535.pdf
"(30–32)According to the Catalogue of Somatic Muta- tions in Cancer (COSMIC) database (http://cancer.sanger.a- c.uk/cancergenome/projects/cosmic/), these cell lines carryuncommon EGFR mutations (KYSE270, L861Q and KYSE450, S768I, respectively).",Non-OADS,/arxiv_data1/oa_pdf/b1/02/CAS-107-1134.PMC4982590.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/8/e1600782/DC1Supplementary Materials and Methodstable S1.,Non-OADS,/arxiv_data1/oa_pdf/99/66/1600782.PMC4982707.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/8/e1600901/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/e2/ee/1600901.PMC4982708.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/8/e1600920/DC1 table S1.,Non-OADS,/arxiv_data1/oa_pdf/bb/b9/1600920.PMC4982709.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/8/e1600323/DC1Supplementary Materials and Methods table S1.,Non-OADS,/arxiv_data1/oa_pdf/85/e5/1600323.PMC4982710.pdf
"SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/8/e1600027/DC1Fabrication process of a rolled-up 3D QWIP deviceBlackbody photocurrent testAtmospheric absorption and photocurrent response of a 3D rolled-up tubular QWIP deviceBlackbody responsivity, spectral responsivity, and quantum efficiency Planar QWIP device with a 45° edge facet Epitaxial structure of the sample with an absorbing peak l p≈3.6mm Numerical simulations based on finite element methodDiameter variation in rolled-up tubular QWIPsCurvature-induced strainsfig.",Non-OADS,/arxiv_data1/oa_pdf/2f/f2/1600027.PMC4982750.pdf
Available at: http://www.acr.org/Quality-Safety/Resources/Contrast-Manual.,Non-OADS,/arxiv_data1/oa_pdf/3b/7e/rli-51-537.PMC4982758.pdf
Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108919.htm.,Non-OADS,/arxiv_data1/oa_pdf/3b/7e/rli-51-537.PMC4982758.pdf
"Key Words: C-reactive protein ◼ cholesterol efflux ◼ dalcetrapib ◼ HDL ◼ pharmacogenetics Circ Cardiovasc Genet is available at http://circgenetics.ahajournals.org DOI: 10.1161/CIRCGENETICS.116.001405Received February 12, 2016; accepted June 23, 2016.",Non-OADS,/arxiv_data1/oa_pdf/28/3b/hcg-9-340.PMC4982759.pdf
"The Data Supplement is available at http://circgenetics.ahajournals.org/lookup/suppl/doi:10.1161/CIRCGENETICS.116.001405/-/DC1.Correspondence to Jean-Claude Tardif, MD, Montreal Heart Institute, 5000 Belanger St, Montreal, H1T 1C8, Canada.",Non-OADS,/arxiv_data1/oa_pdf/28/3b/hcg-9-340.PMC4982759.pdf
2016;6(2):1-3.   http://dx.doi.org/10.4322/acr.2016.036 One should not try to guess what the future holds  without considering the past.,Non-OADS,/arxiv_data1/oa_pdf/a0/a9/autopsy-06-02001.PMC4982777.pdf
2016;6(2):5-7. http://dx.doi.org/10.4322/acr.2016.030Image in Focus Image courtesy Dr. Vera Demarchi Aiello Figure.,Non-OADS,/arxiv_data1/oa_pdf/31/66/autopsy-06-02005.PMC4982778.pdf
1996 ;77(1):107. http://dx.doi.org/10.1016/ S0002-9149(97)89149-7 .,Non-OADS,/arxiv_data1/oa_pdf/31/66/autopsy-06-02005.PMC4982778.pdf
1980 ;191 (2):127 -38. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/31/66/autopsy-06-02005.PMC4982778.pdf
1963 ;1(7279 ):464-8. http://dx.doi.org/10.1016/S0140- 6736(63)92359-6 .,Non-OADS,/arxiv_data1/oa_pdf/31/66/autopsy-06-02005.PMC4982778.pdf
2008 ;109(2):318-20. http://dx.doi.org/10.3171/ JNS/2008/109/8/0318 .,Non-OADS,/arxiv_data1/oa_pdf/31/66/autopsy-06-02005.PMC4982778.pdf
2003 ;163(6):2407 -12. http://dx.doi.org/10.1016/S0002- 9440(10)63595-X .,OADS,/arxiv_data1/oa_pdf/31/66/autopsy-06-02005.PMC4982778.pdf
1994 ;9(1):68-71. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/31/66/autopsy-06-02005.PMC4982778.pdf
1996 ;17(4):271- 81. http://dx.doi.org/10.1097/00000433-199612000- 00001 .,Non-OADS,/arxiv_data1/oa_pdf/31/66/autopsy-06-02005.PMC4982778.pdf
2006 ;82(4):1510 -2. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/31/66/autopsy-06-02005.PMC4982778.pdf
2016 (2016 ):1- 3. http://dx.doi.org/10.1155/2016/3545480 .,Non-OADS,/arxiv_data1/oa_pdf/31/66/autopsy-06-02005.PMC4982778.pdf
1998 ;66(1):285-8. http://dx.doi.org/10.1016/S0003- 4975(98)00481-0 .,OADS,/arxiv_data1/oa_pdf/31/66/autopsy-06-02005.PMC4982778.pdf
2016;6(2):9-18. http://dx.doi.org/10.4322/acr.2016.035 ABSTRACT Amyloidosis comprises a group of diseases that occurs in five to nine cases per million patients per year worldwide irrespective  of its classification.,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
1980 ;302(23):1283 -92. http://dx.doi.org/10.1056/ NEJM198006053022305 .,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
2014 ;7(1):143-56. http://dx.doi.org/10.1586/1 7474086.2014.858594 .,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
http://dx.doi.org/10.1016/S0889-8588(05)70122-2 .,OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
2012 ;65:541-64. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
2003 ;82(5):291-8. http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
1998 ;42(5):727-34. http://dx.doi.org/10.1136/ gut.42.5.727 .,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
2008 ;103(3):776-87.  http://dx.doi.org/10.1111/j.1572-0241.2007.01669.x .,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
2009 ;94(7):1029 -32. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
2003 ;82(5):291-8. http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
1988 ;85(1):73-80. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
1991 ;22(9):904-7. http://dx.doi.org/10.1016/0046- 8177(91)90180-W .,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
1962 ;33(3):349-57.  http://dx.doi.org/10.1016/0002-9343(62)90231-0 .,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
1991 ;32(2):227-30. http://dx.doi.org/10.1136/ gut.32.2.227 .,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
1974 ;10(1):40-51. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
2009 ;24(10):3132 -7.  http://dx.doi.org/10.1093/ndt/gfp201 .,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
2011 ;97(1):75-84. http://dx.doi.org/10.1136/ hrt.2009.190405 .,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
2009 ;23(1):3-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
2014 ;15(12):e538 -48. http://dx.doi.org/10.1016/S1470- 2045(14)70442-5 .,OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
http://dx.doi.org/10.1182/ blood-2011-01-293050 .,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
2009 ;55(3):499-504.  http://dx.doi.org/10.1373/clinchem.2008.117143 .,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
1995 ;26(2):267-85. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/c0/autopsy-06-02009.PMC4982779.pdf
2016;6(2):19-25. http://dx.doi.org/10.4322/acr.2016.037 ABSTRACT The incidence of severe complications of the Neisseria gonorrhoeae  infection has presented variations over recent decades  since the advent of penicillin.,Non-OADS,/arxiv_data1/oa_pdf/6f/53/autopsy-06-02019.PMC4982780.pdf
2012 ;366(6):485-7. http://dx.doi.org/10.1056/ NEJMp1112456 .,Non-OADS,/arxiv_data1/oa_pdf/6f/53/autopsy-06-02019.PMC4982780.pdf
1971 ;74(6):979- 93. http://dx.doi.org/10.7326/0003-4819-74-6-979 .,Non-OADS,/arxiv_data1/oa_pdf/6f/53/autopsy-06-02019.PMC4982780.pdf
1933 ;8(6):821-33. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6f/53/autopsy-06-02019.PMC4982780.pdf
1991 ;301(3):221- 30. http://dx.doi.org/10.1097/00000441-199103000- 00012 .,Non-OADS,/arxiv_data1/oa_pdf/6f/53/autopsy-06-02019.PMC4982780.pdf
1938 ;61(1):26-38. http://dx.doi.org/10.1001/ archinte.1938.00180070031003 .,Non-OADS,/arxiv_data1/oa_pdf/6f/53/autopsy-06-02019.PMC4982780.pdf
2014 ;33(1):23- 7. http://dx.doi.org/10.1007/s10096-013-1921-x .,Non-OADS,/arxiv_data1/oa_pdf/6f/53/autopsy-06-02019.PMC4982780.pdf
Available from: http://www.who.int/reproductivehealth/ news/stis-estimates-2015/en/ 15.,Non-OADS,/arxiv_data1/oa_pdf/6f/53/autopsy-06-02019.PMC4982780.pdf
2014 ;42(2):425-8. http://dx.doi.org/10.1007/ s15010-013-0541-9 .,Non-OADS,/arxiv_data1/oa_pdf/6f/53/autopsy-06-02019.PMC4982780.pdf
1985;312(26):1683 -94. http://dx.doi.org/10.1056/ NEJM198506273122606 .,Non-OADS,/arxiv_data1/oa_pdf/6f/53/autopsy-06-02019.PMC4982780.pdf
2016;6(2):27-31. http://dx.doi.org/10.4322/acr.2016.034 ABSTRACT Raoultella planticola  is an aerobic Gram-negative bacterium belonging to the Enterobacteriaceae family.,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
1981 ;6(2):105-9. http://dx.doi.org/10.1007/BF01569013 .,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2001 ;51(Pt 3):925-32. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
1991 ;274(4):456-64. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2006 ;44(10):3640 -6. http://dx.doi.org/10.1128/ JCM.00940-06 .,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2015 ;43(6):771- 5. http://dx.doi.org/10.1007/s15010-015-0788-4 .,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
1984 ;1(8382 ):909. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2014 ;42(6):1043 -6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2013 ;19(5):E236 -7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2009 ;47(12):4129 -30. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2012 ;61(Pt 10 ):1488 -9.  http://dx.doi.org/10.1099/jmm.0.041129-0 .,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2015 ;144(5):230-4. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2015 ;43(2):245-8. http://dx.doi.org/10.1007/s15010- 015-0722-9 .,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2014 ;107(11):911-3. http://dx.doi.org/10.1093/qjmed/ hcu087 .,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2012 ;44(3):210-2.  http://dx.doi.org/10.3947/ic.2012.44.3.210 .,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2013 ;41(1):259-61. http://dx.doi.org/10.1007/s15010- 012-0294-x .,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2014 ;16(3):461- 4. http://dx.doi.org/10.1111/tid.12213 .,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2010 ;19(8):329-32. http://dx.doi.org/10.12968/ jowc.2010.19.8.77710 .,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2012 ;12(1):59. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2014 ;42(5):927-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
2014 ;58(1):593-5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
http://dx.doi.org/10.1099/ jmmcr0.000265 .,Non-OADS,/arxiv_data1/oa_pdf/68/d8/autopsy-06-02027.PMC4982781.pdf
"2016;6(2):33-38. http://dx.doi.org/10.4322/acr.2016.038 ABSTRACT First described in 1985, intermediate cell histiocytosis is a rare disorder of the cutaneous dendritic cell group with a varied  clinical presentation and evolution.",Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
2009 ;60(1):2-20. http://dx.doi.org/10.1111/j.1600- 0536.2008.01443.x .,Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
http://dx.doi.org/10.4081/ rt.2013.e13 .,Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
2007 ;156(6):1357 -61. http://dx.doi.org/10.1111/j.1365- 2133.2007.07880.x .,Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
1986 ;15(4 Pt 1 ):591- 7. http://dx.doi.org/10.1016/S0190-9622(86)70209-0 .,Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
1988 ;124(8):1250 -3. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
1993 ;92(6):2587 -96.  http://dx.doi.org/10.1172/JCI116873 .,Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
1996 ;17(6):273-8.  http://dx.doi.org/10.1016/0167-5699(96)80544-5 .,Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
2005 ;32(8):552-60. http://dx.doi.org/10.1111/ j.0303-6987.2005.00382.x .,Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
Autopsy and Case Reports  2016;6(2):33-38Indeterminate cell histiocytosis successfully treated with phototherapy 3853. http://dx.doi.org/10.1097/00000372-198802000- 00006 .,Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
2008 ;32(12):1868 -76. http://dx.doi.org/10.1097/ PAS.0b013e31818593d6 .,Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
1999 ;32(4):250-4. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
2001 ;20(7):769- 71. http://dx.doi.org/10.1097/00003226-200110000- 00021 .,Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
2011 ;43(4):372-5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
2012 ;18(2):535-8. http://dx.doi.org/10.1007/s12253- 011-9405-8 .,Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
2011 ;28(5):524- 7. http://dx.doi.org/10.1111/j.1525-1470.2011.01305.x .,Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
2008 ;33(3):301-4.  http://dx.doi.org/10.1111/j.1365-2230.2007.02667.x .,Non-OADS,/arxiv_data1/oa_pdf/5a/21/autopsy-06-02033.PMC4982782.pdf
"2016;6(2):39-43. http://dx.doi.org/10.4322/acr.2016.029 ABSTRACT Mucinous cystadenoma (MC) of the ovary is an unilateral, multilocular cystic benign epithelial tumor.",Non-OADS,/arxiv_data1/oa_pdf/6e/e0/autopsy-06-02039.PMC4982783.pdf
2006 ;61(7):463-70.  http://dx.doi.org/10.1097/01.ogx.0000224614.51356.b7 .,Non-OADS,/arxiv_data1/oa_pdf/6e/e0/autopsy-06-02039.PMC4982783.pdf
2000 ;26(2):89-93.  http://dx.doi.org/10.1111/j.1447-0756.2000.tb01289.x .,Non-OADS,/arxiv_data1/oa_pdf/6e/e0/autopsy-06-02039.PMC4982783.pdf
http://dx.doi.org/10.1067/S0002- 9378(03)00731-2 .,Non-OADS,/arxiv_data1/oa_pdf/6e/e0/autopsy-06-02039.PMC4982783.pdf
2002 ;28(2):104-7. http://dx.doi.org/10.1046/ j.1341-8076.2002.00020.x .,Non-OADS,/arxiv_data1/oa_pdf/6e/e0/autopsy-06-02039.PMC4982783.pdf
2011 ;37(7):893-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6e/e0/autopsy-06-02039.PMC4982783.pdf
2007 ;33(3):384-7. http://dx.doi.org/10.1111/j.1447-0756.2007.00542.x .,Non-OADS,/arxiv_data1/oa_pdf/6e/e0/autopsy-06-02039.PMC4982783.pdf
1973 ;28(9):597-622. http://dx.doi.org/10.1097/00006254- 197309000-00001 .,Non-OADS,/arxiv_data1/oa_pdf/6e/e0/autopsy-06-02039.PMC4982783.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6e/e0/autopsy-06-02039.PMC4982783.pdf
2008 ;34(4):524-8. http://dx.doi.org/10.1111/j.1447- 0756.2008.00744.x .,Non-OADS,/arxiv_data1/oa_pdf/6e/e0/autopsy-06-02039.PMC4982783.pdf
2004 ;85(3):250-4. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6e/e0/autopsy-06-02039.PMC4982783.pdf
"2016;6(2):45-49. http://dx.doi.org/10.4322/acr.2016.033 ABSTRACT The Epstein-Barr virus (EBV) is associated with a broad spectrum of diseases, mainly because of its genomic characteristics,  which result in different latency patterns in immune cells and infective mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
2016 ;1(01):189-97. http://dx.doi.org/10.1017/ S0950268815000850 .,Non-OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
2012 ;30(7):359-60. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
2007 ;20(3):272-7. http://dx.doi.org/10.1097/ QCO.0b013e3280ad4672 .,Non-OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
2014 ;86(9):1522 -7. http://dx.doi.org/10.1002/ jmv.23953 .,Non-OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
2011 ;83(12):2172 -81. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
2013 ;85(3):554-62. http://dx.doi.org/10.1002/ jmv.23470 .,Non-OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
2003 ;42(1):33-40. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
2012 ;15(4):303-6. http://dx.doi.org/10.4103/0972- 2327.104342 .,Non-OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
2012 ;87(4):622-4.  http://dx.doi.org/10.1590/S0365-05962012000400018 .,Non-OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
2015 ;26(1):72- 3. http://dx.doi.org/10.1177/0956462414541241 .,Non-OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
2007 ;195(4):469-70. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
1998 ;74(4):296-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
2013 ;19(2):166-71. http://dx.doi.org/10.1007/s13365- 013-0158-x .,Non-OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
2011 ;22(6):306-7. http://dx.doi.org/10.1258/ ijsa.2010.010405 .,Non-OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
2009 ;8(2):192-204. http://dx.doi.org/10.1016/S1474- 4422(09)70015-8 .,Non-OADS,/arxiv_data1/oa_pdf/fe/39/autopsy-06-02045.PMC4982784.pdf
2016;6(2):51-54. http://dx.doi.org/10.4322/acr.2016.031 ABSTRACT Epidermoid cysts are malformations that are rarely observed in the submental region.,Non-OADS,/arxiv_data1/oa_pdf/ba/53/autopsy-06-02051.PMC4982785.pdf
2002 ;13(2):308-10.  http://dx.doi.org/10.1097/00001665-200203000-00024 .,Non-OADS,/arxiv_data1/oa_pdf/ba/53/autopsy-06-02051.PMC4982785.pdf
2003 ;30(Suppl ):S137 -9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ba/53/autopsy-06-02051.PMC4982785.pdf
1993 ;51(7):790-2. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ba/53/autopsy-06-02051.PMC4982785.pdf
2003 ;3:156-62. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ba/53/autopsy-06-02051.PMC4982785.pdf
2003 ;36(1):35-40. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ba/53/autopsy-06-02051.PMC4982785.pdf
2012 ;3(2):211- 3. http://dx.doi.org/10.4103/0975-5950.111386 .,Non-OADS,/arxiv_data1/oa_pdf/ba/53/autopsy-06-02051.PMC4982785.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ba/53/autopsy-06-02051.PMC4982785.pdf
2016;6(2):55-58. http://dx.doi.org/10.4322/acr.2016.032 Abstract The authors report the case of a 66-year-old male patient diagnosed with a pseudoaneurysm of the distal aorto-aortic  anastomosis treated with the inner tubing technique.,Non-OADS,/arxiv_data1/oa_pdf/d0/74/autopsy-06-02055.PMC4982786.pdf
2005 ;365(9470 ):1577 -89.  http://dx.doi.org/10.1016/S0140-6736(05)66459-8 .,Non-OADS,/arxiv_data1/oa_pdf/d0/74/autopsy-06-02055.PMC4982786.pdf
2012 ;45(1):1-6. http://dx.doi.org/10.1590/S0100- 39842012000100003 .,Non-OADS,/arxiv_data1/oa_pdf/d0/74/autopsy-06-02055.PMC4982786.pdf
2014 ;22(4):386-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/74/autopsy-06-02055.PMC4982786.pdf
2009 ;8(3):255-8. http://dx.doi.org/10.1590/S1677- 54492009005000013 .,Non-OADS,/arxiv_data1/oa_pdf/d0/74/autopsy-06-02055.PMC4982786.pdf
Clinical commissioning policy: disease mod- ifying therapies for patients with multiple sclerosis [online].Available at: http://www.england.nhs.uk/wp-content/uploads/2013/10/d04-p-b.pdf.,Non-OADS,/arxiv_data1/oa_pdf/68/b7/NEURIMMINFL2015007484.PMC4982853.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b8/04/40263_2016_Article_345.PMC4982888.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/bb/6a/40264_2016_Article_426.PMC4982890.pdf
Silver Spring: Center for Devices and Radi-ologic Health; 2015. http://www.fda.gov/downloads/medicald evices/deviceregulationandguidance/guidancedocuments/ucm446680.,Non-OADS,/arxiv_data1/oa_pdf/bb/6a/40264_2016_Article_426.PMC4982890.pdf
London: EMA; 2015. http://www.ema.europa.eu/docs/en_ GB/document_library/Regulatory_and_procedural_guideline/2015/11/WC500196981.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bb/6a/40264_2016_Article_426.PMC4982890.pdf
Silver Spring: CDER;2012. http://www.fda.gov/downloads/drugs/guidancecompliance regulatoryinformation/guidances/ucm331810.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bb/6a/40264_2016_Article_426.PMC4982890.pdf
A search of PubMed ( http://www.ncbi.nlm.nih.gov/pubmed/ ) for ‘ﬁsh oil cardiovascular disease’ in January 2016 retrieved 4585 reports788 B. Lands,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
Chronic disease overview 2015. http://www.cdc.gov/chronicdisease/overview/ .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
2013. http://www.nhlbi.nih.gov/about/factpdf.htm .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3791615/pdf/nihms-508996.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC4083508/pdf/nihms278789.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
2015;2015:285135. http://www.hindawi.com/journals/bmri/2015/285135/ .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
http://www.scirp.org/journal/ PaperInformatio n.aspx?PaperID= 62148 .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
2015. http://www.fda.gov/ Drugs/DrugSafety/ucm451800.htm .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
http://www.fatsoﬂife.com/wp- content/uploads/2015/08/PUFA0815.pdfLands2015 .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
2012. http://www.cdc.gov/ nutritionreport/report.html .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
http://www.jbc.org/content/282/31/ 22254.full.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3533819/pdf/1743-7075-9-46.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC2665692/pdf/nihms89899.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3085271/pdf/nihms252820.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC432905/pdf/pnas00051-0164.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
http://www.jbc.org/content/255/13/6253.,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
http://ajcn.nutrition.org/content/ 83/6/S1483.full.pdf ?html.,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
http://efaeducation.org/?p=124 .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
http://efaeducation.org/omega-3-6-apps/ .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
http://omega3scores.com/ .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3850757/pdf/nihms514426.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
doi: 10.1136/bmj.e8707 .http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/e1/65/40264_2016_Article_438.PMC4982891.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/0c/e3/40264_2016_Article_433.PMC4982893.pdf
2012. http://www.meddra.org/sites/default/ﬁles/guidance/ﬁle/ intguide_15_1_English_0.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0c/e3/40264_2016_Article_433.PMC4982893.pdf
http://support.sas.com/documentation/cdl/en/lrdict/64316/HTML/ default/viewer.htm#a002206133.htm .,OADS,/arxiv_data1/oa_pdf/0c/e3/40264_2016_Article_433.PMC4982893.pdf
20 Jul 2000. http://www.ich.org/ﬁleadmin/Public_ Web_Site/ICH_Products/Guidelines/Efﬁcacy/E11/Step4/E11_ Guideline.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0c/e3/40264_2016_Article_433.PMC4982893.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Resting stateGray matterPeripheral lesionFunctional connectivityHorizontal connections Correlation decay 1.,Non-OADS,/arxiv_data1/oa_pdf/12/20/main.PMC4982914.pdf
http://dx.doi.org/10.1016/j.nicl.2016.07.008 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/12/20/main.PMC4982914.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/20/main.PMC4982914.pdf
A) Pictorial representation of the human body map in the right M1 (obtained from http://www.grandesimagenes.com/homunculo/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/20/main.PMC4982914.pdf
http://dx.doi.org/10.2307/2346101 .,Non-OADS,/arxiv_data1/oa_pdf/12/20/main.PMC4982914.pdf
http://dx.doi.org/10.1016/j.jhsa.2014.10.033 .,OADS,/arxiv_data1/oa_pdf/12/20/main.PMC4982914.pdf
Taylor & Francis URL http://books.google.com/books?id=EFbbcMFZ2mMC .,Non-OADS,/arxiv_data1/oa_pdf/12/20/main.PMC4982914.pdf
"Wiley, Chichester, West Sussex, U.K. URL http://isbnplus.org/ 9780470699584 .",Non-OADS,/arxiv_data1/oa_pdf/12/20/main.PMC4982914.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/f4/main.PMC4982915.pdf
"While induction chemotherapy resulted in clearance of the peripheral lymphoblasts, a post-induction bone marrow evalua- tion showed only a partial response with 15% residualContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2016.07.002 2213-0489/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/49/f4/main.PMC4982915.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/f4/main.PMC4982915.pdf
Molecular Genetics and Metabolism Reports 2016.DOI: doi: http://dx.doi.org/ 10.1016/j.ymgmr.2016.07.008 .,OADS,/arxiv_data1/oa_pdf/57/19/main.PMC4982918.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.08.003 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/57/19/main.PMC4982918.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/19/main.PMC4982918.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Soft drink intakeSugar sweetened beveragesNeighbourhood deprivationNeighbourhood socioeconomic statusObesogenic environment Monitoring of health related behaviours 1.,Non-OADS,/arxiv_data1/oa_pdf/8d/d0/main.PMC4982919.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.08.0052211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/d0/main.PMC4982919.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/d0/main.PMC4982919.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/8d/d0/main.PMC4982919.pdf
"2015; Available at: http://www.statbank.dk/FIKS44 ,2 0 1 6 .",Non-OADS,/arxiv_data1/oa_pdf/8d/d0/main.PMC4982919.pdf
"2015; Available at: http://www.statistikbanken.dk/ statbank5a/SelectVarVal/De ﬁne.asp?Maintable=FU51&PLanguage=1 ,2 0 1 5 .",OADS,/arxiv_data1/oa_pdf/8d/d0/main.PMC4982919.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/43/main.PMC4982920.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.08.002 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/43/main.PMC4982920.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 83 e85,Non-OADS,/arxiv_data1/oa_pdf/3b/43/main.PMC4982920.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d2/8c/main.PMC4982921.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.05.004 310,OADS,/arxiv_data1/oa_pdf/d2/8c/main.PMC4982921.pdf
Susceptibility testing was performed according to the recommendations of the Eu-ropean Committee on Antimicrobial Susceptibility Testing (http://www.eucast.org ).,Non-OADS,/arxiv_data1/oa_pdf/81/f4/main.PMC4982923.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.07.004,Non-OADS,/arxiv_data1/oa_pdf/81/f4/main.PMC4982923.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,8 7–88 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/81/f4/main.PMC4982923.pdf
"Biophysical Journal 111, 619–629, August 9, 2016 619http://dx.doi.org/10.1016/j.bpj.2016.06.029 /C2112016 Biophysical Society.",Non-OADS,/arxiv_data1/oa_pdf/ad/0a/main.PMC4982927.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncom-mercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF PALLIATIVE MEDICINE Volume 19, Number 8, 2016Mary Ann Liebert, Inc.DOI: 10.1089/jpm.2015.0344 874",Non-OADS,/arxiv_data1/oa_pdf/42/84/jpm.2015.0344.PMC4982948.pdf
"Stem Cell Reports Report Gene Correction of iPSCs from a Wiskott-Aldrich Syndrome Patient Normalizes the Lymphoid Developmental and Functional Defects Tamara J. Laskowski,1,8Yasmine Van Caeneghem,2,8Rasoul Pourebrahim,1Chao Ma,3Zhenya Ni,3 Zita Garate,1,4,5Ana M. Crane,1Xuan Shirley Li,1Wei Liao,1Manuel Gonzalez-Garay,6Jose Carlos Segovia,4,5 David E. Paschon,7Edward J. Rebar,7Michael C. Holmes,7Dan Kaufman,3,9Bart Vandekerckhove,2 and Brian R. Davis1,* 1Center for Stem Cell and Regenerative Medicine, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houst on, TX 77030, USA 2Laboratory for Experimental Immunology, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent 9000, Belgium 3Department of Medicine and Stem Cell Institute, University of Minnesota, Minneapolis, MN 55455, USA 4Differentiation and Cytometry Unit, Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energe ´ticas, Medioambientales y Tecnolo ´gicas (CIEMAT) - Centro de Investigaciones Biome ´dicas en Red de Enfermedades Raras (CIBERER), Madrid 28040, Spain 5Advanced Therapies Mixed Unit, Instituto de Investigacio ´n Sanitaria-Fundacio ´n Jime ´nez Dı ´az (IIS-FJD, UAM), Madrid 28040, Spain 6Center for Molecular Imaging, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX 77030, USA 7Sangamo BioSciences Inc, Richmond, CA 94804, USA 8Co-ﬁrst author 9Present address: Department of Medicine, University of California, San Diego, CA 92161, USA *Correspondence: brian.r.davis@uth.tmc.edu http://dx.doi.org/10.1016/j.stemcr.2016.06.003 SUMMARY Wiskott-Aldrich syndrome (WAS) is an X-linked primary immunodeﬁciency disease caused by mutations in the gene encoding the WAS protein (WASp).",Non-OADS,/arxiv_data1/oa_pdf/11/2e/main.PMC4982969.pdf
139 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/2e/main.PMC4982969.pdf
ACCESSION NUMBERS The accession number for the exome sequencing data reported inthis paper is SRP074068 ( http://www.ncbi.nlm.nih.gov/Traces/ sra/).,Non-OADS,/arxiv_data1/oa_pdf/11/2e/main.PMC4982969.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and three tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/11/2e/main.PMC4982969.pdf
"Stem Cell Reports Report Development of Gonadotropin-Releasing Hormone-Secreting Neurons from Human Pluripotent Stem Cells Carina Lund,1Kristiina Pulli,1Venkatram Yellapragada,1Paolo Giacobini,3,4Karolina Lundin,5 Sanna Vuoristo,1Timo Tuuri,5Parinya Noisa,6,7,8and Taneli Raivio1,2,7,8,* 1Faculty of Medicine, Department of Physiology, University of Helsinki, Helsinki 00014, Finland 2Children’s Hospital, Pediatric Research Center, Helsinki University Central Hospital (HUCH), Helsinki 00029, Finland 3Inserm, Jean-Pierre Aubert Research Center, Development and Plasticity of the Neuroendocrine Brain, Unite ´1172, 59045 Lille Cedex, France 4School of Medicine, University of Lille, Lille 59000, France 5Department of Obstetrics and Gynecology, HUCH, Helsinki 00029, Finland 6School of Biotechnology, Institute of Agricultural Technology, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand 7Faculty of Medicine/Physiology, University of Helsinki, Biomedicum Helsinki, PO Box 63 (Haartmaninkatu 8), Helsinki 00014, Finland 8Co-senior author *Correspondence: taneli.raivio@helsinki.ﬁ http://dx.doi.org/10.1016/j.stemcr.2016.06.007 SUMMARY Gonadotropin-releasing hormone (GnRH) neurons regulate human puberty and reproduction.",Non-OADS,/arxiv_data1/oa_pdf/76/65/main.PMC4982984.pdf
149 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/65/main.PMC4982984.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, three ﬁgures, and two tables and can be found with thisarticle online at http://dx.doi.org/10.1016/j.stemcr.2016.06.007 .",OADS,/arxiv_data1/oa_pdf/76/65/main.PMC4982984.pdf
"Stem Cell Reports Article Reciprocal Regulation between Bifunctional miR-9/9*and its T ranscriptional Modulator Notch in Human Neural Stem Cell Self-Renewal andDifferentiation Beate Roese-Koerner,1,4Laura Stappert,1,4Thomas Berger,1Nils Christian Braun,1Monika Veltel,1 Johannes Jungverdorben,1,2Bernd O. Evert,3Michael Peitz,1,2Lodovica Borghese,1and Oliver Bru ¨stle1,2,* 1Institute of Reconstructive Neurobiology, LIFE & BRAIN Center, University of Bonn, 53127 Bonn, Germany 2DZNE, German Center for Neurodegenerative Diseases, 53127 Bonn, Germany 3Department of Neurology, University of Bonn, 53127 Bonn, Germany 4Co-ﬁrst author *Correspondence: brustle@uni-bonn.de http://dx.doi.org/10.1016/j.stemcr.2016.06.008 SUMMARY Tight regulation of the balance between self-renewal and differentiation of neural stem cells is crucial to assure proper neural develop- ment.",OADS,/arxiv_data1/oa_pdf/70/6e/main.PMC4982985.pdf
207 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/6e/main.PMC4982985.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimen-tal Procedures, four ﬁgures and four tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",Non-OADS,/arxiv_data1/oa_pdf/70/6e/main.PMC4982985.pdf
"Stem Cell Reports Article MiR-34a Promotes Osteogenic Differentiation of Human Adipose-Derived Stem Cells via the RBP2 /NOTCH1 /CYCLIN D1 Coregulatory Network Cong Fan,1,4,5Lingfei Jia,2,3,4,5Yunfei Zheng,2,4Chanyuan Jin,1,4Yunsong Liu,1,4Hao Liu,3,4 and Yongsheng Zhou1,4,* 1Department of Prosthodontics 2Department of Oral and Maxillofacial Surgery 3Central Laboratory 4National Engineering Lab for Digital and Material Technology of Stomatology, Beijing Key Laboratory of Digital Stomatology Peking University School and Hospital of Stomatology, Beijing 100081, China 5Co-ﬁrst author *Correspondence: kqzhouysh@hsc.pku.edu.cn http://dx.doi.org/10.1016/j.stemcr.2016.06.010 SUMMARY MiR-34a was demonstrated to be upregulated during the osteogenic differentiation of human adipose-derived stem cells (hASCs).",OADS,/arxiv_data1/oa_pdf/9e/ad/main.PMC4982986.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/ad/main.PMC4982986.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁve ﬁgures and one table and can be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2016.06.010 .,Non-OADS,/arxiv_data1/oa_pdf/9e/ad/main.PMC4982986.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.06.009 SUMMARY Bone marrow niches for hematopoietic progenitor cells are not well deﬁned despite their critical role in blood homeostasis.,Non-OADS,/arxiv_data1/oa_pdf/b9/1a/main.PMC4982987.pdf
"7 j220–235 jAugust 9, 2016 jª2016 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/b9/1a/main.PMC4982987.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes seven ﬁgures and two tablesand can be found with this article online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b9/1a/main.PMC4982987.pdf
"Stem Cell Reports Resource Murine iPSC-Derived Macrophages as a T ool for Disease Modeling of Hereditary Pulmonary Alveolar Proteinosis due to Csf2rb Deﬁciency Adele Mucci,1,2,3Jessica Kunkiel,1,3Takuji Suzuki,4Sebastian Brennig,1,2,3Silke Glage,5Mark P. Ku ¨hnel,6 Mania Ackermann,1,2,3Christine Happle,7,8Alexandra Kuhn,1,3Axel Schambach,3,9Bruce C. Trapnell,4 Gesine Hansen,7,8Thomas Moritz,1,3,10and Nico Lachmann2,3,10,* 1Research Group Reprogramming and Gene Therapy, Cluster of Excellence REBIRTH, Hannover Medical School, 30625 Hannover, Germany 2Junior Research Group Translational Hematology of Congenital Diseases, Cluster of Excellence REBIRTH, Hannover Medical School, Carl-Neuberg-St reet 1, 30625 Hannover, Germany 3Institute of Experimental Hematology, Hannover Medical School, 30625 Hannover, Germany 4Translational Pulmonary Science Center, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA 5Institute of Laboratory Animal Science and Central Animal Facility 6Department of Functional and Applied Anatomy 7Department of Pediatric Pneumology, Allergology and Neonatology Hannover Medical School, 30625 Hannover, Germany 8Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), 30625 Hannover, Germany 9Division of Hematology/Oncology, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA 10Co-senior author *Correspondence: lachmann.nico@mh-hannover.de http://dx.doi.org/10.1016/j.stemcr.2016.06.011 SUMMARY Induced pluripotent stem cells (iPSCs) represent an innovative source for the standardized in vitro generation of macrophages (M 4).",Non-OADS,/arxiv_data1/oa_pdf/19/4f/main.PMC4982988.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/4f/main.PMC4982988.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁve ﬁgures and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.,Non-OADS,/arxiv_data1/oa_pdf/19/4f/main.PMC4982988.pdf
http://dx.doi.org/10.1038/nprot.2009.136 .,Non-OADS,/arxiv_data1/oa_pdf/19/4f/main.PMC4982988.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.07.003 SUMMARY Degenerative cartilage endplate (CEP) shows decreased chondriﬁcation and increased ossiﬁcation.,OADS,/arxiv_data1/oa_pdf/c7/8f/main.PMC4982989.pdf
249 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/8f/main.PMC4982989.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.,OADS,/arxiv_data1/oa_pdf/c7/8f/main.PMC4982989.pdf
"http://dx.doi.org/10.1016/j.stemcr.2016.06.013 SUMMARY Although pluripotent stem cells can be differentiated into the hepatocyte lineages, such cells retain an immature phenotype.",Non-OADS,/arxiv_data1/oa_pdf/d1/ef/main.PMC4982990.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/ef/main.PMC4982990.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, ﬁve ﬁgures, and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.",OADS,/arxiv_data1/oa_pdf/d1/ef/main.PMC4982990.pdf
"Rao,4and Takashi Shinohara1,* 1Department of Molecular Genetics, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan 2Japan Science and Technology Agency, PRESTO, Kyoto 606-8501, Japan 3Department of OB/GYN and Women’s Health, University of Louisville School of Medicine, Louisville, KY 40292, USA 4Departments of Cellular Biology and Pharmacology, Molecular and Human Genetics, and Obstetrics and Gynecology, Reproduction and Development Program, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA*Correspondence: tshinoha@virus.kyoto-u.ac.jp http://dx.doi.org/10.1016/j.stemcr.2016.07.005 SUMMARY Spermatogenesis originates from self-renewal of spermatogonial stem cells (SSCs).",Non-OADS,/arxiv_data1/oa_pdf/46/24/main.PMC4983063.pdf
279 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/24/main.PMC4983063.pdf
ACCESSION NUMBERS Raw datasets have been submitted to the Gene Expression Omnibus database ( http://www.ncbi.nlm.nih.gov/geo ) and are available under the accession number GEO: GSE77500 ( http:// www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77500 ).,OADS,/arxiv_data1/oa_pdf/46/24/main.PMC4983063.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and three tables and can be found with this article on-line at http://dx.doi.org/10.1016/j.stemcr.2016.07.005 .,OADS,/arxiv_data1/oa_pdf/46/24/main.PMC4983063.pdf
"Stem Cell Reports Report Functional Blood Progenitor Markers in Developing Human Liver Progenitors Orit Goldman,1Idan Cohen,1and Valerie Gouon-Evans1,* 1Department of Developmental and Regenerative Biology, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA*Correspondence: gouonevans@gmail.com http://dx.doi.org/10.1016/j.stemcr.2016.07.008 SUMMARY In the early fetal liver, hematopoietic progenitors expand and mature together with hepatoblasts, the liver progenitors of hepatocytes and cholangiocytes.",Non-OADS,/arxiv_data1/oa_pdf/c6/62/main.PMC4983080.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/62/main.PMC4983080.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/c6/62/main.PMC4983080.pdf
"Stem Cell Reports Article Cell-Surface Protein Proﬁling Identiﬁes Distinctive Markers of Progenitor Cells in Human Skeletal Muscle Akiyoshi Uezumi,1,*Masashi Nakatani,1Madoka Ikemoto-Uezumi,2Naoki Yamamoto,3Mitsuhiro Morita,4 Asami Yamaguchi,4Harumoto Yamada,4Takehiro Kasai,5Satoru Masuda,6Asako Narita,6 Yuko Miyagoe-Suzuki,6Shin’ichi Takeda,6So-ichiro Fukada,7Ichizo Nishino,8and Kunihiro Tsuchida1 1Division for Therapies Against Intractable Diseases, Institute for Comprehensive Medical Science, Fujita Health University, 1-98 Dengakugakubo , Kutsukake, Toyoake, Aichi 470-1192, Japan 2Department of Regenerative Medicine, National Institute for Longevity Sciences, National Center for Geriatrics and Gerontology, 35 Gengo, Moriok a, Obu, Aichi 474-8511, Japan 3Laboratory of Molecular Biology & Histochemistry 4Department of Orthopaedic Surgery Fujita Health University, Toyoake, Aichi 470-1192, Japan 5Department of Orthopedic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, Aichi 466-8550, Japan 6Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higashi, Kodaira, Tokyo 187-8502, Japan 7Department of Immunology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamada-oka, Suita, Osaka 565-0871, Japan 8Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa-higas hi, Kodaira, Tokyo 187-8502, Japan*Correspondence: uezumi@fujita-hu.ac.jp http://dx.doi.org/10.1016/j.stemcr.2016.07.004 SUMMARY Skeletal muscle contains two distinct stem/progenitor populations.",OADS,/arxiv_data1/oa_pdf/12/10/main.PMC4983081.pdf
263 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/10/main.PMC4983081.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, six ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.07.004 .",OADS,/arxiv_data1/oa_pdf/12/10/main.PMC4983081.pdf
"Stem Cell Reports Correction A Method to Identify and Isolate Pluripotent Human Stem Cells and Mouse Epiblast Stem Cells Using Lipid Body-Associated Retinyl Ester Fluorescence Thangaselvam Muthusamy, Odity Mukherjee, Radhika Menon, Megha Prakash Bangalore, and Mitradas M. Panicker * *Correspondence: panic@ncbs.res.in http://dx.doi.org/10.1016/j.stemcr.2016.07.023 (Stem Cell Reports 3, 169–184; July 8, 2014) Megha Prakash Bangalore’s name was listed incorrectly as P.B.",Non-OADS,/arxiv_data1/oa_pdf/5a/b6/main.PMC4983098.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/b6/main.PMC4983098.pdf
"Stem Cell Reports Article Embryonic Stem Cell Culture Conditions Support Distinct States Associated with Different Developmental Stages and Potency Javier Martin Gonzalez,1,3Sophie M. Morgani,2,3Robert A. Bone,2Kasper Bonderup,1Sahar Abelchian,1 Cord Brakebusch,1and Joshua M. Brickman2,* 1Transgenic Core Facility 2The Danish Stem Cell Centre - DanStem University of Copenhagen, 3B Blegdamsvej, 2200 Copenhagen N, Denmark 3Co-ﬁrst author *Correspondence: joshua.brickman@sund.ku.dk http://dx.doi.org/10.1016/j.stemcr.2016.07.009 SUMMARY Embryonic stem cells (ESCs) are cell lines derived from the mammalian pre-implantation embryo.",OADS,/arxiv_data1/oa_pdf/d8/b7/main.PMC4983099.pdf
177 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/b7/main.PMC4983099.pdf
Probe intensities were analyzed using the NIA Array Analysis tool ( http://lgsun.grc.nia.nih.,OADS,/arxiv_data1/oa_pdf/d8/b7/main.PMC4983099.pdf
"Analysis of microarray data was carried out using ExAtlas online tool for meta-analysis of gene-expression data developed by the NIA ( http://lgsun.grc.nia.nih.gov/exatlas/ )(Sharov et al., 2015 ).",OADS,/arxiv_data1/oa_pdf/d8/b7/main.PMC4983099.pdf
Gene ontology analysis was performed using the Gene Ontology Consortium online tool ( http://geneontology.org ).,OADS,/arxiv_data1/oa_pdf/d8/b7/main.PMC4983099.pdf
Statistical Analysis Statistical analysis was performed using the QuickCalc GraphPad (http://www.graphpad.com/quickcalcs/index.cfm ).,OADS,/arxiv_data1/oa_pdf/d8/b7/main.PMC4983099.pdf
"The statistical signiﬁcance of theoverlap of gene lists was assessed using http://nemates.org/MA/ progs/overlap_stats.cgi , using a genome size of 25,000.",OADS,/arxiv_data1/oa_pdf/d8/b7/main.PMC4983099.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, three ﬁgures, and ten tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/d8/b7/main.PMC4983099.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/66/main.PMC4983102.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/66/main.PMC4983102.pdf
http://dx.doi.org/10.1016/j.eucr.2016.07.004Urology Case Reports 8 (2016) 63 e65,Non-OADS,/arxiv_data1/oa_pdf/7f/66/main.PMC4983102.pdf
http://dx.doi.org/10.1136/bcr.06.2010.3079 .,Non-OADS,/arxiv_data1/oa_pdf/7f/66/main.PMC4983102.pdf
http://dx.doi.org/10.1016/j.gore.2016.08.001 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/65/main.PMC4983106.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).2.,Non-OADS,/arxiv_data1/oa_pdf/5e/65/main.PMC4983106.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/0b/main.PMC4983108.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.08.001 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/77/0b/main.PMC4983108.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 86 e88,Non-OADS,/arxiv_data1/oa_pdf/77/0b/main.PMC4983108.pdf
[6]https://extranet.who.int/sree/Reports?op ¼Replet &name¼%2FWHO_HQ_ Reports%2FG2%2FPROD%2FEXT% 2FTBCountryPro ﬁle&ISO2¼PR&LAN¼EN&outtype ¼html .,OADS,/arxiv_data1/oa_pdf/77/0b/main.PMC4983108.pdf
[10] http://www.who.int/tb/publications/global_report/gtbr2015_executive_ summary.pdf .,Non-OADS,/arxiv_data1/oa_pdf/77/0b/main.PMC4983108.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/80/main.PMC4983109.pdf
"Astonishingly, some studies sug- gest that omeprazole exerts antioxidant effects [10] and may in- duce vascular relaxation that is partially NO-mediated [11,12], andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.08.001 2213-2317/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/aa/80/main.PMC4983109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/80/main.PMC4983109.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/aa/num-08-03-29574.PMC4983115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/88/main.PMC4983137.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.07.020 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/3f/88/main.PMC4983137.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Violence Prevention AdolescentsPublic health Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/c3/e1/main.PMC4983138.pdf
It is notPreventive Medicine Reports 4 (2016) 376 –380 http://dx.doi.org/10.1016/j.pmedr.2016.07.007 2211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/c3/e1/main.PMC4983138.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/e1/main.PMC4983138.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/c3/e1/main.PMC4983138.pdf
Campbell Systematic Reviews ( http://nnscommunities.org/old-site- ﬁles/Braga_Pulling_Levers_Review_CAMPBELL_RECORD.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c3/e1/main.PMC4983138.pdf
The Online Journal of Issues in Nursing 19(Manuscript 3. http://www.nursingworld.org/MainMenuCategories/ANAMarketplace/ ANAPeriodicals/OJIN/TableofContents/Vol-19-2014/No1-Jan-2014/Gang-Violence-Prevention-Public-Health-Approach.html .,Non-OADS,/arxiv_data1/oa_pdf/c3/e1/main.PMC4983138.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/b5/main.PMC4983139.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.07.007 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/89/b5/main.PMC4983139.pdf
"Keywords: Biochemistry, Bioengineering, Biophysics, Biotechnology, Cell biology, EngineeringReceived: 7 April 2016 Revised: 6 July 2016 Accepted: 2 August 2016 Heliyon 2 (2016) e00139 http://dx.doi.org/10.1016/j.heliyon.2016.e00139 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
"To evaluate the effectiveness of this approach for cancer detection, we subcutaneously injected AsPC-1 activated humanpancreatic cancer cells into a living mouse, followed by intravenous injection of Article No~e00139 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00139 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
Article No~e00139 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00139 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
Article No~e00139 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00139 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
Article No~e00139 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00139 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
Article No~e00139 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00139 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
Article No~e00139 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00139 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
"Wallace, Real-time increased detection of Article No~e00139 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00139 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
http://www.cellvizio.net .,Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
Article No~e00139 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00139 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/72/main.PMC4983142.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/ec/main.PMC4983144.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.08.001 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/99/ec/main.PMC4983144.pdf
"Security and Effectiveness Based on Ipilateral Breast Tumor Recurrence, Department of Oncology, Barretos Cancer Hospital, 2015 (Dissertation), https://www.hcancerbarretos.com.br/ upload/doc/86c4cee0a4f2989c2ef93493862fd3f6.pdf .",Non-OADS,/arxiv_data1/oa_pdf/99/ec/main.PMC4983144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
: +1 415 476 5567. http://dx.doi.org/10.1016/j.nicl.2015.08.0022213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.07.00717761438 .,OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
"6, 197. http://dx.doi.org/10.3389/fnins.2012.",Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1016/j.neuroimage.2009.07.03619632335 .,OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.3233/JAD- 2009-119119661618 .,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1016/S1474-4422(12)70320-423290598 .,OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1016/j.neurobiolaging.2007.05.01417604879 .,OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1212/WNL.,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1212/WNL.,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2009.07.01119615450 .,OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1212/WNL.49.3.7869305341 .,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/ 10.1212/WNL.0b013e3181a7123619470967 .,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/ 10.1093/brain/awn23418829698 .,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1212/01.WNL.0000106827.39764.,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/ 10.1097/00146965-200312000-0000214665820 .,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
"24 (1), 43 –48.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1212/01.WNL.0000113729.,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
"An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets.Neuroimage 19 (3), 1233 –123 9. http://dx.doi.org/10.1016/S1053-8119(03)00169- 112880848 .",OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1017/S10416102970048709447441 .,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1097/WAD.,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1093/ brain/awr17921810890 .,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1212/WNL.58.11.,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1212/01.wnl.0000173837.,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.3233/ JAD-2012-11155622406442 .,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1212/01.wnl.0000327889.,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1212/WNL.58.2.19811805245.,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1093/brain/awg20412876142 .,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1136/jnnp.2010.,OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1037/h0054651 .,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1007/s13311-010-0012- 221274688.,Non-OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1093/imammb/ dqp02219942608 .,OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/10.1016/j.jalz.2013.05.176923932184 .,OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2009.12.00720005963 .340 A. Pankov et al.,OADS,/arxiv_data1/oa_pdf/04/29/main.PMC4983147.pdf
This  is  an  open  access  article under the CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/58/main.PMC4983148.pdf
They  are  often triggered  during  micturition  hence  termed  ‘micturition  attacks’  and http://dx.doi.org/10.1016/j.ijscr.2016.07.008 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/e1/58/main.PMC4983148.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/af/main.PMC4983149.pdf
Transposition  of  the  spinal  cord  includes  the  anterior  stage  where transposition  of  the  spinal  cord  is  performed  through  the  transtho- racic  approach  to  the  anterior  vertebral  portions;  and  the  posterior http://dx.doi.org/10.1016/j.ijscr.2016.07.037 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/83/af/main.PMC4983149.pdf
"23  (June  (6)) (2014)  1237–1243,  http://dx.doi.org/10.1007/s00586-014-3270-6 .",Non-OADS,/arxiv_data1/oa_pdf/83/af/main.PMC4983149.pdf
"Sides,  Pulmonary function  in  adolescent  idiopathic  scoliosis  relative  to  the  surgical  procedure:  a 10-year  follow-up  analysis,  Spine  (Phila  Pa  1976)  36  (September  (20))  (2011) 1665–1672,  http://dx.doi.org/10.1097/BRS.0b013e31821bcf4c .",Non-OADS,/arxiv_data1/oa_pdf/83/af/main.PMC4983149.pdf
"25  (February  (2))  (2016)  363–371,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/83/af/main.PMC4983149.pdf
"Long-term  results  with  an  unexpected  high revision rate,  Scoliosis  7  (January  (1))  (2012)  13,  http://dx.doi.org/10.1186/ 1748-7161-7-13 .",Non-OADS,/arxiv_data1/oa_pdf/83/af/main.PMC4983149.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: (Prolonged) disorders of consciousness Functional near infrared spectroscopy Brain function assessment in disorders ofconsciousness 1.,Non-OADS,/arxiv_data1/oa_pdf/18/b2/main.PMC4983150.pdf
http://dx.doi.org/10.1016/j.nicl.2016.07.0132213-1582/Crown Copyright © 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/18/b2/main.PMC4983150.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/b2/main.PMC4983150.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/fa/num-08-03-35864.PMC4983153.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/1e/num-08-03-35467.PMC4983154.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/8c/num-08-03-30261.PMC4983155.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 179 –182 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.06.004 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/2f/63/main.PMC4983156.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/63/main.PMC4983156.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 211 –215 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.05.001 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/91/38/main.PMC4983157.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/91/38/main.PMC4983157.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 223 –227 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.06.005 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/79/fa/main.PMC4983158.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/fa/main.PMC4983158.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 198 –202 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.06.006 2090-598X /C2112016 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/aa/c5/main.PMC4983159.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/c5/main.PMC4983159.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 234 –239 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.05.002 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/e2/c7/main.PMC4983160.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/c7/main.PMC4983160.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 183 –191 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.07.001 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC4983161.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/main.PMC4983161.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 203 –206 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.06.002 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/3c/f2/main.PMC4983162.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/f2/main.PMC4983162.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 207 –210 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.06.001 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/01/6d/main.PMC4983163.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/6d/main.PMC4983163.pdf
http://dx.doi.org/10.1007/s00120-008-1730-5 .,Non-OADS,/arxiv_data1/oa_pdf/01/6d/main.PMC4983163.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 192 –197 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.06.003 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/a2/1d/main.PMC4983164.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/1d/main.PMC4983164.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 228 –233 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.05.003 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/ed/d3/main.PMC4983165.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/d3/main.PMC4983165.pdf
"Production and hosting by ElsevierArab Journal of Urology (2016) 14, 216 –222 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.04.005 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/2e/73/main.PMC4983166.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/73/main.PMC4983166.pdf
Available at: http://uroweb.org/wp-content/ uploads/22-Urolithiasis_LR.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2e/73/main.PMC4983166.pdf
Anoxic proxies of surface sediments and water occurred in theReceived: 22 September 2015 Revised: 11 May 2016 Accepted: 27 July 2016 Heliyon 2 (2016) e00137 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
These results should modify current viewson the mechanism of the latest Permian extinction event to reflect a high flux of Article No~e00137 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
The paleo-water depths Article No~e00137 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
For this Article No~e00137 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
"Another diagenetic proxy, ββ/(αα+ββ) C29 sterane, ranged from 0.42 to 0.56 in Bulla, 0.53 to 0.56 in Kamura, 0.44 to 0.66 inHuangzhishan, 0.50 to 0.59 (two samples were exceptionally low, 0.19 and 0.29) in Article No~e00137 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This Article No~e00137 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
"Following land invasion by plants in the Silurian and Devonian, an increase in soil erosion led to an increase in the Pr/Ph ratios because of the intrusion of pristane Article No~e00137 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
"Thus, the redox conditions were euxinic at a gammacerane index > 10 or a C35 homohopane index > 6 and a Pr/Ph ratio <1.3; anoxic at a gammacerane or C35 homohopane index > 3 and a Pr/Ph ratio <1.3; suboxic at a Article No~e00137 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
"In a previous study, the Mo EF,UEF, and V EFvalues at Opal Creek were ∼10,∼2, and∼2, respectively, in CI Zones II and III, and <10,∼2, and 1 –2 in CI Zones Article No~e00137 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
The strong euxinic trend of a much higher Mo EF Article No~e00137 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
"In Bulla, which had a higher resolution and the shallowest section, the highest DBF/Phe values occurred in thebasal 19 cm of Bed 8 and were followed by a maximum in the (C28TT + C29TT)/ Article No~e00137 24 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
"The values of Mo EF,U EF, and V EFin Huangzhishan, Bianzhonglu, and Shangsi after the latest Permian extinction were Article No~e00137 25 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 26 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
The high flux of soil-derived Article No~e00137 27 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 28 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
The decrease could have contributed to the rapid decrease Article No~e00137 29 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
"This wasfollowed by an increase in greenhouse gases, warming, the latest Permian Article No~e00137 30 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
"Additional information Supplementary content related to this article has been published online at http://dx.doi.org/10.1016/j.heliyon.2016.e00137 Acknowledgments We thank M. Fujibayashi for measuring organic carbon isotope ratios, and H. Takayanagi and Y. Iryu for measuring carbonate carbon isotope ratios for theBianzhonglu section.",Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 31 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 32 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 33 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Changes in depth-transectredox conditions spanning the end-Permian mass extinction and their impact on the Article No~e00137 34 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 35 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 36 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 37 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 38 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 39 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
Article No~e00137 40 http://dx.doi.org/10.1016/j.heliyon.2016.e00137 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/6f/main.PMC4983274.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/55/num-08-03-34770.PMC4983407.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/47/num-08-03-37443.PMC4983408.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/af/num-08-03-36527.PMC4983409.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/0c/num-08-03-37840.PMC4983449.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/22/num-08-03-37878.PMC4983454.pdf
Keywords Calcium; Stress; Ischemia; Traumatic brain injury; Endoplasmic reticulum This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/a7/nihms800984.PMC4983525.pdf
"In contrast, Tau12 and Tau13 both identified discontinuous epitopes in the amino  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8f/1b/nihms795386.PMC4983528.pdf
Supplementary data Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.nbd.,OADS,/arxiv_data1/oa_pdf/8f/1b/nihms795386.PMC4983528.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/64/main.PMC4983633.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.08.006 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/1f/64/main.PMC4983633.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/ac/main.PMC4983634.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.07.033 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/16/ac/main.PMC4983634.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Major depressionSeverity of symptomsDiagnosisFunctional magnetic resonance imagingMachine learningClassi ﬁcation Support vector machine 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/87/main.PMC4983635.pdf
http://dx.doi.org/10.1016/j.nicl.2016.07.0122213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/87/main.PMC4983635.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/87/main.PMC4983635.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/9e/main.PMC4983636.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.07.025 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/29/9e/main.PMC4983636.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/0d/main.PMC4983637.pdf
"The  patient  was awake  and  hemodynamically  stable  with  a  Glasgow  Coma  Scale score  of  E4V5M6,  respiratory  rate  of  20  breaths/min,  heart  rate  of 96 beats/min,  blood  pressure  of  189/118  mmHg,  and  body  temper- http://dx.doi.org/10.1016/j.ijscr.2016.08.002 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/9a/0d/main.PMC4983637.pdf
This  is  an  open  access  article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/4b/main.PMC4983638.pdf
A hemoglobin  value  of  5.2  g/dl  suggested  the  cause  of  the  acute http://dx.doi.org/10.1016/j.ijscr.2016.07.009 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ec/4b/main.PMC4983638.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.06.016,Non-OADS,/arxiv_data1/oa_pdf/e3/bb/main.PMC4983639.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,8 9 –91 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/e3/bb/main.PMC4983639.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,8 9 –91 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/e3/bb/main.PMC4983639.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Multiple sclerosisPredictionLesionNeuroimagingMRI 1.,Non-OADS,/arxiv_data1/oa_pdf/ec/30/main.PMC4983640.pdf
http://dx.doi.org/10.1016/j.nicl.2016.07.015 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/30/main.PMC4983640.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/30/main.PMC4983640.pdf
"For image preprocessing, we used Medical Image Processing Analy- sis and Visualization ( http://mipav.cit.nih.gov ) and the Java Image Sci- ence Toolkit ( http://www.nitrc.org/projects/jist )(Lucas et al., 2010 ).",OADS,/arxiv_data1/oa_pdf/ec/30/main.PMC4983640.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/10/main.PMC4983641.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.07.023 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/10/main.PMC4983641.pdf
"19 (2013) 3, http://dx.doi.org/10.4274/Tnd.88156 .",Non-OADS,/arxiv_data1/oa_pdf/fe/10/main.PMC4983641.pdf
"34 (3) (March 2016) 403 e406, http://dx.doi.org/10.1016/j.ajem.2015.11.009 pii: S0735e6757(15)00960-2.",OADS,/arxiv_data1/oa_pdf/fe/10/main.PMC4983641.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/1e/main.PMC4983642.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.08.003 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/84/1e/main.PMC4983642.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Juvenile Absence EpilepsyVoxel based morphometryMRICortical thicknessSurface areaSodium valproate 1.,Non-OADS,/arxiv_data1/oa_pdf/93/e6/main.PMC4983643.pdf
http://dx.doi.org/10.1016/j.nicl.2016.07.0072213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/93/e6/main.PMC4983643.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/e6/main.PMC4983643.pdf
Voxel-based morphometry analysis VBM was performed using VBM8 ( http://dbm.neuro.uni-jena.de/ vbm/ ) a toolbox of SPM8 ( http://www.,OADS,/arxiv_data1/oa_pdf/93/e6/main.PMC4983643.pdf
"To identify GM differences between JAE and controls, we per- formed a t-test comparison between the two groups and a double statis- tical threshold was used (voxel-wise p b0.001 and cluster size ≥686 voxels, as determined by AlphaSim with 10,000 Monte Carlo simula- tions) to obtain an overall alpha level of b0.05 (see details on the proce- dure at http://afni.nimh.nih.gov/afni/doc/manual/AlphaSim )(Forman et al., 1995 ).",OADS,/arxiv_data1/oa_pdf/93/e6/main.PMC4983643.pdf
"The morphometric results are displayed onto the normalized SPM-glass brain (left images) and warped to the PALS-B12 atlas in Caret (Caret, http://brainvis.wustl.edu/wiki/index.php/Caret:About; (Van Essen, 2005 )) (mesial and dorsal view) for right (R) and left (L) hemisphere (right images).",OADS,/arxiv_data1/oa_pdf/93/e6/main.PMC4983643.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Instrumental learningCausal awarenessVolumetricsShape analysis Pallidum Youth 1.,Non-OADS,/arxiv_data1/oa_pdf/66/c7/main.PMC4983644.pdf
http://dx.doi.org/10.1016/j.nicl.2016.06.017 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/66/c7/main.PMC4983644.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/c7/main.PMC4983644.pdf
http://dx.doi.org/10.1017/S1355617710001566 .,Non-OADS,/arxiv_data1/oa_pdf/66/c7/main.PMC4983644.pdf
"PLoS One 8 (3), e59108.http://dx.doi.org/10.1371/journal.pone.0059108.t003 .",Non-OADS,/arxiv_data1/oa_pdf/66/c7/main.PMC4983644.pdf
http://dx.doi.org/10.1016/j.jad.2011.10.023 .,OADS,/arxiv_data1/oa_pdf/66/c7/main.PMC4983644.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/c7/main.PMC4983644.pdf
"57, 1 –11.http://dx.doi.org/10.1016/j.jpsychires.2014.06.",OADS,/arxiv_data1/oa_pdf/66/c7/main.PMC4983644.pdf
"5(4), 1–10.http://dx.doi.org/10.1038/tp.2015.50 .",Non-OADS,/arxiv_data1/oa_pdf/66/c7/main.PMC4983644.pdf
"31 (7), 2474 –24 80. http://dx.doi.org/10.1523/ JNEUROSCI.3354-10.2011 .291 K.R.",Non-OADS,/arxiv_data1/oa_pdf/66/c7/main.PMC4983644.pdf
"37 (1), 73–83.http://dx.doi.org/10.1093/schbul/sbp034 .",Non-OADS,/arxiv_data1/oa_pdf/66/c7/main.PMC4983644.pdf
http://dx.doi.org/10.1017/S0033291710001613 .,Non-OADS,/arxiv_data1/oa_pdf/66/c7/main.PMC4983644.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/f7/main.PMC4983645.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.07.026 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/f7/main.PMC4983645.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Magnetoencephalography (MEG)Young childrenAutism spectrum disorder (ASD)Hyperactivity P1m 1.,Non-OADS,/arxiv_data1/oa_pdf/13/81/main.PMC4983646.pdf
http://dx.doi.org/10.1016/j.nicl.2016.07.0092213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/13/81/main.PMC4983646.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/81/main.PMC4983646.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
This variation  needs  to  be  assessed  to  make  a  valid  statement  about http://dx.doi.org/10.1016/j.bdq.2016.06.004 2214-7535/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.bdq.2016.06.004 .",OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"Quake,  Digital  PCR  provides sensitive  and  absolute  calibration  for  high  throughput  sequencing,  BMC Genomics 10  (2009)  116,  http://dx.doi.org/10.1186/1471-2164-10-116 .",OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"Rutledge, D.  Sisti,  A.  Lievens,  K.  De  Preter,  S.  Derveaux,  J.  Hellemans,  J.  Vandesompele, Evaluation of  qPCR  curve  analysis  methods  for  reliable  biomarker  discovery: bias, resolution,  precision,  and  implications,  Methods  (San  Diego,  CA)  59  (1) (2013) 32–46, http://dx.doi.org/10.1016/j.ymeth.2012.08.011 .",OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"61  (2)  (2015) 379–388, http://dx.doi.org/10.1373/clinchem.2014.230656 http://www.",Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"[5] S. Rödiger, M. Burdukiewicz,  P.  Schierack,  chipPCR:  an  R  package  to pre-process raw  data  of  ampliﬁcation  curves,  Bioinformatics  31  (17)  (2015) 2900–2902,  http://dx.doi.org/10.1093/bioinformatics/btv205  http:// bioinformatics.oxfordjournals.org/content/31/17/2900.abstract .",Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"5  (2015),  http://dx.doi.org/10.1016/j.bdq.2015.07.001  http:// www.sciencedirect.com/science/article/pii/S2214753515300012 .",Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"1  (1)  (2014)  23–33,  http://dx.doi.org/10.1016/j.bdq.2014.08.002  http://www.",OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"3  (2015)  A1–A5,  http://dx.doi.org/10.1016/j.bdq.2015.01.001  http:// www.sciencedirect.com/science/article/pii/S2214753515000029 .",OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"87  (16)  (2015)  8203–8209,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"Marks,  Digital  PCR  modeling  for  maximal sensitivity,  dynamic  range  and  measurement  precision,  PLOS  ONE  10  (3) (2015) e0118833,  http://dx.doi.org/10.1371/journal.pone.0118833 .",Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"[12] S. Dube,  J.  Qin,  R.  Ramakrishnan,  Mathematical  analysis  of  copy  number variation  in  a  DNA  sample  using  digital  PCR  on  a  nanoﬂuidic  device,  PLoS  ONE 3  (8)  (2008)  e2876,  http://dx.doi.org/10.1371/journal.pone.0002876 .",Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"394  (2)  (2009)  457–467,  http://dx.doi.org/ 10.1007/s00216-009-2729-5 .",Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
7 (2)  (2015)  127–150  http://journal.r-project.org/archive/2015-1/RJ- 2015-1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
27  (8)  (2008)  1–25  http://www.jstatsoft.org/v27/i08 .,Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"26 (22) (2007) 4063–4073, http://dx.doi.org/10.1002/sim.2873 .",Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"57  (1) (1995) 289–300,  http://dx.doi.org/10.2307/2346101 .",Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"16  (2)  (2001)  101–133,  http://dx.doi.org/10.1214/ss/ 1009213286 .",Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"62  (318)  (1967)  626–633,  http://dx.doi.org/ 10.1080/01621459.1967.10482935 .",Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"[26]  M.  Burdukiewicz,  S.  Rödiger,  B.  Jacobs,  P.  Sobczyk,  dpcR:  Digital  PCR  Analysis, R  Package  Version  0.2,  2015  http://CRAN.R-project.org/package=dpcR .",Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"[28]  M.  Fay,  rateratio.test:  Exact  Rate  Ratio  Test,  R  Package  Version  1.0-2,  2014 https://CRAN.R-project.org/package=rateratio.test .",Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
"[29] H. Wickham,  ggplot2:  Elegant  Graphics  for  Data  Analysis,  Springer,  New  York, 2009 http://had.co.nz/ggplot2/book .",Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
49  (9)  (2012)  1–34 http://www.jstatsoft.org/v49/i09 .,Non-OADS,/arxiv_data1/oa_pdf/71/27/main.PMC4983647.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
The  basis  of  this http://dx.doi.org/10.1016/j.bdq.2016.06.001 2214-7535/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"Primers  and  hydrolysis  probes  were  designed  using  an  in  house developed  primerXL  assay  design  engine  (Lefever  et  al.,  in  prepara- tion; http://www.primerxl.org ),  avoiding  SNPs  under  the  primer and  probe  annealing  sites,  avoiding  secondary  structures,  and",OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"Additionally,  a  Shiny  web  application  is  available  at http://antonov.ugent.be:3838/dPCR/  that  does  not  require  any  type of  programming,  but  relies  on  a  spreadsheet-like  data  input  and point  and  click  interface.",Non-OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"Supplementary  Data Supplementary data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.bdq.2016.06.001 .",OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"1  (2014)  1–2, http://dx.doi.org/10.1016/j.bdq.2014.06.001 .",OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"61  (2015)  79–88,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"83  (2011) 6474–6484, http://dx.doi.org/10.1021/ac103230c .",Non-OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"Richman,  Highly  precise  measurement  of  HIV  DNA  by Droplet  digital  PCR,  PLOS  ONE  8  (4)  (2013)  e55943,  http://dx.doi.org/10.1371/ journal.pone.0055943 .",Non-OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"40  (2012)  e82, http://dx.doi.org/10.1093/nar/gks203 .",Non-OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"[10] S. Dube,  J.  Qin,  R.  Ramakrishnan,  Mathematical  analysis  of  copy  number variation  in  a  DNA  sample  using  digital  PCR  on  a  nanoﬂuidic  device,  PLoS  ONE 3 (2008)  e2876,  http://dx.doi.org/10.1371/journal.pone.0002876 .",Non-OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"Markowitz,  MethyLight  droplet  digital  PCR  for  detection  and  absolute quantiﬁcation  of  infrequently  methylated  alleles,  Epigenetics  10  (9)  (2015) 803–809,  http://dx.doi.org/10.1080/15592294.2015.1068490 .",Non-OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"Salzberg,  Ultrafast  and  memory-efﬁcient alignment  of  short  DNA  sequences  to  the  human  genome,  Genome  Biology  10 (3) (2009)  R25,  http://dx.doi.org/10.1186/gb-2009-10-3-r25 .",OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"43  (8) (2006)  625–633,  http://dx.doi.org/10.1136/jmg.2005.039453 .",Non-OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"52  (6)  (2009)  398–403,  http://dx.doi.org/10.1016/j.ejmg.2009.09.002 .",OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"10  (2009)  89,  http://dx.doi.org/10.1186/1471-2350-10-89 .",Non-OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"15 (2014) 283,  http://dx.doi.org/10.1186/1471-2105-15-283 .",Non-OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"21  (18)  (2002)  2723–2738,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"[23]  B.  D’haene,  J.  Vandesompele,  J.  Hellemans,  Accurate  and  objective  copy number  proﬁling  using  real-time  quantitative  PCR,  Methods  50.4  (2010) 262–270,  http://dx.doi.org/10.1016/j.ymeth.2009.12.007 .",Non-OADS,/arxiv_data1/oa_pdf/ee/0e/main.PMC4983648.pdf
"Key words: broiler chick, post-hatch transportation, breeder flock age, animal welfare, productivity 2016 Poultry Science 95:1973–1979 http://dx.doi.org/10.3382/ps/pew155 INTRODUCTION Early life environment and experiences are crucial for the development and performance of chicks later in life (Decuypere et al., 2001 ; Valros et al., 2008 ; Mitchell, 2009 ).",Non-OADS,/arxiv_data1/oa_pdf/12/9a/pew155.PMC4983684.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribu- tion Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/9a/pew155.PMC4983684.pdf
"Key words: poultry, welfare, immunity 2016 Poultry Science 95:2216–2218 http://dx.doi.org/10.3382/ps/pew159 INTRODUCTION When trying to answer the question to which extent immune responses can contribute to welfare and be in- corporated in new and improved management practices, it is important to make the distinction between innate and adaptive immune responses.",Non-OADS,/arxiv_data1/oa_pdf/2c/e2/pew159.PMC4983685.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribu- tion Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/e2/pew159.PMC4983685.pdf
"Key words: residual feed intake, feeding behavior, mule duck, carcass composition, general behavior 2016 Poultry Science 95:1999–2010 http://dx.doi.org/10.3382/ps/pew185 INTRODUCTION Approximately 95% of the fatty liver produced in France comes from mule ducks, an infertile hybrid cross between female common ducks ( Anas platyrhynchos ) and Muscovy drakes ( Cairina moschata ).",Non-OADS,/arxiv_data1/oa_pdf/80/c8/pew185.PMC4983686.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re-use, distribu- tion, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/c8/pew185.PMC4983686.pdf
A hypothetical Aar model was cre-ated by using Pymol program (http://pymol.org/) inagreement with the secondary structure prediction(Supporting Information Fig.,OADS,/arxiv_data1/oa_pdf/5a/d8/MMI-101-314.PMC4983702.pdf
Bioinformatic and statistical analysis Protein secondary structures were analyzed by using Pro- mals3d algorithms http://prodata.swmed.edu/promals3d/pro- mals3d.php.,OADS,/arxiv_data1/oa_pdf/5a/d8/MMI-101-314.PMC4983702.pdf
Protein model for Aar was generated by Pymol software (http://pymol.org/).,OADS,/arxiv_data1/oa_pdf/5a/d8/MMI-101-314.PMC4983702.pdf
Hypothetical proteins were ana- lyzed by using Clustalw algorithms (http://www.genome.jp/ tools/clustalw/).,OADS,/arxiv_data1/oa_pdf/5a/d8/MMI-101-314.PMC4983702.pdf
The sequences for ANR homologs andAraC homologs were obtained from UniProtkB/Swiss-Prot (http://www.uniprot.org/uniprot) and NCBI (http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/5a/d8/MMI-101-314.PMC4983702.pdf
Accession numbers We used UniProtkB/Swiss-Prot (http://www.uniprot.org/uni- prot) and NCBI (http://www.ncbi.nlm.nih.gov/nucleotide) sequences in our in silico genome analysis.,OADS,/arxiv_data1/oa_pdf/5a/d8/MMI-101-314.PMC4983702.pdf
"[http://dx.doi.org/10.2174/138945012798868452] [PMID: 21777188] [2] Sladeczek, F.; Pin, J.P.; Récasens, M.; Bockaert, J.; Weiss, S. Glutamate stimulates inositol phosphate formation in striatal neurones.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/ 10.1038/317717a0] [PMID: 2865680] [3] Cotman, C.W.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1113/jphysiol.1986.sp016227] [PMID: 3795109] [4] Nicoletti, F.; Wroblewski, J.T.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1038/ 349760a0] [PMID: 1847995] [6] Houamed, K.M.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1126/science.1656524] [PMID: 1656524] [7] Conn, P.J.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1146/annurev.pharmtox.37.1.205] [PMID: 9131252] [8] Tang, F.R.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.2174/092986709788612710] [PMID: 19519386] [9] Lüscher, C.; Huber, K.M.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/ j.neuroscience.2014.05.062] [PMID: 24928353] [12] Tang, F.R.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/S0920-1211(01)00276-5] [PMID: 11463519] [13] Akbar, M.T.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/S0169-328X(96)00162-3] [PMID: 9037524] [14] Bianchi, R.; Wong, R.K.; Merlin, L.R.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1093/med/9780199746545.003.0011] [15] Attwell, P.J.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/ S0006-8993(97)01500-X] [PMID: 9518652] [16] Attwell, P.J.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/S0006-8993(98)00698-2] [PMID: 9733953] [17] Watanabe, Y.; Kaida, Y.; F u k u h a r a ,  S .",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1111/j.1528-1167.2010.02764.x] [PMID: 21054350] [18] Rohde, J.; Kirschstein, T.; Wilkars, W.; Müller, L.; Tokay, T.; Porath, K.; Bender, R.A.; Köhling, R. Upregulation of presynaptic mGluR2, but not mGluR3 in the epileptic medial perforant path.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/ 10.1016/j.neuropharm.2011.12.012] [PMID: 22202905] [19] Abdul-Ghani, A.S.; Attwell, P.J.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/ j.brainres.2010.10.047] [PMID: 20971086] [21] Caulder, E.H.; Riegle, M.A.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1016/j.eplepsyres.,OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/ 10.1016/j.neuropharm.2008.05.034] [PMID: 18585398] [23] Enz, R. The trick of the tail: protein-protein interactions of metabotropic glutamate receptors.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1002/bies.20518] [PMID: 17187376] [24] Aramori, I.; Nakanishi, S. Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluR1, in transfected CHO cells.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1016/j.seizure.2010.06.,OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.1964-12.2012] [PMID: 23152621] [30] Ferreira, L.T.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1385/JMN:26:2-3:277] [PMID: 16012201] [32] Doumazane, E.; Scholler, P.; Zwier, J.M.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/ 10.1186/1756-6606-6-9] [PMID: 23406666] [34] Renner, M.; Specht, C.G.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1016/j.conb.2008.09.,OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1074/ jbc.M109.042663] [PMID: 19640847] [36] Li, Y.; Krogh, K.A.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/j.neuropharm.2012.07.014] [PMID: 22814532] [37] Cavarsan, C.F.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/ j.eplepsyres.2012.04.011] [PMID: 22591751] [38] Bockaert, J.; Perroy, J.; Bécamel, C.; Marin, P.; Fagni, L. GPCR interacting proteins (GIPs) in the nervous system: Roles in physiology and pathologies.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1146/annurev.pharmtox.010909.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/ j.neuropharm.2007.08.012] [PMID: 17904168] [41] DeLorenzo, R.J.; Sun, D.A.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/S0074-7742(06)81005-6] [PMID: 17433918] [42] Zhao, W .",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.1944-14.2015] [PMID: 25568123] [43] Tang, F.R.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.2174/ 157015905774322525] [PMID: 18369399] [44] Blümcke, I.; Becker, A.J.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1002/(SICI)1097-4547(19981101) 54:3<412::AID-JNR12>3.0.CO;2-E] [PMID: 9819146] [46] Tang, F.R.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/j.eplepsyres.2004.04.002] [PMID: 15246118] [47] Chen, J.; Larionov, S.; Pitsch, J.; Hoerold, N.; Ullmann, C.; Elger, C.E.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/ j.neulet.2004.11.008] [PMID: 15694259] [48] Guilfoyle, D.N.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1007/s12031-013-0211-5] [PMID: 24390354] [49] Tang, F.R.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/S0304-3940(01)01579-8] [PMID: 11226630] [50] Bough, K.J.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/ 10.1152/jn.00315.2004] [PMID: 15152022] [51] Ermolinsky, B.; Pacheco Otalora, L.F.; Arshadmansab, M.F.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1016/j.brainres.2008.,OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1111/j.1528-1167.2007.01000.x] [PMID: 17430409] [53] Das, A.; Wallace, G.C., IV; Holmes, C.; McDowell, M.L.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/ j.neuroscience.2012.06.002] [PMID: 22698689] [54] Kandratavicius, L.; Rosa-Neto, P.; Monteiro, M.R.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1093/brain/awh673] [PMID: 16311265] [57] Tang, F.R.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1023/A:1011939223872] [PMID: 11577252] [58] Grigorenko, E.; Glazier, S.; Bell, W.; Tytell, M.; Nosel, E.; Pons, T.; Deadwyler, S.A. Changes in glutamate receptor subunit composition in hippocampus and cortex in patients with refractory epilepsy.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1002/(SICI)1097-4547(19980201)51:3<339:: AID-JNR7>3.0.CO;2-H] [PMID: 9486769] [60] Aronica, E.; Gorter, J.A.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1046/j.1528-1157.2003.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1016/j.ceca.2007.,OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1016/ j.cell.2009.01.050] [PMID: 19345194],OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1111/j.1460-9568.2004.03768.x] [PMID: 15579147] [64] Sakagami, Y.; Yamamoto, K.; Sugiura, S.; Inokuchi, K.; Hayashi, T.; Kato, N. Essential roles of Homer-1a in homeostatic regulation of pyramidal cell excitability: a possible link to clinical benefits  of electroconvulsive shock.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1111/j.1460-9568.2005.04165.x] [PMID: 16026461] [65] Potschka, H.; Krupp, E.; Ebert, U.; Gümbel, C.; Leichtlein, C.; Lorch, B.; Pickert, A.; Kramps, S.; Young, K.; Grüne, U.; Keller, A.; Welschof, M.; Vogt, G.; Xiao, B.; Worley, P.F.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1046/j.1460-9568.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/j.neuron.2010.11.008] [PMID: 21172614] [67] Maejima, T.; Hashimoto, K.; Yoshida, T.; Aiba, A.; Kano, M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/S0896-6273(01)00375-0] [PMID: 11516402] [68] Karr, L.; Pan, Y.Z.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1111/j.1528-1167.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.0945-05.2005] [PMID: 16033892] [70] Kim, D.; Jun, K.S.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1038/38508] [PMID: 9305844] [71] Park, D.; Lee, S.; Jun, K.; Hong, Y.M.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1038/nn1033] [PMID: 12640460] [72] Hannan, A.J.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1038/85132] [PMID: 11224545] [73] Domenici, M.R.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1046/j.1460-9568.2003.02649.x] [PMID: 12786971] [74] Chuang, S.C.; Bianchi, R.; Kim, D.; Shin, H.S.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1152/jn.00548.2005] [PMID: 16049142] [76] Tang, F.R.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1002/hipo.10156] [PMID: 15058486] [77] Liu, J.X.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/ 10.1016/j.eplepsyres.2008.07.014] [PMID: 18774262] [78] Uchino, M.; Sakai, N.; Kashiwagi, K.; Shirai, Y.; Shinohara, Y.; Hirose, K.; Iino, M.; Yamamura, T.; Saito, N. Isoform-specific phosphorylation of metabotropic glutamate receptor 5 by protein kinase C (PKC) blocks Ca2+ oscillation and oscillatory trans- location of Ca2+-dependent PKC.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1074/jbc.M309894200] [PMID: 14561742] [79] Dale, L.B.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1074/jbc.M103847200] [PMID: 11461909] [80] Fuortes, M.G.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/ 10.1074/jbc.M501696200] [PMID: 15970592] [83] Turner, J.H.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/ 10.1124/jpet.106.112581] [PMID: 17050776] [84] Navarro, G.; Aymerich, M.S.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1074/ jbc.M109.034231] [PMID: 19632986] [85] Xia, Z.; Storm, D.R.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1038/nrn1647] [PMID: 15803158] [86] Lee, J.H.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1073/ pnas.0712033105] [PMID: 18715999] [87] Minakami, R.; Jinnai, N.; Sugiyama, H. Phosphorylation and calmodulin binding of the metabotropic glutamate receptor subtype 5 (mGluR5) are antagonistic in vitro.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1074/jbc.272.32.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1046/j.1365-2443.1999.00269.x] [PMID: 10469171] [89] Suh, Y.H.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1016/j.neuron.2008.03.028] [PMID: 18549785],OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/ 10.1074/jbc.274.39.27573] [PMID: 10488094] [91] O’Connor, V.; El Far, O.; Bofill-Cardona, E.; Nanoff, C.; Freissmuth, M.; Karschin, A.; Airas, J.M.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1126/science.1178496] [PMID: 20007903] [93] Zhang, C.S.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1111/j.1471-4159.2011.07233.x] [PMID: 21371038] [96] Gregory, K.J.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/B978-0-12-394587-7.00002-6] [PMID: 23415092] [97] Hovelsø, N.; Sotty, F.; Montezinho, L.P.; Pinheiro, P.S.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.2174/157015912799362805] [PMID: 22942876] [98] Bianchi, R.; Chuang, S.C.; Zhao, W.; Young, S.R.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1523/ JNEUROSCI.5447-08.2009] [PMID: 19295155] [99] Lojková-Janecková, D.; Ng, J.; Mares, P. Antagonists of group I metabotropic glutamate receptors and cortical afterdischarges in immature rats.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/S0028-3908(99)00242-7] [PMID: 10854901] [101] De Vry, J.; Horváth, E.; Schreiber, R. Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/S0014-2999(01)01296-1] [PMID: 11675037] [102] Chapman, A.G.; Yip, P.K.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/S0014-2999(99)00014-X] [PMID: 10096765] [103] Bruno, V.; Battaglia, G.; Kingston, A.; O’Neill, M.J.; Catania, M.V.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/ S0028-3908(98)00159-2] [PMID: 10218860] [104] Kingston, A.E.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1007/ s00210-004-0942-5] [PMID: 15241581] [106] Renaud, J.; Emond, M.; Meilleur, S.; Psarropoulou, C.; Carmant, L. AIDA, a class I metabotropic glutamate-receptor antagonist limits kainate-induced hippocampal dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1046/j.1528-1157.2002.10402.x] [PMID: 12423379] [107] Thomsen, C.; Klitgaard, H.; Sheardown, M.; Jackson, H.C.; Eskesen, K.; Jacobsen, P.; Treppendahl, S.; Suzdak, P.D.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1046/j.1471-4159.1994.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/ S0028-3908(01)00044-2] [PMID: 11445181] [110] Yip, P.K.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/S0014-2999(99)00615-9] [PMID: 10556677] [112] Chapman, A.G.; Talebi, A.; Yip, P.K.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/j.brainres.2009.05.049] [PMID: 19481536] [115] Thomsen, C.; Dalby, N.O.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/S0028-3908(98)00138-5] [PMID: 9886669] [116] Fei, F.; Rao, W.; Zhang, L.; Chen, B.G.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"5    561 [http://dx.doi.org/10.1016/j.neuroscience.2014.02.037] [PMID: 24607348] [117] Lv, M.M.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/j.bbrc.2014.07.044] [PMID: 25026550] [118] Cui, Z.; Zhou, L.; Liu, C.; Zhu, G.; Wu, X.; Yan, Y.; Xia, X.; Ben, Z.; Song, Y.; Zhou, Y.; Zhang, H.; Zhang, D. The role of Homer1b/c in neuronal apoptosis following LPS-induced neuroinflammation.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1007/s11064-014-1460-6] [PMID: 25503822] [119] Luo, P.; Chen, T.; Zhao, Y.; Zhang, L.; Yang, Y.; Liu, W.; Li, S.; Rao, W.; Dai, S.; Yang, J.; Fei, Z. Postsynaptic scaffold protein Homer 1a protects against traumatic brain injury via r e g u l a t i n g  group I metabotropic glutamate receptors.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1038/cddis.2014.116] [PMID: 24722299] [120] Fei, F.; Li, J.; Rao, W.; Liu, W.; Chen, X.; Su, N.; Wang, Y.; Fei, Z. Upregulation of Homer1a Promoted Retinal Ganglion Cell Survival After Retinal Ischemia and Reperfusion via I n t e r a c t i n g  with Erk Pathway.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1007/s10571-015-0198-2] [PMID: 25924704] [121] Kammermeier, P.J.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1523/ JNEUROSCI.4499-14.2015] [PMID: 25740522] [123] Sato, M.; Suzuki, K.; Nakanishi, S. NMDA receptor stimulation and brain-derived neurotrophic factor upregulate homer 1a mRNA via t h e  m i t o g e n-activated protein kinase cascade in cultured cerebellar granule cells.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/ j.pnpbp.2013.06.010] [PMID: 23800465] [125] Wang, Y.; Fei, Z.; Ma, Y.H.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/ 10.1016/j.neulet.2012.03.016] [PMID: 22445886] [126] Beldhuis, H.J.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/ 0306-4522(93)90311-3] [PMID: 8232906] [127] Ohta, K.; Miyamoto, H.; Yaguchi, T.; Nagai, K.; Yamamoto, S.; Nomura, T.; Tanaka, A.; Nishizaki, T. Stearic acid facilitates hippocampal neurotransmission by enhancing nicotinic ACh receptor responses via a PKC pathway.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1016/j.molbrainres.2003.,OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.2174/156720507783018163] [PMID: 18220527] [129] Porcher, C.; Hatchett, C.; Longbottom, R.E.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1074/jbc.M110.201582] [PMID: 21474450] [130] Coelho, W.S.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1007/s11010-012-1462-0] [PMID: 23010892] [131] Cavaliere, F.; Benito-Muñoz, M.; Panicker, M.; Matute, C. NMDA modulates oligodendrocyte differentiation of subventricular zone cells through PKC activation.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.3389/fncel.2013.00261] [PMID: 24391542] [132] Ren, S.Q.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1038/emboj.2013.60] [PMID: 23511975] [133] Sobhia, M.E.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1517/13543776.2013.812073] [PMID: 23795866] [134] Yang, T.; Roder, K.E.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1007/s11095-005-9143-2] [PMID: 16450214] [135] Mach, U.R.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1002/cmdc.200500068] [PMID: 16892365] [136] Sun, H.; Lu, L.; Zuo, Y.; Wang, Y.; Jiao, Y.; Zeng, W.Z.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1038/ncomms5980] [PMID: 25236484] [137] Cuny, G.D. Kinase inhibitors as potential therapeutics for acute and chronic neurodegenerative conditions.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.2174/138161209789649330] [PMID: 19751204] [138] Connolly, C.N.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1074/jbc.274.51.36565] [PMID: 10593956] [139] Meier, J.; Akyeli, J.; Kirischuk, S.; Grantyn, R. GABA(A) receptor activity and PKC control inhibitory synaptogenesis in CNS tissue slices.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1002/ana.410160716] [PMID: 6150680] [141] Mikuni, N.; Nishiyama, K.; Babb, T.L.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1097/ 00001756-199905140-00040] [PMID: 10380990] [142] Kochan, L.D.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/ 10.1016/S0306-4522(99)00462-5] [PMID: 10670440] [143] Churn, S.B.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/S0028-3908(00) 00147-7] [PMID: 11114399] [145] Blair, R.E.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1016/j.ejphar.2008.04.021] [PMID: 18495112] [146] Ashpole, N.M.; Song, W.; Brustovetsky, T.; Engleman, E.A.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1074/jbc.M111.323915] [PMID: 22253441] [147] Ambrosino, P.; Alaimo, A.; Bartollino, S.; Manocchio, L.; De Maria, M.; Mosca, I.; Gomis-Perez, C.; Alberdi, A.; Scambia, G.; Lesca, G.; Villarroel, A.; Taglialatela, M.; Soldovieri, M.V.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1016/j.bbadis.,OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"[http://dx.doi.org/10.1111/jnc.12434] [PMID: 24032403] [151] Suh, Y.H.",OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
[http://dx.doi.org/10.1074/jbc.M112.439513] [PMID: 23612982],Non-OADS,/arxiv_data1/oa_pdf/a6/dc/CN-14-551.PMC4983745.pdf
"Neurosci., 2014, 34, 6-17. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuroscience, 2000, 98(3), 407-427.http://dx.doi.org/10.1016/S0306-4522(00)00146-9 [6] Nicoll, R.A.; Schmitz, D. Synaptic plasticity at hippocampal mossy fibre synapses.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Brain Res., 2007, 163, 43-61.http://dx.doi.org/10.1016/S0079-6123(07)63003-9 [8] Poschel, B.; Stanton, P.K.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Brain Res., 2007, 163, 473-500.http://dx.doi.org/10.1016/S0079-6123(07)63026-X [9] Cosgrove, K.E.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurobiol., 2011, 44(1), 9 3-101.http://dx.doi.org/10.1007/s12035-011-8187-z [10] Traynelis, S.F.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Rev., 2010, 62(3), 405-496.http://dx.doi.org/10.1124/pr.109.002451 [11] Vyklicky, V.; Korinek, M.; Smejkalova, T.; Balik, A.; Krausova, B.; Kaniakova, M.; Lichnerova, K.; Cerny, J.; Krusek, J.; Dittert, I.; Horak, M.; Vyklicky, L. Structure, function, and pharmacology of NMDA receptor channels.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurochem., 1994, 63(2), 769-772.http://dx.doi.org/10.1046/j.1471-4159.1994.63020769.x [14] Schoepp, D.D.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuropharmacology, 1996, 35(12), 1661-1672.http://dx.doi.org/ 10.1016/S0028-3908(96)00121-9 [15] Sladeczek, F.; Pin, J.P.; Recasens, M.; Bockaert, J.; Weiss, S. Glutamate stimulates inositol phosphate formation in striatal neurones.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Nature, 1985, 317(6039), 717-719.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Nature, 1987, 325(6104), 531-533.http://dx.doi.org/10.1038/325531a0 [17] Toms, N.J.; Jane, D.E.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Pharmacol., 1995, 116(7), 2824-2827.http://dx.doi.org/10.1111/ j.1476-5381.1995.tb15932.x [18] Ferraguti, F.; Conquet, F.; Corti, C.; Grandes, P.; Kuhn, R.; Knopfel, T. Immunohistochemical localization of the mGluR1beta metabotropic glutamate receptor in the adult rodent forebrain: evidence for a differential distribution of mGluR1 splice variants.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurol., 1998, 400(3), 391-407.http://dx.doi.org/ 10.1002/(SICI)1096-9861(19981026)400:3%3C391::AID-CNE8%3E3.0.CO;2-3 [19] Gereau, R.W.t.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Pharmacol., 1992, 107(2), 539-543.http://dx.doi.org/10.1111/j.1476-5381.1992.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuron, 1995, 14(5), 1029-1038.http://dx.doi.org/ 10.1016/0896-6273(95)90341-0 [24] McCool, B.A.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"U.S.A., 1992, 89(17), 8040-8044.http://dx.doi.org/ 10.1073/pnas.89.17.8040 [26] Tanabe, Y.; Nomura, A.; Masu, M.; Shigemoto, R.; Mizuno, N.; Nakanishi, S. Signal transduction, pharmacological properties, and expression patterns of two rat metabotropic glutamate receptors, mGluR3 and mGluR4.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurol., 1993, 335(2), 252-266. http://dx.doi.org/10.1002/cne.903350209 [28] Winder, D.G.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Res., 1996, 46(2), 131-137.http://dx.doi.org/10.1002/ (SICI)1097-4547(19961015)46:2%3C131::AID-JNR1%3E3.0.CO;2-I [29] Winder, D.G.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Physiol., 1996, 494 (Pt 3), 743-755.http://dx.doi.org/10.1113/jphysiol.1996.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuropharmacology, 2008, 54(5), 804-814. http://dx.doi.org/10.1016/j.neuropharm.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Cell Tissue Res., 2006, 326(2), 483-504.http://dx.doi.org/10.1007/ s00441-006-0266-5 [34] Jalan-Sakrikar, N.; Field, J.R.; Klar, R.; Mattmann, M.E.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2014, 5(12), 1221-1237.http://dx.doi.org/10.1021/ cn500153z [35] Corti, C.; Restituito, S.; Rimland, J.M.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurochem., 1998, 71(2), 636-645.http://dx.doi.org/10.1046/j.1471-4159.1998.71020636.x [37] Bradley, S.R.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Chem., 2004, 279(10), 9313-9320.http://dx.doi.org/10.1074/jbc.M310878200 [40] Conn, P .",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Drug Discov., 2014, 13(9), 692-708.http://dx.doi.org/10.1038/nrd4308 [41] Niswender, C.M.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Toxicol., 2010, 50, 295-322.http://dx.doi.org/10.1146/annurev.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Cell Signal, 2014, 26(10), 2284-2297.http://dx.doi.org/10.1016/j.cellsig.2014.04.022 [43] Schwartzkroin, P.A.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Brain Res., 1975, 89(1), 107-119.http://dx.doi.org/10.1016/ 0006-8993(75)90138-9 [44] Dudek, S.M.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"J Physiol, 1983, 334, 33-46.http://dx.doi.org/10.1113/jphysiol.1983.sp014478 [46] Dunwiddie, T.; Lynch, G. Long-term potentiation and depression of synaptic responses in the rat hippocampus: localization and frequency dependency.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Nature, 1986, 320(6062), 529-530.http://dx.doi.org/10.1038/ 320529a0 [48] Morris, R.G.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Nature, 1986, 319(6056), 774-776.http://dx.doi.org/10.1038/319774a0 [49] Larson, J.; Wong, D.; Lynch, G. Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Brain Res., 1986, 368(2), 347-350.http://dx.doi.org/ 10.1016/0006-8993(86)90579-2 [50] Larson, J.; Lynch, G. Induction of synaptic potentiation in hippocampus by patterned stimulation involves two events.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Science, 1986, 232(4753), 985-988.http://dx.doi.org/10.1126/ science.3704635 [51] Larson, J.; Lynch, G. Role of N-methyl-D-aspartate receptors in the induction of synaptic potentiation by burst stimulation patterned after the hippocampal theta-rhythm.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Brain Res., 1988, 441(1-2), 111-118. http://dx.doi.org/10.1016/0006-8993(88)91388-1 [52] Aiba, A.; Chen, C.; Herrup, K.; Rosenmund, C.; Stevens, C.F.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Cell, 1994, 79(2), 365-375.http://dx.doi.org/10.1016/0092-8674(94)90204-6 [53] Conquet, F.; Bashir, Z.I.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Nature, 1994, 372(6503), 237-243.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2008, 27(6), 1345-1352.http://dx.doi.org/10.1111/ j.1460-9568.2008.06109.x [55] Lan, J.Y.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"mGluR1-mediated potentiation of NMDA receptors involves a rise in intracellular calcium and activation of protein kinase C. Neuropharmacology, 2001, 40(7), 856-865.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Nature, 2003, 426(6964), 285-291.http://dx.doi.org/10.1038/nature02162 [58] Mannaioni, G.; Marino, M.J.; Valenti, O.; Traynelis, S.F.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Cortex, 2005, 15(11), 1703-1713.http://dx.doi.org/10.1093/ cercor/bhi047 [61] Jia, Z.; Lu, Y.; Henderson, J.; Taverna, F.; Romano, C.; Abramow-Newerly, W.; Wojtowicz, J.M.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Brain Res., 2004, 1022(1-2), 12-18.http://dx.doi.org/10.1016/j.brainres.2004.06.060 [64] Shalin, S.C.; Hernandez, C.M.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"J., 2001, 359(Pt 3), 465-484.http://dx.doi.org/10.1042/bj3590465 [68] Chevaleyre, V.; Castillo, P.E.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2014, 34(50), 16762-16773.http://dx.doi.org/10.1523/JNEUROSCI.2869-13.2014 [70] Younts, T.J.; Chevaleyre, V.; Castillo, P.E.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2013, 33(34), 13743-13757.http://dx.doi.org/10.1523/ JNEUROSCI.0817-13.2013 [71] Deadwyler, S.A.; Dunwiddie, T.; Lynch, G. A critical level of protein synthesis is required for long-term potentiation.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Synapse, 1987, 1(1), 90-95.http://dx.doi.org/10.1002/syn.890010112 [72] Frey, U.; Krug, M.; Reymann, K.G.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Brain Res., 1988, 452(1-2), 57-65.http://dx.doi.org/10.1016/0006-8993(88)90008-X [73] Stanton, P.K.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuropsychopharmacology, 2009, 34(9), 2057-2071. http://dx.doi.org/10.1038/npp.2009.30 [75] Noetzel, M.J.; Gregory, K.J.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Pharmacol., 2013, 83(4), 835-847.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuroscience, 1993, 53(4), 1009-1018.http://dx.doi.org/10.1016/0306-4522(93) 90485-X [78] Breakwell, N.A.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuron, 1994, 12(5), 1121-1129.http://dx.doi.org/10.1016/0896-6273(94)90319-0 [81] Gereau, R.W.t.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Lett., 1995, 186(2-3), 119-122.http://dx.doi.org/10.1016/0304-3940(95)11300-L [82] Ota, Y.; Zanetti, A.T.; Hallock, R.M.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurophysiol., 2003, 89(4), 1910-1919.http://dx.doi.org/10.1152/jn.00842.2002 [84] Kristensen, P.; Suzdak, P.D.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Lett., 1993, 155(2), 159-162.http://dx.doi.org/ 10.1016/0304-3940(93)90697-J [85] Kalinichev, M.; Rouillier, M.; Girard, F.; Royer-Urios, I.; Bournique, B.; Finn, T.; Charvin, D.; Campo, B.; Le Poul, E.; Mutel, V.; Poli, S.; Neale, S.A.; Salt, T.E.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Ther., 2013, 344(3), 624-636.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Pharmacol., 2010, 77(3), 459-468.http://dx.doi.org/10.1124/mol.109.058768 [87] Rosemond, E.; Wang, M.; Yao, Y.; Storjohann, L.; Stormann, T.; Johnson, E.C.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Pharmacol., 2004, 66(4), 834-842.http://dx.doi.org/ 10.1124/mol.104.002956 [88] Baskys, A.; Malenka, R.C.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Physiol., 1991, 444, 687-701.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Scientific World Journal, 2002, 2, 730-737.http://dx.doi.org/10.1100/ tsw.2002.146 [90] Shigemoto, R.; Kulik, A.; Roberts, J.D.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Nature, 1996, 381(6582), 523-525.http://dx.doi.org/10.1038/381523a0 [91] Callaerts-Vegh, Z.; Beckers, T.; Ball, S.M.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2006, 26(24), 6573-6582.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Learn Mem., 2008, 90(1), 103-111.http://dx.doi.org/10.1016/j.ejphar.2009.08.047 [93] Hikichi, H.; Murai, T.; Okuda, S.; Maehara, S.; Satow, A.; Ise,  S.; Nishino, M.; Suzuki, G.; Takehana, H.; Hata, M.; Ohta, H. Effects of a novel metabotropic glutamate receptor 7 negative allosteric modulator, 6-(4-methoxyphenyl)-5-methyl-3-pyridin-4-ylisoxazonolo[4,5-c]pyridin-4(5H)-one (MMPIP), on the central nervous system in rodents.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Pharmacol., 2010, 639(1-3), 106-114.http://dx.doi.org/10.1016/j.ejphar.2009.08.047 [94] Holscher, C.; Schmid, S.; Pilz, P.K.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Learn Mem., 2005, 12(5), 450-455.http://dx.doi.org/10.1101/lm.98305 [96] Fitzjohn, S.M.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuropharmacology, 1999, 38(10), 1577-1583.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Science, 2000, 288(5469), 1254-1257.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuropharmacology, 1997, 36(11-12), 1517-1532.http://dx.doi.org/10.1016/S0028-3908(97)00181-0 [100] Snyder, E.M.; Philpot, B.D.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2001, 4(11), 1079-1085. http://dx.doi.org/10.1038/nn746 [101] Fitzjohn, S.M.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Physiol., 2001, 537(Pt 2), 421-430.http://dx.doi.org/10.1111/j.1469-7793.2001.00421.x [102] Kemp, N.; McQueen, J.; Faulkes, S.; Bashir, Z.I.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuropharmacology, 1997, 36(3), 397-399.http://dx.doi.org/10.1016/S0028-3908(96)90015-5 [104] Kemp, N.; Bashir, Z.I.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuropharmacology, 1999, 38(4), 495-504.http://dx.doi.org/10.1016/S0028-3908(98)00222-6 [105] Manahan-Vaughan, D. Group 1 and 2 metabotropic glutamate receptors play differential roles in hippocampal long-term depression and long-term potentiation in freely moving rats.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurobiol., 2006, 66(3), 205-219.http://dx.doi.org/10.1002/ neu.20213 [107] Uyama, Y.; Ishida, M.; Shinozaki, H. DCG-IV, a potent metabotropic glutamate receptor agonist, as an NMDA receptor agonist in the rat cortical slice.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Brain Res., 1997, 752(1-2), 327-330.http://dx.doi.org/10.1016/S0006-8993(97)00079-6 [108] Wilsch, V.W.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Pharmacol., 1994, 262(3), 287-291.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Lett., 2011, 504(2), 102-106.http://dx.doi.org/10.1016/j.neulet.2011.09.007 [110] Lodge, D.; Tidball, P.; Mercier, M.S.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuro- pharmacology, 2013, 74, 135-146.http://dx.doi.org/10.1016/ j.neuropharm.2013.03.011 [111] Otani, S.; Daniel, H.; Takita, M.; Crepel, F. Long-term depression induced by postsynaptic group II metabotropic glutamate receptors linked to phospholipase C and intracellular calcium rises in rat prefrontal cortex.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2007, 26(5), 1166-1172.http://dx.doi.org/10.1111/j.1460-9568.2007.05742.x [114] Naie, K.; Gundimi, S.; Siegmund, H.; Heinemann, U.; Manahan-Vaughan, D. Group III metabotropic glutamate receptor-mediated, chemically induced long-term depression differentially affects cell viability in the hippocampus.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Eur J Pharmacol, 2006, 535(1-3), 104-113.http://dx.doi.org/10.1016/j.ejphar.2006.01.030 [115] Claiborne, B.J.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Hippocampus, 1993, 3(2), 115-121.http://dx.doi.org/ 10.1002/hipo.450030202 [116] Toth, K.; Suares, G.; Lawrence, J.J.; Philips-Tansey, E.; McBain, C.J.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Hippocampus, 1993, 3(2), 165-182.http://dx.doi.org/10.1002/hipo.450030209 [119] Jonas, P.; Major, G.; Sakmann, B. Quantal components of unitary EPSCs at the mossy fibre synapse on CA3 pyramidal cells of rat hippocampus.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Physiol., 1993, 472, 615-663.http://dx.doi.org/ 10.1113/jphysiol.1993.sp019965 [120] Lawrence, J.J.; Grinspan, Z.M.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"5    471 Physiol., 2004, 554(Pt 1), 175-193.http://dx.doi.org/10.1113/ jphysiol.2003.049551 [121] Zalutsky, R.A.; Nicoll, R.A.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Science, 1990, 248(4963), 1619-1624.http://dx.doi.org/10.1126/science.2114039 [122] Contractor, A.; Swanson, G.; Heinemann, S.F.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuron, 2001, 29(1), 209-216.http://dx.doi.org/10.1016/S0896-6273(01)00191-X [123] Fedele, D.E.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Brain, 2005, 128(Pt 10), 2383-2395.http://dx.doi.org/ 10.1093/brain/awh555 [124] Moore, K.A.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"U.S.A., 2003, 100(24), 14397-14402.http://dx.doi.org/ 10.1073/pnas.1835831100 [125] Schmitz, D.; Mellor, J.; Nicoll, R.A. Presynaptic kainate receptor mediation of frequency facilitation at hippocampal mossy fiber synapses.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Science, 2001, 291(5510), 1972-1976.http://dx.doi.org/ 10.1126/science.1057105 [126] Kamiya, H.; Ozawa, S. Dual mechanism for presynaptic modulation by axonal metabotropic glutamate receptor at the mouse mossy fibre-CA3 synapse.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Physiol., 1999, 518 (Pt 2), 497-506.http://dx.doi.org/10.1111/j.1469-7793.1999.0497p.x [127] Yokoi, M.; Kobayashi, K.; Manabe, T.; Takahashi, T.; Sakaguchi, I.; Katsuura, G.; Shigemoto, R.; Ohishi, H.; Nomura, S.; Nakamura, K.; Nakao, K.; Katsuki, M.; Nakanishi, S. Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Science, 1996, 273(5275), 645-647.http://dx.doi.org/10.1126/ science.273.5275.645 [128] Scanziani, M.; Salin, P.A.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Nature, 1997, 385(6617), 630-634.http://dx.doi.org/10.1038/385630a0 [129] Vogt, K.E.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Brain Res., 1984, 290(1), 174-178.http://dx.doi.org/10.1016/0006-8993(84)90750-9 [131] Manzoni, O.J.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuropharmacology, 1995, 34(8), 965-971. http://dx.doi.org/10.1016/0028-3908(95)00060-J [132] Harris, E.W.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 1998, 10(2), 478-487.http://dx.doi.org/10.1046/j.1460-9568.1998.00063.x [134] Weisskopf, M.G.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Nature, 1995, 376(6537), 256-259.http://dx.doi.org/ 10.1038/376256a0 [135] Staubli, U.; Larson, J.; Lynch, G. Mossy fiber potentiation and long-term potentiation involve different expression mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Synapse, 1990, 5(4), 333-335.http://dx.doi.org/10.1002/syn.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"U.S.A., 1996, 93(10), 4712-4717.http://dx.doi.org/10.1073/ pnas.93.10.4712 [138] Tong, G.; Malenka, R.C.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuron, 1996, 16(6), 1147-1157.http://dx.doi.org/ 10.1016/S0896-6273(00)80141-5 [139] Ito, I .",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuroreport, 1991, 2(6), 333-336.http://dx.doi.org/10.1097/00001756-199106000-00008 [140] Bashir, Z.I.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Nature, 1993, 363(6427), 347-350.http://dx.doi.org/10.1038/363347a0 [141] Yeckel, M.F.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 1999, 2(7), 625-633.http://dx.doi.org/10.1038/ 10180 [142] Nistico, R.; Dargan, S.L.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Rep., 2011, 1, 103.http://dx.doi.org/10.1038/srep00103 [143] Hsia, A.Y.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuropharmacology, 1995, 34(11), 1567-1572.http://dx.doi.org/10.1016/0028-3908(95)00115-M [144] Manzoni, O.J.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 1994, 6(6), 1050-1054.http://dx.doi.org/10.1111/j.1460-9568.1994.tb00599.x [145] Mellor, J.; Nicoll, R.A. Hippocampal mossy fiber LTP is independent of postsynaptic calcium.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2001, 4(2), 125-126.http://dx.doi.org/10.1038/83941 [146] Katsuki, H.; Kaneko, S.; Tajima, A.; Satoh, M. Separate mechanisms of long-term potentiation in two input systems to CA3 pyramidal neurons of rat hippocampal slices as revealed by the whole-cell patch-clamp technique.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Res., 1991, 12(3), 393-402.http://dx.doi.org/10.1016/0168-0102(91)90070-F [147] Langdon, R.B.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurobiol., 1995, 26(3), 370-385.http://dx.doi.org/10.1002/neu.480260309 [148] Sokolov, M.V.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2003, 17(7), 1425-1437.http://dx.doi.org/10.1046/j.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuron, 2008, 57(1), 108-120.http://dx.doi.org/ 10.1016/j.neuron.2007.11.024 [150] Rebola, N.; Lujan, R.; Cunha, R.A.; Mulle, C. Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuron, 2008, 57(1), 121-134.http://dx.doi.org/10.1016/j.neuron.2007.11.023 [151] Galvan, E.J.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2010, 30(8), 2844-2855.http://dx.doi.org/10.1523/ JNEUROSCI.5269-09.2010 [153] Pelkey, K.A.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Physiol., 2008, 586(6), 1495-1502.http://dx.doi.org/10.1113/jphysiol.2007.148635 [154] Kobayashi, K.; Manabe, T.; Takahashi, T. Presynaptic long-term depression at the hippocampal mossy fiber-CA3 synapse.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Science, 1996, 273(5275), 648-650.http://dx.doi.org/10.1126/science.273.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuron, 2002, 33(6), 921-933. http://dx.doi.org/10.1016/S0896-6273(02)00608-6 [157] Maccaferri, G.; Toth, K.; McBain, C.J.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Science, 1998, 279(5355), 1368-1370.http://dx.doi.org/10.1126/science.279.5355.1368 [158] Pelkey, K.A.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuropharmacology, 2007, 52(1), 108-117.http://dx.doi.org/10.1016/j.neuropharm.2006.07.020 [160] Bischofberger, J.; Jonas, P. TwoB or not twoB: differential transmission at glutamatergic mossy fiber-interneuron synapses in the hippocampus.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Trends Neurosci., 2002, 25(12), 600-603.http://dx.doi.org/10.1016/S0166-2236(02)02259-2 [161] Lei, S.; McBain, C.J.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2004, 24(9), 2112-2121.http://dx.doi.org/10.1523/ JNEUROSCI.4645-03.2004 [162] Pelkey, K.A.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuron, 2006, 52(3), 497-510.http://dx.doi.org/10.1016/j.neuron.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Dis., 2006, 21(1), 217-227.http://dx.doi.org/10.1016/j.nbd.2005.07.005 [164] Auerbach, B.D.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Nature, 2011, 480(7375), 63-68.http://dx.doi.org/10.1038/ nature10658 [165] Fischer, A.; Sananbenesi, F.; Pang, P.T.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuron, 2005, 48(5), 825-838.http://dx.doi.org/10.1016/j.neuron.2005.10.033 [166] Huber, K.M.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2008, 28(7), 1342-1350.http://dx.doi.org/10.1111/j.1460-9568.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"J. N e u r o s c i ., 2006, 26(1), 319-327.http://dx.doi.org/10.1523/JNEUROSCI.2623-05.2006 [169] Na, E.S.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2012, 32(9), 3109-3117.http://dx.doi.org/10.1523/JNEUROSCI.6000-11.2012 [170] Qiu, S.; Korwek, K.M.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Mem., 2006, 85(3), 228-242.http://dx.doi.org/10.1016/ j.nlm.2005.11.001 [171] Tian, D.; Stoppel, L.J.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2015.http://dx.doi.org/10.1038/nn.3911 [172] Weng, S.M.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuroscience, 2011, 180, 314-321.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Brain Behav., 2005, 4(6), 393-398.http://dx.doi.org/10.1111/j.1601-183X.2005.00135.x [174] Bear, M.F.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Trends Neurosci., 2004, 27(7), 370-377.http://dx.doi.org/10.1016/j.tins.2004.04.009 [175] Golzio, C.; Willer, J.; Talkowski, M.E.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Genet., 2001, 27(3), 322-326.http://dx.doi.org/ 10.1038/85899 [177] Horev, G.; Ellegood, J.; Lerch, J.P.; Son, Y.E.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2002, 25, 315-338.http://dx.doi.org/10.1146/annurev.neuro.25.112701.142909 [179] Portmann, T.; Yang, M.; Mao, R.; Panagiotakos, G.; Ellegood, J.; Dolen, G.; Bader, P.L.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Cell Rep., 2014, 7(4), 1077-1092.http://dx.doi.org/10.1016/j.celrep.2014.03.036 [180] Michalon, A.; Sidorov, M.; Ballard, T.M.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuron, 2012, 74(1), 49-56.http://dx.doi.org/10.1016/ j.neuron.2012.03.009 [181] Thomas, A.M.; Bui, N.; Perkins, J.R.; Yuva-Paylor, L.A.; Paylor, R. Group I metabotropic glutamate receptor antagonists alter  select behaviors in a  m o u s e  m o d e l  f o r  f r a g i l e  X  s y n d r o m e .",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Psychopharmacology (Berl), 2012, 219(1), 47-58. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2013, 31(7), 667-678. http://dx.doi.org/10.1016/j.ijdevneu.2013.02.008 [183] Luikenhuis, S.; Giacometti, E.; Beard, C.F.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"A, 2010, 152A(5), 1079-1088. http://dx.doi.org/10.1002/ajmg.a.33184 [185] Hardy, J.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neuron, 2006, 52(1), 3-13.http://dx.doi.org/10.1016/j.neuron.2006.09.016 [186] Urban, N.N.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Hippocampus, 2001, 11(4), 408-417.http://dx.doi.org/10.1002/hipo.1055 [187] Hagena, H.; Manahan-Vaughan, D. Learning-facilitated synaptic plasticity at CA3 mossy fiber and commissural-associational synapses reveals different roles in information processing.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Cortex, 2011, 21(11), 2442-2449.http://dx.doi.org/10.1093/cercor/bhq271 [188] Daumas, S.; Ceccom, J.; Halley, H.; Frances, B.; Lassalle, J.M.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Learn Mem., 2009, 16(8), 504-507.http://dx.doi.org/10.1101/lm.1418309 [189] Gibson, H.E.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2005, 22(7), 1701-1712.http://dx.doi.org/ 10.1111/j.1460-9568.2005.04349.x [190] Witton, J.; Brown, J.T.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2014, 5(7), 597-610.http://dx.doi.org/10.1021/ cn5000343 [192] Cho, H.P.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Biol., 2014, 9(10), 2334-2346.http://dx.doi.org/10.1021/cb500560h [193] Lovell, K.M.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Lett., 2013, 23(13), 3713-3718.http://dx.doi.org/10.1016/j.bmcl.2013.05.020 [194] Wenthur, C.J.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Chem., 2013, 56(12), 5208-5212.http://dx.doi.org/ 10.1021/jm400439t [195] Chen, Y.; Nong, Y.; Goudet, C.; Hemstapat, K.; de Paulis, T.; Pin, J.P.; Conn, P.J.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Pharmacol., 2007, 71(5), 1389-1398.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Lett., 2014, 24(15), 3641-3646.http://dx.doi.org/10.1016/j.bmcl.2014.04.087 [198] Varnes, J.G.",OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Lett., 2011, 21(5), 1402-1406.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"FASEB J., 2012, 26(4), 1682-1693.http://dx.doi.org/10.1096/fj.11-195941 [201] Nosyreva, E.D.",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Neurosci., 2005, 25(11), 2992-3001.http://dx.doi.org/10.1523/JNEUROSCI.3652-04.2005",Non-OADS,/arxiv_data1/oa_pdf/39/d2/CN-14-455.PMC4983746.pdf
"Gene Only SCZ Patients Only Controls Both GRM1 8 1 1 GRM2 2 0 2 GRM3 2 2 0 GRM4 0 0 0 GRM5 5 2 0 GRM6 1 1 0 GRM7 0 2 0 GRM8 2 3 1 Total 20 11 4   We also queried the database (http://exac.broadinstitute.org) provided by Exome Aggregation Consortium (ExAC) collecting the whole-exome sequencing data for a total of 61,486 u n r e l a t e d  i n d i vi d u al s  f r o m  b o t h  h e a l t h y  c o h o r t s  a nd  large genetic studies on complex diseases (including SCZ).",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Genet., 2008, 40(7),  827-834. http://dx.doi.org/10.1038/ng.171 [3] Gottesman, I.I.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"J. Psychiatry, 2003, 160(4), 636-645.http://dx.doi.org/10.1176/appi.ajp.160.4.636 [4] Greenwood, T.A.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"J. Psychiatry, 2013, 170( 5), 521-532.http://dx.doi.org/10.1176/appi.ajp.2012.12020186 [5] A. Yasuhara and S. Chaki, Metabotropic glutamate receptors: potential drug targets for psychiatric disorders., Open Med.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"J., 2010, 4, 20-36.http://dx.doi.org/10.2174/1874104501004020020 [6] Marsman, A.; van den Heuvel, M.P.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Bull., 2013, 39(1), 120-129.http://dx.doi.org/10.1093/schbul/sbr069 [7] Field, J.R.; Walker, A.G.; Conn, P.J.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Med., 2011, 17(12), 689-698. http://dx.doi.org/10.1016/j.molmed.2011.08.004 [8] C.M.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Toxicol., 2010, 50, 295-322.http://dx.doi.org/10.1146/annurev.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Bull., 2008, 34(4), 791-797.http://dx.doi.org/10.1093/ schbul/sbn050 [10] Tabor, H.K.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Genet., 2002, 3(5), 391-397.http://dx.doi.org/10.1038/nrg796 [11] Stranger, B.E.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
367-383.http://dx.doi.org/10.1534/genetics.,Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Nucleic Acids Res., 2012, 40(9), 3785-3799.http://dx.doi.org/ 10.1093/nar/gkr1265 [13] Pabinger, S.; Dander, A.; Fischer, M.; Snajder, R.; Sperk, M.; Efremova, M.; Krabichler, B.; Speicher, M.R.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Bioinform., 2014, 15(2), 256-278.http://dx.doi.org/ 10.1093/bib/bbs086 [14] Slatkin, M. Linkage disequilibrium--understanding the evolutionary past and mapping the medical future.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Genet., 2008, 9,  477-485.http://dx.doi.org/10.1038/nrg2361 [15] Browning, S.R.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Genet., 2011, 12, 703-714.http://dx.doi.org/10.1038/nrg3054 [16] Ewens, W.J.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Genet., 2 0 0 3, 13(2), 71-76.http://dx.doi.org/10.1097/01.ypg.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Genet., 2005, 77(6), 918-936.http://dx.doi.org/10.1086/ 497703 [20] Chen, Q.; He, G.; Chen, Q.; Wu, S.; Xu, Y.; Feng, G.; Li, Y.; Wang, L.; He, L. A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population., Schizophr.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Res., 2005, 73(1), 21-26.http://dx.doi.org/10.1016/j.schres.2004.07.002 [21] Norton, N.; Williams, H.J.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"BMC Psychiatry, 2005, 5, 23.http://dx.doi.org/10.1186/1471-244X-5-23 [22] Mössner, R.; Schuhmacher, A.; Schulze-Rauschenbach, S.; Kühn, K.-U.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Neuropsychopharmacol., 2008, 18(10), 768-772.http://dx.doi.org/10.1016/j.euroneuro.2008.05.007 [23] O’Brien, N.L.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Genet., 2014, 24(6), 277-278.http://dx.doi.org/10.1097/YPG.0000000000000050 [24] Albalushi, T.; Horiuchi, Y.; Ishiguro, H.; Koga, M.; Inada, T.; Iwata, N.; Ozaki, N.; Ujike, H.; Watanabe, Y.; Someya, T.; Arinami, T. Replication study and meta-analysis of the genetic association of GRM3 gene polymorphisms with schizophrenia in a large Japanese case-control population.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Genet., 2000, 10(2), 83-86.http://dx.doi.org/10.1097/00041444-200010020-00005 [26] Bolonna, A.A.; Kerwin, R.W.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Res., 2001, 47(1), 99-103. http://dx.doi.org/10.1016/S0920-9964(99)00235-2 [27] Ohtsuki, T.; Koga, M.; Ishiguro, H.; Horiuchi, Y.; A r a i ,  M .",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Res., 2008, 101(1-3), 9-16.http://dx.doi.org/10.1016/j.schres.2008.01.027 [28] Ganda, C.; Schwab, S.G.; Amir, N.; Heriani, H.; Irmansyah, I.; Kusumawardhani, A.; Nasrun, M.; Widyawati, I.; Maier, W.; Wildenauer, D.B.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Neuropsychopharmacol., 2009, 12(9), 1283-1289. http://dx.doi.org/10.1017/S1461145709990356 [29] Shibata, H.; Tani, A.; Chikuhara, T.; Kikuta, R.; Sakai, M.; Ninomiya, H .",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Psychiatry Res., 2009, 167(1-2), 88-96.http://dx.doi.org/10.1016/ j.psychres.2007.12.002 [30] Zhao, Y.; Zhang, K.; Xu, Q.; Shen, Y.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Genet., 2004, 128(1), 6-14. http://dx.doi.org/10.1002/ajmg.b.20108 [32] Joo, A.; Shibata, H.; Ninomiya, H.; Kawasaki, H.; Tashiro, N.; Fukumaki, Y.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Psychiatry, 2001, 6(2), 186-192. http://dx.doi.org/10.1038/sj.mp.4000841 [33] Tsunoka, T.; Kishi, T.; Kitajima, T.; Okochi, T.; Okumura, T.; Yamanouchi, Y. ; Kinoshita, Y.; Kawashima, K.; Naitoh, H.; Inada, T.; Ujike, H.; Yamada, M.; Uchimura, N.; Sora, I.; Iyo, M.; Ozaki, N.; Iwata, N. Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Psychiatry, 2010, 34(4), 639-644. http://dx.doi.org/10.1016/ j.pnpbp.2010.03.002 [34] Ayoub, M.A.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Genet., 2002, 114(1), 46-50.http://dx.doi.org/ 10.1002/ajmg.1624 [36] Ohtsuki, T.; Toru, M.; Arinami, T. Mutation screening of the metabotropic glutamate receptor mGluR4 (GRM4) gene in patients with schizophrenia.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Genet., 2001, 11(2), 79-83. http://dx.doi.org/10.1097/00041444-200106000-00004 [37] Devon, R.S.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Psychiatry, 2001, 6(3), 311-314. http://dx.doi.org/10.1038/sj.mp.4000848 [38] Bishop, J.R.; Ellingrod, V.L.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Res., 2005, 77(2-3), 253-260. http://dx.doi.org/10.1016/j.schres.2005.04.001 [39] Tan, H.-Y.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"http://dx.doi.org/10.1093/cercor/bhm069 [40] Mounce, J.; Luo, L.; Caprihan, A.; Liu, J.; Perrone-Bizzozero, N.I.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Res., 2014, 155(1-3), 8-14. http://dx.doi.org/10.1016/j.schres.2014.03.003 [41] Kinoshita, A.; Takizawa, R.; Koike, S.; Satomura, Y.; Kawasaki, S.; Kawakubo, Y.; Marumo, K.; Tochigi, M.; Sasaki, T.; Nishimura, Y.; Kasai, K. Effect of metabotropic glutamate receptor-3 variants on prefrontal brain activity in schizophrenia: An imaging genetics study using multi-channel near-infrared spectroscopy.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Psychiatry, 2015. http://dx.doi.org/10.1016/j.pnpbp.2015.04.006 [42] Hu, W.; MacDonald, M.L.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Phar- macogenomics J., 2009, 9(5), 311-318. http://dx.doi.org/10.1038/ tpj.2009.24 [45] Whirl-Carrillo, M.; McDonagh, E.M.; Hebert, J.M.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Ther., 2012, 92(4), 414-417. http://dx.doi.org/ 10.1038/clpt.2012.96 [46] Bishop, J.R.; Reilly, J.L.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Psychopharmacol., 2011, 1(1), 5-18. http://dx.doi.org/10.1177/2045125311400779 [48] Bush, W.S.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Biol., 2012, 8(12), 1002822. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Nature, 2009, 460, 748-752. http://dx.doi.org/10.1038/nature08185 [50] Magri, C.; Sacchetti, E.; Traversa, M.; Valsecchi, P.; Gardella, R.; Bonvicini, C.; Minelli, A.; Gennarelli, M.; Barlati, S. New copy number variations in schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Psychiatry, 2007, 15(5), 245-258. http://dx.doi.org/10.1080/10673220701679838 [55] Stroup, T.S.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Genet., 2011, 43(10), 969-976. http://dx.doi.org/10.1038/ ng.940 [57] Uher, R. Gene-environment interactions in severe mental illness.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Neurosci., 2014, 17(6), 756-763. http://dx.doi.org/10.1038/nn.3716 [61] Schreiber, M.; Dorschner, M.; Tsuang, D. Next-generation sequencing in schizophrenia and other neuropsychiatric disorders.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Genet., 2013, 162B(7), 671-678. http://dx.doi.org/10.1002/ajmg.b.32156 [62] Kato, T. Whole genome/exome sequencing in mood and psychotic disorders.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Genet., 2011, 43(9), 864-868. http://dx.doi.org/10.1038/ng.902 [64] Xu, B.; Ionita-Laza, I.; Roos, J.L.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Cell, 2013, 154(3), 518-529. http://dx.doi.org/10.1016/j.cell.2013.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Nature, 2014, 506(7487), 179-184.http://dx.doi.org/ 10.1038/nature12929 [67] Guipponi, M.; Santoni, F.A.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"PLoS One, 2014, 9(11), e112745.http://dx.doi.org/ 10.1371/journal.pone.0112745 [68] Ionita-Laza, I.; Xu, B.; Makarov, V.; Buxbaum, J.D.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"U.S.A., 2014, 111(1), 343-348. http://dx.doi.org/10.1073/ pnas.1309475110 [69] McCarthy, S.E.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Psychiatry, 2014, 19(6), 652-658. http://dx.doi.org/10.1038/mp.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Neuron, 2014, 82(4), 773-780.http://dx.doi.org/10.1016/j.neuron.2014.04.043 [71] Purcell, S.M.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Nature, 2014, 506(7487), 185-190. http://dx.doi.org/10.1038/ nature12975 [72] Need, A.C.; McEvoy, J.P.; Gennarelli, M.; Heinzen, E.L.; Ge, D.; Maia, J.M.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Genet., 2012, 91(2), 303-312.http://dx.doi.org/10.1016/j.ajhg.2012.06.018 [73] Bundo, M.; Toyoshima, M.; Okada, Y.; Akamatsu, W.; Ueda, J.; Nemoto-Miyauchi, T.; Sunaga, F.; Toritsuka, M.; Ikawa, D.; Kakita, A.; K a t o , M.; Kasai, K.; Kishimoto, T.; Nawa, H.; Okano, H.; Yoshikawa, T.; K a t o ,  T .",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Neuron, 2014, 81(2), 306-313. http://dx.doi.org/10.1016/j.neuron.2013.",OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"http://dx.doi.org/10.1371/journal.pgen.1003709 [76] Moore, C.B.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Res., 2014, 152(2-3), 325-332. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Drug Targets, 2012, 13(1), 145-156. http://dx.doi.org/10.2174/138945012798868452 [79] Moghaddam, B.; Javitt, D. From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Neuropsychopharmacology, 2012, 37(1), 4-15. http://dx.doi.org/10.1038/npp.2011.181 [81] Patil, S.T.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"http://dx.doi.org/10.1186/s12888-014-0351-3 [83] Lencz, T.; Malhotra, A.K.",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Psychiatry, 2015. http://dx.doi.org/10.1038/mp.2015.28",Non-OADS,/arxiv_data1/oa_pdf/17/11/CN-14-540.PMC4983747.pdf
"Neurosci., 2013, 14(7), 502-511.http://dx.doi.org/10.1038/nrn3516 [3] Zhuo, M. Cortical excitation and chronic pain.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurosci., 2008, 31(4), 199-207.http://dx.doi.org/10.1016/j.tins.2008.01.003 [4] Vogt, B.A.",OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurosci., 2009, 10(1), 59-70.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Physiol., 2001, 532(3), 823-833.http://dx.doi.org/10.1111/j.1469-7793.2001.0823e.x [8] Wu, M.F.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurobiol., 2012, 22(3), 461-469.http://dx.doi.org/10.1016/j.conb.2011.12.006 [10] Ferraguti, F.; Shigemoto, R. Metabotropic glutamate receptors.",OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Res., 2006, 326(2), 483-504.http://dx.doi.org/10.1007/ s00441-006-0266-5 [11] Shigemoto, R.; Mizuno, N. Chapter III Metabotropic glutamate receptors — i m m u n o c y t o c h e m i c a l  and in situ h y b r i d i z a t i o n  analyses; Handbook of Chemical Neuroanatomy.",OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Elsevier B.V: Amsterdam, 2000, 18, 63-98.http://dx.doi.org/10.1016/S0924-8196(00)80044-5 [12] Bliss, T.V.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Nature, 1993, 361(6407), 31-39.http://dx.doi.org/10.1038/361031a0 [13] Nicoll, R.A.; Schmitz, D. Synaptic plasticity at hippocampal mossy fibre synapses.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Brain, 2012, 5(14), 1-12.http://dx.doi.org/10.1186/1756-6606-5-14 [15] Zhuo, M. Long-term potentiation in the anterior cingulate cortex and chronic pain.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Molecular Brain, 2013, 6(5), 1-14.http://dx.doi.org/10.1186/1756-6606-6-5 [17] Collingridge, G.L.",OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurosci., 2010, 11(7), 459-473.http://dx.doi.org/10.1038/nrn2867 [18] Zhao, M.G.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neuron, 2005, 47(6), 859-872.http://dx.doi.org/10.1016/j.neuron.2005.08.014 [19] Qiu, S.; Chen, T.; Koga, K.; Guo, Y.Y.",OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Signal., 2013, 6(275), 1-11.http://dx.doi.org/10.1126/scisignal.2003778 [20] Toyoda, H.; Zhao, M.G.",OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurosci., 2005, 22(2), 485-494.http://dx.doi.org/10.1111/j.1460-9568.2005.04236.x [21] Zhao, M.G.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurosci., 2012, 32(33), 11318-11329. http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Pain, 2014, 10 (1), 1-14.http://dx.doi.org/10.1186/1744-8069-10-1 [26] Qiu, S.; Zhang, M.; Liu, Y.; Guo, Y.; Zhao, H.; Song, Q.;  Zhao, M.; Huganir, R.L.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurosci., 2014, 34(40), 13505-13515. http://dx.doi.org/10.1523/JNEUROSCI.1431-14.2014 [27] Singer, T.; Seymour, B.; O'Doherty, J.; Kaube, H.; Dolan, R.J.; Frith, C.D.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurophysiol., 2005, 94(1), 878-882.http://dx.doi.org/ 10.1152/jn.01205.2004 [32] Wu, L.J.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Pain, 2007, 3(11), 1-6.http://dx.doi.org/10.1186/1744-8069-3-11 [33] Wang, H.; Xu, H.; Wu, L.J.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Med., 2011, 3(65), 1-13.http://dx.doi.org/10.1126/scitranslmed.3001269",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neuron, 2002, 36(4), 713-726.http://dx.doi.org/10.1016/S0896-6273(02)01019-X [35] Hayashi, Y.; Shi, S.H.",OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Science., 2000, 287(5461), 2262-2267.http://dx.doi.org/10.1126/ science.287.5461.2262 [36] Passafaro, M.; Piëch, V.; Sheng, M. Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons.",OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurosci., 2001, 4(9), 917-926.http://dx.doi.org/ 10.1038/nn0901-917 [37] Toyoda, H.; Wu, L.J.",OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurobiol., 2007, 67(4), 498-509.http://dx.doi.org/10.1002/dneu.20380 [38] Toyoda, H.; Wu, L.J.",OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Physiol., 2007, 211(2), 336-343.http://dx.doi.org/10.1002/jcp.20940 [39] Liu, M.G.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurophysiol., 2013, 110(2), 505-521.http://dx.doi.org/10.1152/jn.01104.2012 [40] Liu, M.G.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Brain, 2014, 7 (27), 1-13.http://dx.doi.org/10.1186/ 1756-6606-7-27 [41] Wu, L.J.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurosci., 2005, 25, 11107-11116. http://dx.doi.org/10.1523/JNEUROSCI.1678-05.2005 [42] Xu, H.M.; Wu, L.J.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurosci., 2008, 28(29), 7445-7453.http://dx.doi.org/10.1523/ JNEUROSCI.1812-08.2008 [43] Chen, T.; Koga, K.; Descalzi, G.; Qiu, S.; Wang, J.; Zhang, L.S.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Pain, 2014, 10(33), 1-16.http://dx.doi.org/10.1186/ 1744-8069-10-S1-P1 [44] Chen, T.; Wang, W.; Dong, Y.L.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Brain, 2014, 7(76), 1-12.http://dx.doi.org/10.1186/s13041-014-0076-8 [45] Naik, M.U.",OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurol., 2000, 426(2), 243-258.http://dx.doi.org/10.1002/1096-9861(20001016) 426:2%3C243::AID-CNE6%3E3.0.CO;2-8 [46] Malenka, R.C.",OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neuron., 2004, 44(1), 5-21.http://dx.doi.org/10.1016/ j.neuron.2004.09.012 [47] Liu, M.G.",OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurosci., 2013, 38(8), 3128-3145.http://dx.doi.org/ 10.1111/ejn.12330 [48] Chiou, C.S.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Pain, 2012, 153(10), 2097-2108.http://dx.doi.org/10.1016/j.pain.2012.06.031 [49] Koga, K.; Descalzi, G.; Chen, T.; Ko H.G; Lu, J.; Li, S.; Son, J.; Kim, T.H.",OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurosci., 2015, 35(5), 2033-2043.http://dx.doi.org/10.1523/JNEUROSCI.2644-14.2015 [51] Abraham, W.C.; Bear, M.F.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurosci., 1996, 19(4), 126-130.http://dx.doi.org/10.1016/S0166-2236(96)80018-X [52] Abraham, W.C. Metaplasticity: tuning synapses and networks for plasticity.",OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurosci., 2008, 9(5), 1-13.http://dx.doi.org/ 10.1038/nrn2356 [53] Chiechio, S.; Nicoletti, F. Metabotropic glutamate receptors and the control of chronic pain.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Pharmacol., 2012, 12(1), 28-34.http://dx.doi.org/10.1016/j.coph.2011.10.010 [54] Palazzo, E.; Marabese, I.; de Novellis, V.; Rossi, F.; Maione, S. Supraspinal metabotropic glutamate receptors: a target for pain relief and beyond.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Pain, 2000, 4(1), 83-96.http://dx.doi.org/10.1053/eujp.1999.0158 [57] Ji, G.; Neugebauer, V. Pain-related deactivation of medial prefrontal cortical neurons involves mGluR1 and GABA(A) receptors.",Non-OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"Neurophysiol., 2011, 106(5), 2642-2652.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/a4/db/CN-14-427.PMC4983748.pdf
"[http://dx.doi.org/10.1007/ s00018-008-8263-3] [PMID: 18712277] [2] Lüscher, C.; Huber, K.M.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/ 10.1016/j.neuron.2010.01.016] [PMID: 20188650] [3] Anwyl, R. Metabotropic glutamate receptor-dependent long-term potentiation.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1146/annurev-neuro-060909-153138] [PMID: 22483044] [5] Ribeiro, F.M.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.2174/187152710793361612] [PMID: 20632969] [6] Goudet, C.; Magnaghi, V.; Landry, M.; Nagy, F.; Gereau, R.W., IV; Pin, J.P. Metabotropic receptors for glutamate and GABA in pain.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1016/j.coph.2011.10.010] [PMID: 22040745] [8] Niswender, C.M.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1016/ j.bbr.2012.11.042] [PMID: 23228523] [10] Herman, E.J.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1007/978-3-642-25758-2_11] [11] Cho, H.P.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1021/ cb500560h] [PMID: 25137254] [12] Pomierny-Chamioło, L.; Rup, K.; Pomierny, B.; Niedzielska, E.; Kalivas, P.W.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1016/j.pharmthera.2013.12.012] [PMID: 24362085] [13] Inanobe, A.; Kurachi, Y. Membrane channels as integrators of G-protein-mediated signaling.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1016/j.bbamem.2013.08.018] [PMID: 24028827] [14] Fagni, L.; Ango, F.; Perroy, J.; Bockaert, J.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/ 10.1016/S0166-2236(99)01492-7] [PMID: 10652549] [16] Hermans, E.; Challiss, R.A.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1042/bj3590465] [PMID: 11672421] [17] Hou, L.; Klann, E. Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1523/ JNEUROSCI.0995-04.2004] [PMID: 15254091] [18] Costa-Mattioli, M.; Sossin, W.S.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.org/10.1016/j.neuron.,OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.4940-13.2014] [PMID: 24553949] [23] Ritter, S.L.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1038/nrm2803] [PMID: 19935667] [24] Dhami, G.K.; Dale, L.B.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1074/jbc.M314090200] [PMID: 14764583] [25] Ribeiro, F.M.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/ 10.1074/jbc.M109.000778] [PMID: 19564331] [26] Iacovelli, L.; Salvatore, L.; Capobianco, L.; Picascia, A.; Barletta, E.; Storto, M.; Mariggiò, S.; Sallese, M.; Porcellini, A.; Nicoletti, F.; De Blasi, A.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1074/jbc.M203992200] [PMID: 12519791] [27] Dhami, G.K.; Ferguson, S.S. Regulation of metabotropic glutamate receptor signaling, desensitization and endocytosis.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.org/10.1016/j.pharmthera.,OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1007/ s00441-006-0266-5] [PMID: 16847639] [29] Lisman, J.; Yasuda, R.; Raghavachari, S. Mechanisms of CaMKII action in long-term potentiation.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.3192-12.2013] [PMID: 23426668] [31] Jin, D.Z.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1111/jnc.12434] [PMID: 24032403] [32] Coultrap, S.J.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1016/j.tins.2012.05.003] [PMID: 22717267] [33] Mockett, B.G.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1038/nrn1647] [PMID: 15803158] [35] Choi, K.Y.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.6253-10.2011] [PMID: 21508217] [36] Patel, H.H.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/ 10.1146/annurev.pharmtox.48.121506.124841] [PMID: 17914930] [37] Liu, P.; Rudick, M.; Anderson, R.G.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.5824-08.2009] [PMID: 19295163] [39] Takayasu, Y.; Takeuchi, K.; Kumari, R.; Bennett, M.V.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1074/jbc.M113.475863] [PMID: 24045944] [41] Emery, A.C.; Pshenichkin, S.; Takoudjou, G.R.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1074/jbc.M110.139899] [PMID: 20566651] [42] Boulware, M.I.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.org/10.1523/JNEUROSCI.,Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.1647-07.2007] [PMID: 17855608] [44] Walsh, T.; McClellan, J.M.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1126/ science.1155174] [PMID: 18369103] [45] Allen, J.A.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1038/tp.2011.35] [PMID: 22832607] [46] Mochizuki, R.; Dateki, M.; Yanai, K.; Ishizuka, Y.; Amizuka, N.; Kawashima, H.; Koga, Y.; Ozawa, H.; Fukamizu, A.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1016/j.bbrc.2003.09.153] [PMID: 14559245] [47] Wang, H.; Westin, L.; Nong, Y.; Birnbaum, S.; Bendor, J.; Brismar, H.; Nestler, E.; Aperia, A.; Flajolet, M.; Greengard, P.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1126/science.1178496] [PMID: 20007903] [48] Oku, S.; Takahashi, N.; Fukata, Y.; Fukata, M. In silico screening for palmitoyl substrates reveals a role for DHHC1/3/10 (zDHHC1/3/11)-mediated neurochondrin palmitoylation in its targeting to Rab5-positive endosomes.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.org/10.1074/jbc.M112.,Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.org/10.1111/j.1460-9568.2003.,Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/ 10.1038/sj.mp.4001404] [PMID: 14699440] [51] Shiraishi-Yamaguchi, Y.; Furuichi, T. The Homer family proteins.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1186/gb-2007-8-2-206] [PMID: 17316461] [52] Ango, F.; Prézeau, L.; Muller, T.; Tu, J.C.; Xiao, B.; Worley, P.F.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/ 10.1038/35082096] [PMID: 11418862] [53] Bockaert, J.; Perroy, J.; Bécamel, C.; Marin, P .",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.org/10.1146/annurev.pharmtox.010909.,Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1016/j.neubiorev.2014.02.003] [PMID: 24548786] [55] Mao, L.; Yang, L.; Tang, Q.; Samdani, S.; Zhang, G.; Wang, J.Q.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.5019-07.2008] [PMID: 18184796] [57] Ronesi, J.A.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1038/nn.3033] [58] Turrigiano, G.G.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/ 10.1016/j.cell.2008.10.008] [PMID: 18984155] [59] Hu, J.H.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1016/j.neuron.2010.11.008] [PMID: 21172614] [60] Lüscher, C.; Malenka, R.C.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.org/10.1016/j.neuron.2011.,OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1038/nn.3590] [PMID: 24270186] [62] Park, J.M.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1016/j.cell.2013.07.001] [PMID: 23911326] [63] Rubinsztein, D.C.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1038/nature05291] [PMID: 17051204] [64] Ross, C.A.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1038/nrm1742] [PMID: 16167052] [65] Spires-Jones, T.L.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1016/j.neuron.2014.05.004] [PMID: 24853936] [66] Milnerwood, A.J.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.org/10.1016/j.neuron.,OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.org/10.1016/j.tins.,OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1074/jbc.272.10.6324] [PMID: 9045652] [69] Laurén, J.; Gimbel, D.A.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1038/nature07761] [PMID: 19242475] [70] Um, J.W.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1016/j.neuron.2013.06.036] [PMID: 24012003] [71] Haas, L.T.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1074/jbc.M114.584342] [PMID: 25148681] [72] Um, J.W.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1038/nn.3178] [PMID: 22820466] [73] Park, S.; Park, J.M.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1016/j.neuron.2008.05.023] [PMID: 18614030] [74] Hu, N.W.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1038/ncomms4374] [PMID: 24594908] [75] Labbadia, J.; Morimoto, R.I. Huntington’s disease: underlying molecular mechanisms and emerging concepts.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.org/10.1016/j.tibs.2013.,OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1074/jbc.M504508200] [PMID: 16091361] [77] Ribeiro, F.M.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"5    503 [http://dx.doi.org/10.1523/JNEUROSCI.4974-09.2010] [PMID: 20053912] [78] Bhave, G.; Karim, F.; Carlton, S.M.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1038/nn.3103] [PMID: 22561452] [80] Cabello, N.; Remelli, R.; Canela, L.; Soriguera, A.; Mallol, J.; Canela, E.I.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1074/ jbc.M608880200] [PMID: 17311919] [81] Ferreira, L.T.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/ 10.1074/jbc.M109.050872] [PMID: 19717561] [82] Daigle, T.L.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1038/npp.2014.97] [PMID: 24776686] [83] Jaubert, P.J.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1111/j.1601-183X.2006.00240.x] [PMID: 16734773] [84] Szumlinski, K.K.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1111/j.1601-183X.2005.00120.x] [PMID: 16011574] [85] Roche, K.W.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1074/jbc.274.36.25953] [PMID: 10464340] [86] Szumlinski, K.K.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.1529-05.2005] [PMID: 16049182] [87] Szumlinski, K.K.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1016/j.neuron.2004.07.019] [PMID: 15294147] [88] Rezvani, K.; Baalman, K.; Teng, Y.; Mee, M.P.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1074/jbc.M602262200] [PMID: 16891310] [90] Rezaie, T.; Child, A.; Hitchings, R.; Brice, G.; Miller, L.; Coca-Prados, M.; Héon, E.; Krupin, T.; Ritch, R.; Kreutzer, D.; Crick, R.P.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1126/science.1066901] [PMID: 11834836] [91] Nicodemo, A.A.; Pampillo, M.; Ferreira, L.T.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1186/1756-6606-3-4] [PMID: 20180987] [92] Esseltine, J.L.",Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
[http://dx.doi.org/10.1523/JNEUROSCI.,Non-OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/ 10.1073/pnas.0403042101] [PMID: 15163799] [94] Ogawa, M.; Miyakawa, T.; Nakamura, K.; Kitano, J.; Furushima, K.; Kiyonari, H.; Nakayama, R.; Nakao, K.; Moriyoshi, K.; Nakanishi, S. Altered sensitivities to morphine and cocaine in scaffold protein tamalin knockout mice.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.5493-11.2012] [PMID: 22396401] [96] Kitano, J.; Kimura, K.; Yamazaki, Y.; Soda, T.; Shigemoto, R.; Nakajima, Y.; Nakanishi, S. Tamalin, a PDZ domain-containing protein, links a protein complex formation of group 1 metabotropic glutamate receptors and the guanine nucleotide exchange factor cytohesins.",OADS,/arxiv_data1/oa_pdf/54/d6/CN-14-494.PMC4983749.pdf
"[http://dx.doi.org/10.7326/0003-4819-138-8-200304150-00013] [PMID: 12693888] [2] Toulouse, A.; Sullivan, A.M. Progress in Parkinson’s disease-where do we stand?",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/j.tips.2005.05.002] [PMID: 15936832] [4] Fabbrini, G.; Brotchie, J.M.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1002/mds.21475] [PMID: 17427940] [5] Ahlskog, J.E.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/ 10.1002/mds.1090] [PMID: 11391738] [6] Hely, M.A.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1002/mds.20324] [PMID: 15551331] [7] Jenner, P. Molecular mechanisms of L-DOPA-induced dyskinesia.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/ j.nbd.2003.07.003] [PMID: 14678757] [9] Chase, T.N.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1038/nrd3430] [PMID: 21532567] [12] Sawada, H.; Oeda, T.; Kuno, S.; Nomoto, M.; Yamamoto, K.; Yamamoto, M.; Hisanaga, K.; Kawamura, T. Amantadine for dyskinesias in Parkinson’s disease: a randomized controlled trial.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1371/ journal.pone.0015298] [PMID: 21217832] [13] Schaeffer, E.; Pilotto, A.; Berg, D. Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1007/s40263-014-0205-z] [PMID: 25342080] [14] Verhagen Metman, L.; Del Dotto, P.; van den Munckhof, P.; Fang, J.; Mouradian, M.M.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1212/ WNL.50.5.1323] [PMID: 9595981] [15] Stocchi, F.; Tagliati, M.; Olanow, C.W.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1002/mds.22052] [PMID: 18781681] [16] Conn, P.J.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1038/ nrn1763] [PMID: 16276355] [17] Morin, N.; Grégoire, L.; Morissette, M.; Desrayaud, S.; Gomez-Mancilla, B.; Gasparini, F.; Di Paolo, T. MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1007/s00702-010-0526-0] [PMID: 21161716] [23] Dekundy, A.; Pietraszek, M.; Schaefer, D.; Cenci, M.A.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.1016/j.brainresbull.,OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1007/s00702-008-0098-4] [PMID: 18690408] [25] Levandis, G.; Bazzini, E.; Armentero, M.T.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.1016/j.nbd.,OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1111/ j.1471-4159.2007.04456.x] [PMID: 17359492] [27] Grégoire, L.; Morin, N.; Ouattara, B.; Gasparini, F.; Bilbe, G.; Johns, D.; Vranesic, I.; Sahasranaman, S.; Gomez-Mancilla, B.; Di Paolo, T. The acute antiparkinsonian and antidyskinetic effect of AFQ056, a novel metabotropic glutamate receptor type 5 antagonist, in L-Dopa-treated parkinsonian monkeys.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/ j.parkreldis.2011.01.008] [PMID: 21315648] [28] Johnston, T.H.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1124/jpet.110.166629] [PMID: 20231306] [29] Morin, N.; Grégoire, L.; Gomez-Mancilla, B.; Gasparini, F.; Di Paolo, T. Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/ j.neuropharm.2009.12.024] [PMID: 20074579] [30] Marin, C.; Bonastre, M.; Aguilar, E.; Jiménez, A.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1002/syn.20941] [PMID: 21484883] [31] Addex Therapeutics, Geneva, Switzerland [media release].",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"Available from: http://www.addextherapeutics.com/ investors/press-releases/news-details/article/addex-reports-positive-top-line-phase-iia-data-for-dipraglurant-in-parkinsons-disease-levodopa-indu/, 2013 [(Acessed 2013 Feb 11)]; [32] Berg, D.; Godau, J.; Trenkwalder, C.; Eggert, K.; Csoti, I.; Storch, A.; Huber, H.; Morelli-Canelo, M.; Stamelou, M.; Ries, V.; Wolz, M.; Schneider, C.; Di Paolo, T.; Gasparini, F.; Hariry, S.; Vandemeulebroecke, M.; Abi-Saab, W.; Cooke, K.; Johns, D.; Gomez-Mancilla, B. AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trials.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1002/mds.23616] [PMID: 21484867] [33] Stocchi, F.; Rascol, O.; Destee, A.; Hattori, N.; Hauser, R.A.; Lang, A.E.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1002/mds.25561] [PMID: 23853029] [34] Stocchi, F.; Balaguer, E.; Trekwalder, C.; Shah, A.; Dronamraju, N.; Tran, M.; Kenney, C.; Graf, A.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1111/j.1471-4159.2006.04124.x] [PMID: 16942598] [37] Blandini, F.; Armentero, M.T.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1517/ 13543784.2012.651457] [PMID: 22233485] [38] Beaulieu, J.M.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1124/pr.110.002642] [PMID: 21303898] [39] DeLong, M.R.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/ 10.1001/archneur.64.1.20] [PMID: 17210805] [40] Hurd, Y.L.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/ 10.1126/science.877576] [PMID: 877576] [42] Lee, T.; Seeman, P.; Rajput, A.; Farley, I.J.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1038/ 273059a0] [PMID: 692671] [43] Guttman, M.; Seeman, P.; Reynolds, G.P.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1002/ana.410190510] [PMID: 2940960] [44] Quik, M.; Spokes, E.G.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/ 10.1016/0022-510X(79)90021-2] [PMID: 521836] [45] Rinne, U.K.; Lönnberg, P.; Koskinen, V. Dopamine receptors in the Parkinsonian brain.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1007/BF01664007] [PMID: 6114985] [46] Bédard, P.J.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/ 10.1016/0006-8993(86)90783-3] [PMID: 3488796] [47] Falardeau, P.; Bouchard, S.; Bédard, P.J.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/ 0014-2999(88)90750-9] [PMID: 3261249] [48] Gagnon, C.; Bédard, P.J.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/ 10.1002/ana.20296] [PMID: 15514976] [54] Herrero, M.T.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/S0169-328X(96)00157-X] [PMID: 8915594] [55] Fuxe, K.; Marcellino, D.; Rivera, A.; Diaz-Cabiale, Z.; Filip, M.; Gago, B.; Roberts, D.C.; Langel, U.; Genedani, S.; Ferraro, L.; de la Calle, A.; Narvaez, J.; Tanganelli, S.; Woods, A.; Agnati, L.F. Receptor-receptor interactions within receptor mosaics.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/j.brainresrev.2007.11.007] [PMID: 18222544] [56] Samadi, P.; Rouillard, C.; Bédard, P.J.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/S0072-9752(07)83002-8] [PMID: 18808909] [57] Cosford, N.D.; Tehrani, L.; Roppe, J.; Schweiger, E.; Smith, N.D.; Anderson, J.; Bristow, L.; Brodkin, J.; Jiang, X.; McDonald, I.; Rao, S.; Washburn, M.; Varney, M.A.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1021/ jm025570j] [PMID: 12519057] [58] Gasparini, F.; Lingenhöhl, K.; Stoehr, N.; Flor, P.J.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/S0028-3908(99) 00082-9] [PMID: 10530811] [59] Lea, P.M., IV; Faden, A.I.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1111/j.1527-3458.2006.00149.x] [PMID: 16958988] [60] Mathiesen, J.M.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/j.pharep.2015.01.004] [PMID: 25933979] [62] Dunwiddie, T.V.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1146/annurev.neuro.24.1.31] [PMID: 11283304] [63] Ribeiro, J.A.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/ S0301-0082(02)00155-7] [PMID: 12576292] [64] Ferré, S.; Ciruela, F.; Canals, M.; Marcellino, D.; Burgueno, J.; Casadó, V.; Hillion, J.; Torvinen, M.; Fanelli, F.; Benedetti Pd, Pd.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/ 10.1271/bbb.65.1447] [PMID: 11515525],Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1111/j.1471-4159.1991.tb08257.x] [PMID: 1713612] [69] Svenningsson, P.; Le Moine, C.; Aubert, I.; Burbaud, P.; Fredholm, B.B.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1002/(SICI)1096-9861(19980921) 399:2<229::AID-CNE6>3.0.CO;2-2] [PMID: 9721905] [70] Domenici, M.R.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.1212/01.WNL.0000095205.33940.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1002/(SICI)1096-9861(19981116) 401:2<163::AID-CNE2>3.0.CO;2-D] [PMID: 9822147] [75] Ferré, S.; Fredholm, B.B.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/S0166-2236(97)01096-5] [PMID: 9347617] [76] Svenningsson, P.; Le Moine, C.; Fisone, G.; Fredholm, B.B.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/0169-328X(92) 90173-9] [PMID: 1279342] [78] Pollack, A.E.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/0006-8993(93)91204-6] [PMID: 8298989] [79] Chase, T.N.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1212/01.WNL.0000095223.08711.48] [PMID: 14663022] [80] Calon, F.; Dridi, M.; Hornykiewicz, O.; Bédard, P.J.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1093/brain/awh128] [PMID: 15033896] [81] Grondin, R.; Bédard, P.J.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1212/WNL.52.8.1673] [PMID: 10331698] [82] Kanda, T.; Jackson, M.J.; Smith, L.A.; Pearce, R.K.; Nakamura, J.; Kase, H.; Kuwana, Y.; Jenner, P. Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1  or D2 dopamine agonists increases antiparkinsonian activity  but not dyskinesia in MPTP-treated monkeys.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1006/exnr.2000.7350] [PMID: 10739638] [83] Morelli, M.; Pinna, A. Interaction between dopamine and adenosine A2A receptors as a basis for the treatment of Parkinson’s disease.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.1212/01.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/j.expneurol.2010.07.011] [PMID: 20655910] [86] Salamone, J.D.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1007/s00213-008-1214-8] [PMID: 18594798] [88] Jenner, P. An overview of adenosine A2A receptor antagonists in Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/B978-0-12-801022-8.00006-4] [PMID: 25175964] [90] Preti, D.; Baraldi, P.G.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1002/med.21344] [PMID: 25821194] [91] Tomiyama, M. Adenosine receptors and dyskinesia in patho- physiology.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.1254/jphs.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1007/s00018-006-6216-2] [PMID: 17058035] [95] Schiffmann, S.N.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.1016/ j.pneurobio.2007.05.001] [PMID: 17646043],OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.1016/j.physbeh.,OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1074/jbc.M306451200] [PMID: 12933819] [99] Hillion, J.; Canals, M.; Torvinen, M.; Casado, V.; Scott, R.; Terasmaa, A.; Hansson, A.; Watson, S.; Olah, M.E.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1385/JMN:25:2:191] [PMID: 15784967] [101] Salim, H.; Ferré, S.; Dalal, A.; Peterfreund, R.A.; Fuxe, K.; Vincent, J.D.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.1046/j.1471-4159.2000.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/j.expneurol.2013.12.021] [PMID: 24412491] [104] Bogenpohl, J.W.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1002/cne.22751] [PMID: 21858817] [105] Fuxe, K.; Agnati, L.F.; Jacobsen, K.; Hillion, J.; Canals, M.; Torvinen, M.; Tinner-Staines, B.; Staines, W.; Rosin, D.; Terasmaa, A.; Popoli, P.; Leo, G.; Vergoni, V.; Lluis, C.; Ciruela, F.; Franco, R.; Ferré, S. Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson’s disease.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1212/01.WNL.0000095206.44418.5C] [PMID: 14663004] [106] Nishi, A.; Liu, F.; Matsuyama, S.; Hamada, M.; Higashi, H.; Nairn, A.C.; Greengard, P. Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/ 10.1523/JNEUROSCI.3660-05.2005] [PMID: 16280580] [109] Morin, N.; Jourdain, V.A.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/j.neuropharm.2014.01.014] [PMID: 24456747] [110] Furlong, T.J.; Pierce, K.D.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.101 6/ 0304-3940(91)90391-6] [PMID: 1795877] [112] Morissette, M.; Dridi, M.; Calon, F.; Hadj Tahar, A.; Meltzer, L.T.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1017/S146114571100126X] [PMID: 21816123] [114] Varani, K.; Vincenzi, F.; Tosi, A.; Gessi, S.; Casetta, I.; Granieri, G.; Fazio, P.; Leung, E.; MacLennan, S.; Granieri, E.; Borea, P.A.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1371/journal.pone.0017338] [PMID: 21386999] [116] Ramlackhansingh, A.F.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1212/ WNL.0b013e31821ccce4] [PMID: 21606452] [117] Schwarzschild, M.A.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/ j.tins.2006.09.004] [PMID: 17030429] [118] Huot, P.; Johnston, T.H.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/ 10.1124/pr.111.005678] [PMID: 23319549] [119] Ghiglieri, V.; Bagetta, V.; Pendolino, V.; Picconi, B.; Calabresi, P. Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1155/2012/358176] [120] Bonsi, P.; Cuomo, D.; Picconi, B.; Sciamanna, G.; Tscherter, A.; Tolu, M.; Bernardi, G.; Calabresi, P.; Pisani, A. Striatal meta- botropic glutamate receptors as a target for pharmacotherapy in Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1007/s40263-012-0016-z] [PMID: 23114872] [122] Johnson, K.A.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.2174/ 187152709789824606] [PMID: 19702565] [123] Samadi, P.; Rajput, A.; Calon, F.; Grégoire, L.; Hornykiewicz, O.; Rajput, A.H.; Di Paolo, T. Metabotropic glutamate receptor II in the brains of Parkinsonian patients.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1097/NEN.0b013 e31819cabe4] [PMID: 19287314] [124] Jones, C.K.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.1124/jpet.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.1016/j.pneurobio.2004.09.,OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1007/s00213-009-1600-x] [PMID: 19636538] [127] Yamamoto, N.; Soghomonian, J.J. Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.1124/jpet.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.2702-13.2014] [PMID: 24672017] [131] Cenci, M.A.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"[http://dx.doi.org/10.1016/S0079-6123(10)83011-0] [PMID: 20696322] [132] Rylander, D.; Iderberg, H.; Li, Q.; Dekundy, A.; Zhang, J.; Li, H.; Baishen, R.; Danysz, W.; Bezard, E.; Cenci, M.A.",OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
[http://dx.doi.org/10.1016/j.nbd.2010.05.,OADS,/arxiv_data1/oa_pdf/2e/5f/CN-14-481.PMC4983750.pdf
"Rev., 1999, 23, 743-760. http://dx.doi.org/10.1016/S0149-7634(99) 00016-0 [2] LeDoux, J.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neuron, 2012, 73, 653-676.http://dx.doi.org/10.1016/j.neuron.2012.02.004 [3] Hamm, A.O.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Psychophysiol., 2005, 57, 5-14.http://dx.doi.org/10.1016/j.ijpsycho.2005.01.006 [4] McNally, G.P.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Mem., 2006, 13, 245-253.http://dx.doi.org/10.1101/lm.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Mem., 2014, 21, 232-252. http://dx.doi.org/10.1101/lm.032995.113 [6] Tanimoto, H.; Heisenberg, M.; Gerber, B.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Nature, 2004, 430, 983-983.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Behav., 2008, 76, 1173-1185.http://dx.doi.org/10.1016/j.anbehav.2008.05.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Learn Mem., 2012, 19, 518-526.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"B, 2010, 277, 2411-2416.http://dx.doi.org/10.1098/rspb.2010.0103 [11] Andreatta, M.; Mühlberger, A.; Glotzbach-Schoon, E.; Pauli, P. Pain predictability reverses valence ratings of a relief-associated stimulus.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Cell Tissue Res., 2013, 354, 287-295. http://dx.doi.org/10.1007/ s00441-013-1599-5 [14] Koch, M. The neurobiology of startle.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neurobiol., 1999, 59, 107-128.http://dx.doi.org/10.1016/S0301-0082(98)00098-7 [15] Grillon, C. Models and mechanisms of anxiety: evidence from startle studies.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neuropsychopharmacology, 2009, 34, 1783-1796. http://dx.doi.org/10.1038/npp.2008.236 [18] Li, X.; Li, J.; Gardner, E.L.; Xi, Z.X.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neurochem., 2010, 114, 1368-1380.http://dx.doi.org/10.1111/ j.1471-4159.2010.06851.x [19] Mitsukawa, K.; Yamamoto, R.; Ofner, S.; Nozulak, J.; Pescott, O.; Lukic, S.; Stoehr, N.; Mombereau, C.; Kuhn, R.; McAllister, K.H.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"USA, 2005, 102, 18712-18717.http://dx.doi.org/10.1073/ pnas.0508063102 [20] Paxinos, G.; Watson, C. The Rat Brain in Stereotaxic Coordinates.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"http://dx.doi.org/10.1111/bph.13070 [22] Miserendino, M.J.D.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Nature, 1990, 345, 716-718.http://dx.doi.org/10.1038/345716a0 [23] Siegl, S.; Flor, P.J.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neuro Report, 2008, 19, 1147-1150.http://dx.doi.org/10.1097/ WNR.0b013e328307f295 [24] Yarali, A.; Gerber, B.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neurosci., 2010, 4, 189-235. http://dx.doi.org/10.1080/ 01677060802441372 [25] Yarali, A.; Krischke, M.; Michels, B.; Saumweber, T.; Mueller, M.J.; Gerber, B.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"http://dx.doi.org/10.1080/01677060802441372 [26] Walasek, G.; Wesierska, M.; Zielinski, K. Conditioning of fear and conditioning of safety in rats.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neurophysiol., 2013, 110, 1221-1226. http://dx.doi.org/10.1152/ jn.00284.2013 [29] Christianson, J.P.; Fernando, A.B.P.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neurosci., 2012, 32, 14118-14124. http://dx.doi.org/10.1523/JNEUROSCI.3340-12.2012 [30] Lohr, J.M.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Rev., 2007, 27, 114-126.http://dx.doi.org/10.1016/j.cpr.2006.07.005 [31] Josselyn, S.A.; Falls, W.A.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neuropsychopharmacology, 2005, 30, 17-26.http://dx.doi.org/10.1038/sj.npp.1300530 [32] Franklin, J.C.; Lee, K.M.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Sci., 2013, 24, 521-529.http://dx.doi.org/10.1177/0956797612458805 [33] Leknes, S.; Lee, M.; Berna, C.; Andersson, J.; Tracey, I.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"PLoS ONE, 2011, 6, e17870.http://dx.doi.org/10.1371/journal.pone.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neurosci., 2005, 8, 1234-1240.http://dx.doi.org/10.1038/ nn1527 [35] Fernando, A.B.P.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Psychopharmacology, 2013, 227, 195-208.http://dx.doi.org/10.1007/s00213-012-2952-1 [36] Kalivas, P.W.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neurobiol., 1999, 9, 223-227.http://dx.doi.org/10.1016/S0959-4388(99)80031-2 [37] Ikemoto, S. Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neurosci., 2005, 8, 1481-1489.http://dx.doi.org/10.1038/nn1579 [39] Schultz, W. Predictive reward signal of dopamine neurons.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neuropharmacology, 2008, 54, 542-551.http://dx.doi.org/ 10.1016/j.neuropharm.2007.11.005 [42] Li, X.; Xi, Z.X.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neuropharmacology, 2013, 66, 12-23. http://dx.doi.org/10.1016/j.neuropharm.2012.04.010 [43] Fendt, M.; Schmid, S.; Thakker, D.R.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Psychiatry, 2008, 13, 970-979.http://dx.doi.org/10.1038/sj.mp.4002073 [44] Fendt, M.; Imobersteg, S.; Peterlik, D.; C h a p e r o n ,  F .",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neuropharmacology, 2013, 72, 215-223.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Behav., 1975, 3, 47-55. http://dx.doi.org/10.1016/0091-3057(75) 90079-9 [46] Dolan, S.; Gunn, M.D.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Pharmacol., 2009, 20, 596-604. http://dx.doi.org/10.1097/FBP.0b013e32832ec5d1 [47] Dolan, S.; Gunn, M.D.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Pharmacol., 2011, 22, 582-588.http://dx.doi.org/10.1097/ FBP.0b013e3283478802 [48] Palazzo, E.; Fu, Y.; Ji, G.; Maione, S.; Neugebauer, V. Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neuropharmacology, 2008, 55, 537-545.http://dx.doi.org/10.1016/j.neuropharm.2008.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neuropharmacology, 2011, 61, 1334-1344.http://dx.doi.org/10.1016/j.neuropharm.2011.08.006 [50] Sukoff Rizzo, S.J.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"T h e r ., 2011, 338, 345-352.http://dx.doi.org/10.1124/jpet.110.177378 [51] Kalivas, P.W.",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Brain Res., 1995, 675, 325-328.http://dx.doi.org/10.1016/0006-8993(95) 00013-G [52] Saulskaya, N.; Marsden, C.A.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Brain Res., 1995, 698, 114-120.http://dx.doi.org/10.1016/0006-8993(95)00848-K [53] Gear, R.W.",OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"Neurosci., 2002, 15, 861-868.http://dx.doi.org/10.1046/j.1460-9568.2002.01915.x",Non-OADS,/arxiv_data1/oa_pdf/bf/c5/CN-14-405.PMC4983753.pdf
"[http://dx.doi.org/10.1146/annurev.pharmtox.37.1.205] [PMID: 9131252] [2] Swanson, C.J.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1038/nrd1630] [PMID: 15665858] [3] Ferraguti, F.; Shigemoto, R. Metabotropic glutamate receptors.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1007/  s00441-006-0266-5] [PMID: 16847639] [4] Ritter, S.L.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1038/nrm2803] [PMID: 19935667] [5] Shigemoto, R.; Kulik, A.; Roberts, J.D.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1038/ 381523a0] [PMID: 8632825] [6] D’Antoni, S.; Berretta, A.; Bonaccorso, C.M.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1002/cne.903600402] [PMID: 8801249] [8] Petralia, R.S.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/0306-4522(95)00533-1] [PMID: 8684625] [9] Vardi, N.; D u v o i s i n ,  R .",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1002/ 1096-9861(20000731)423:3<402::AID-CNE4>3.0.CO;2-E] [PMID: 10870081] [10] Cajina, M.; Nattini, M.; Song, D.; Smagin, G.; Jørgensen, E.B.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1021/ ml400338f] [PMID: 24900783] [11] Kinzie, J.M.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/0306-4522(95)00244-D] [PMID: 8637615] [12] Corti, C.; Restituito, S.; Rimland, J.M.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.org/ 10.1002/(SICI)1096-9861(19980420)393:4<493::AID-CNE8>3.0.,Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1093/cercor/12.9.961] [PMID: 12183395] [17] Somogyi, P.; Dalezios, Y.; Luján, R.; Roberts, J.D.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.org/10.1046/j.1460-9568.2003.,Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.org/10.1074/jbc.M109.,Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1002/(SICI)1096-9861 (19991213)415:2<266::AID-CNE9>3.0.CO;2-7] [PMID: 10545164] [20] Brandstätter, J.H.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1002/(SICI)1096-9861(19970901) 385:3<372::AID-CNE3>3.0.CO;2-0] [PMID: 9300765] [22] Gu, Z.; Liu, W.; Wei, J.; Yan, Z.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1074/jbc.M111.325175] [PMID: 22287544] [23] Flor, P.J.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/ 10.1016/S0028-3908(96)00176-1] [PMID: 9144652] [24] Kinoshita, A.; Shigemoto, R.; Ohishi, H.; van der Putten, H.; Mizuno, N. Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: a light and electron microscopic study.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1002/(SICI)1096-9861(19980413)393:3<332:: AID-CNE6>3.0.CO;2-2] [PMID: 9548554] [25] Schulz, H.L.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/ S0304-3940(02)00306-3] [PMID: 12052533] [26] Julio-Pieper, M.; Hyland, N.P.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1254/jphs.09R16FM] [PMID: 20093783] [28] Scaccianoce, S.; Matrisciano, F.; Del Bianco, P.; Caricasole, A.; Di Giorgi Gerevini, V.; Cappuccio, I.; Melchiorri, D.; Battaglia, G.; Nicoletti, F. Endogenous activation of group-II metabotropic glutamate receptors inhibits the hypothalamic-pituitary-adrenocortical axis.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/ 10.1016/S0028-3908(03)00027-3] [PMID: 12668041] [29] Friedman, R.A.; Van Laer, L.; Huentelman, M.J.; Sheth, S.S.; Van Eyken, E.; Corneveaux, J.J.; Tembe, W.D.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1093/hmg/ddn402] [PMID: 19047183] [30] Schoepp, D.D.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1074/jbc.M109044200] [PMID: 11825890] [32] Laezza, F.; Doherty, J.J.; Dingledine, R. Long-term depression in hippocampal interneurons: joint requirement for pre- a n d  p o s t- synaptic events.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1111/j.0953-816X.2004.03394.x] [PMID: 15147307] [34] Pelkey, K.A.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.org/10.1016/j.neuropharm.,OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/j.neuroscience.2003.08.014] [PMID: 14614910] [37] Kyuyoung, C.L.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1046/j.1471-4159.2003.02093.x] [PMID: 14622100] [39] Li, X.; Gardner, E.L.; Xi, Z.X.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1152/ jn.00356.2007] [PMID: 17507496] [41] Ugolini, A.; Large, C.H.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/j.neuropharm.2008.04.020] [PMID: 18533198] [42] Ren, W.; Palazzo, E.; Maione, S.; Neugebauer, V. Differential effects of mGluR7 and mGluR8 activation on pain-related synaptic activity in the amygdala.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/j.neuropharm.2011.08.006] [PMID: 21854791] [43] Gee, C.E.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1074/ jbc.M113.542654] [PMID: 24596089] [44] Perroy, J.; Prezeau, L.; De Waard, M.; Shigemoto, R.; Bockaert, J.; Fagni, L. Selective blockade of P/Q-type calcium channels by the metabotropic glutamate receptor type 7 involves a phospholipase C pathway in neurons.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1126/science.274.5287.594] [PMID: 8849448] [46] Pelkey, K.A.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.org/10.1016/j.neuron.,OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1111/j.1460-9568.2007.05660.x] [PMID: 17650109] [48] Saugstad, J.A.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/ 10.1074/jbc.274.39.27573] [PMID: 10488094] [50] Macek, T.A.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/j.neuron.2008.03.028] [PMID: 18549785] [52] Suh, Y.H.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1074/jbc.M112.439513] [PMID: 23612982] [53] Bertaso, F.; Zhang, C.; Scheschonka, A.; de Bock, F.; Fontanaud, P.; Marin, P.; Huganir, R.L.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1038/nn.2142] [PMID: 18641645] [54] Tomioka, N.H.; Yasuda, H.; Miyamoto, H.; Hatayama, M.; Morimura, N.; Matsumoto, Y.; Suzuki, T.; Odagawa, M.; Odaka, Y.S.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1038/ ncomms5501] [PMID: 25047565] [55] Gu, Z.; Cheng, J.; Zhong, P.; Qin, L.; Liu, W .",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1100/ tsw.2002.146] [PMID: 12805997] [58] Hölscher, C.; Schmid, S.; Pilz, P.K.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1101/lm.98305] [PMID: 16204199] [60] O’Connor, R.M.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/ 10.1016/j.ejphar.2010.02.059] [PMID: 20371242] [61] Goddyn, H.; Callaerts-Vegh, Z.; Stroobants, S.; Dirikx, T.; Vansteenwegen, D.; Hermans, D.; van der Putten, H.; D’Hooge, R. Deficits in acquisition and extinction of conditioned responses in mGluR7 knockout mice.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/j.nlm.2008.01.001] [PMID: 18289889] [62] Callaerts-Vegh, Z.; Beckers, T.; Ball, S.M.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1037/0735-7044.107.6.1093] [PMID: 8136063] [65] Yamamoto, T.; Shimura, T.; Sako, N.; Yasoshima, Y.; Sakai, N. Neural substrates for conditioned taste aversion in the rat.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/0166-4328(94)90097-3] [PMID: 7718144] [66] Masugi, M.; Yokoi, M.; Shigemoto, R.; Muguruma, K.; Watanabe, Y.; Sansig, G.; van der Putten, H.; Nakanishi, S. Metabotropic glutamate receptor subtype 7 ablation c a u s e s  d e f i c i t  i n  f e a r  response and conditioned taste aversion.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/ 10.1046/j.1460-9568.2003.02667.x] [PMID: 12814372] [68] Stachowicz, K.; Brañski, P.; Kłak, K.; van der Putten, H.; Cryan, J.F.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1097/ FBP.0b013e32830cd839] [PMID: 18690114] [69] Fendt, M.; Imobersteg, S.; Peterlik, D.; Chaperon, F.; Mattes, C.; Wittmann, C.; Olpe, H.R.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1210/edrv-17-2-187] [PMID: 8706631] [72] Barden, N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/S0140-6736(80)92755-5] [PMID: 6106823] [74] Hoshaw, B.A.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/ j.brainres.2005.01.007] [PMID: 15777771] [75] Kłak, K.; Pałucha, A.; Brański, P.; Sowa, M.; Pilc, A.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1007/s00726-006-0316-z] [PMID: 16868652] [76] Lafon-Cazal, M.; Fagni, L.; Guiraud, M.J.; Mary, S.; Lerner-Natoli, M.; Pin, J.P.; Shigemoto, R.; Bockaert, J. mGluR7-like metabotropic glutamate receptors inhibit NMDA-mediated excitotoxicity in cultured mouse cerebellar granule neurons.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1046/j.1460-9568.1999.00475.x] [PMID: 10051767] [77] Pin, J.P.; De Colle, C.; Bessis, A.S.; Acher, F. New perspectives for the development of selective metabotropic glutamate receptor ligands.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/ 10.1073/pnas.0508063102] [PMID: 16339898] [79] Acher, F.C.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1021/jm970207b] [PMID: 9301676] [80] Pałucha-Poniewiera, A.; Kłodzińska, A.; Stachowicz, K.; Tokarski, K.; Hess, G.; Schann, S.; Frauli, M.; Neuville, P.; Pilc, A.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/ 10.1016/j.neuropharm.2008.06.033] [PMID: 18619473] [81] Kingston, A.E.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/S0028-3908(97)00191-3] [PMID: 9680254] [82] Flor, P.J.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/ j.bcp.2012.04.013] [PMID: 22554564] [83] Sukoff Rizzo, S.J.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1124/jpet.110.177378] [PMID: 21508084] [84] Conn, P.J.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1073/ pnas.0510051103] [PMID: 16407154] [85] Fendt, M.; Schmid, S.; Thakker, D.R.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1038/sj.mp.4002073] [PMID: 17712315] [86] Siegl, S.; Flor, P.J.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/ 10.1097/WNR.0b013e328307f295] [PMID: 18596617] [87] Mickley, G.A.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/j.brainres.2005.05.033] [PMID: 15961067] [88] Palazzo, E.; Fu, Y.; Ji, G.; Maione, S.; Neugebauer, V. Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.org/10.1016/j.neuropharm.,OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1007/s00213-007-0856-2] [PMID: 17622518] [90] Dobi, A.; Sartori, S.B.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/ j.neuropharm.2012.05.025] [PMID: 22643400] [91] Palucha, A.; Pilc, A. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.org/10.1016/j.pharmthera.,OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/j.neuroscience.2012.05.024] [PMID: 22617702] [94] Ferrante, M.; Migliore, M.; Ascoli, G.A.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.org/10.1016/j.pain.2007.08.,Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/0306-4522(94)90548-7] [PMID: 7891863] [97] G, S.; Suvarna, P.; Hadigal, S.; Kamath, P.; Prabhu, N.; Shenoy K, A.; Lc, P. Can Metabotropic Glutamate Receptor 7 (mGluR 7) be a Novel Target for Analgesia?",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.org/10.1016/j.pain.2008.03.,OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1097/FBP.0b013 e3283478802] [PMID: 21597362] [100] Pelkey, K.A.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.org/10.1016/j.neuropharm.2006.07.,Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.org/10.1111/j.1369-1600.2010.00310.x] [PMID: 21392179],Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1016/j.neuropharm.2012.04.010] [PMID: 22546614] [103] Suzuki, G.; Tsukamoto, N.; Fushiki, H.; Kawagishi, A.; Nakamura, M.; Kurihara, H.; Mitsuya, M.; Ohkubo, M.; Ohta, H. In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1124/jpet.107.124701] [PMID: 17609420] [104] Nakamura, M.; Kurihara, H.; Suzuki, G.; Mitsuya, M.; Ohkubo, M.; Ohta, H. Isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.org/10.1016/j.bmcl.2009.,OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1186/1744-8069-9-44] [PMID: 24004843] [107] Palazzo, E.; Romano, R.; Luongo, L.; Boccella, S.; De Gregorio, D.; Giordano, M.E.",Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"[http://dx.doi.org/10.1124/mol.109.058768] [PMID: 20026717] [109] Kalinichev, M.; Rouillier, M.; Girard, F.; Royer-Urios, I.; Bournique, B.; Finn, T.; Charvin, D.; Campo, B.; Le Poul, E.; Mutel, V.; Poli, S.; Neale, S.A.; Salt, T.E.",OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
[http://dx.doi.org/ 10.1124/jpet.112.200915] [PMID: 23257312],Non-OADS,/arxiv_data1/oa_pdf/2c/35/CN-14-504.PMC4983754.pdf
"Nature, 1993, 361, 31-39. http://dx.doi.org/10.1038/361031a0 [2] Collingridge, G.L.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neurosci., 2010, 11, 459-473.http://dx.doi.org/10.1038/nrn2867 [3] Gladding, C.M.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Rev., 2009, 61(4), 395-412.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Chem., 279(13), 12286-12292.http://dx.doi.org/10.1074/ jbc.M312868200 [5] Moult, P.R.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Physiol., 2008, 586(10), 2499-2510.http://dx.doi.org/10.1113/jphysiol.2008.153122 [6] Eales, K.L.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Cell Biol., 2006, 7(2), 120-130. http://dx.doi.org/10.1038/nrm1834 [8] Correa, S.A.L.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Signal Transduct., 2012, 2012, 649079. doi:10.1155/2012/649079 http://dx.doi.org/10.1155/2012/649079 [9] Ronkina, N.; Kotlyarov, A.; Dittrich-Breiholz, O.; Kracht, M.; Hitti, E.; Milarski, K.; Askew, R.; Marusic, S.; Lin, L.; Gaestel, M.; Telliez, J.B.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Cell Biol., 2007, 27(1), 170-181.http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neurosci., 2010, 30(41), 13750-13759.http://dx.doi.org/10.1523/JNEUROSCI.2998-10.2010 [11] Kotlyarov, A.; Neininger, A.; Schubert, C.; Eckert, R.; Birchmeier, C.; Volk, H.D.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Cell Biol., 1999, 1(2), 94-97. http://dx.doi.org/10.1038/10061 [12] Vician, L.J.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"J. Neuro Res., 2004, 78, 315-328.http://dx.doi.org/10.1002/jnr.20251 [13] Thomas, T.; Hitti, E.; Kotlyarov, A.; Potschka, H.; Gaestel, M.  MAP-kinase-activated protein kinase 2 expression and activity is induced after neuronal depolarization.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neurosci., 2008, 28, 642-654.http://dx.doi.org/10.1111/j.1460-9568.2008.06382.x [14] Culbert, A.A.; Skaper, S.; Howlett, D.; Evans, N.A., Facci, L.; Soden, P.E.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Physiol., 2005, 90(5), 663-670.http://dx.doi.org/10.1113/ expphysiol.2005.030734 [16] McCoy, M.K.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neuroinflamm., 2008, 5, 45.http://dx.doi.org/ 10.1186/1742-2094-5-45 [17] Beattie, E.C.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Science, 2002, 295, 2282-2285.http://dx.doi.org/10.1126/science.1067859 [18] Santello M and Volterra A; TNFα in synaptic function: switching gears.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Trends Neurosci., 2012, 35, 638-647.http://dx.doi.org/ 10.1016/j.tins.2012.06.001 [19] Stellwagen, D.; Beattie, E.C.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"J. Neurosci,, 2005, 25(12), 3219-3228.http://dx.doi.org/10.1523/JNEUROSCI.4486-04.2005 [20] Kobayashi, M., Nishita, M.; Mishima, T.; Ohashi, K.; Mizuno, K. MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"2006, 25, 713-726.http://dx.doi.org/10.1038/sj.emboj.7600973 [21] Cingolani, L. A.; Goda, Y.  Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neurosci., 2008, 9, 344-356.http://dx.doi.org/10.1038/nrn2373 [22] Hollmann, M.; Heinemann, S. Cloned Glutamate Receptors.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neurosci., 1994, 17, 31-108.http://dx.doi.org/10.1146/ annurev.ne.17.030194.000335 [23] Craig, A.M.; Blackstone, C.D.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neuron, 1993, 10, 1055-1068.http://dx.doi.org/10.1016/0896-6273(93)90054-U [24] Hollmann, M.; Hartley, M.; Heinemann, S. Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Science, 1991, 252(5007), 851-853.http://dx.doi.org/ 10.1126/science.1709304 [25] Isaac, J.T., Ashby, M.C.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neuron, 2007, 54, 859-871.http://dx.doi.org/10.1016/j.neuron.2007.06.001 [26] Weiss, J.H.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Trends Neurosci., 2000, 23(8), 365-371. http://dx.doi.org/10.1016/ S0166-2236(00)01610-6 [27] Hitti, E.; Iakovleva, T.; Brook, M.; Deppenmeier, S.; Gruber, A.; Radzioch, D.; Clark, A.; Blackshear, P.; Kotlyarov, A.; Gaestel, M.  Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Regulates Tumor Necrosis Factor mRNA Stability and Translation Mainly by Altering Tristetraprolin Expression, Stability, and Binding to Adenine/Uridine-Rich Element.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neurosci., 2005, 25(29), 6734-6744.http://dx.doi.org/10.1523/JNEUROSCI.1510-05.2005 [30] Stellwagen, D.; and Malenka.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Nature, 2006, 440, 1054-1059.http://dx.doi.org/ 10.1038/nature04671 [31] Wang, Q.; Chang, L.; Rowan, M.J.; Anwyl, R. Developmental dependence, the role of the kinases p38 MAPK and PKC, and the involvement of tumor necrosis factor-R1 in the induction of mGlu-5 LTD in the dentate gyrus.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neuroscience, 2007, 144(1),110-118.http://dx.doi.org/10.1016/j.neuroscience.2006.09.011 [32] Olmos, G.; Lladó, J. Tumor Necrosis Factor Alpha: A Link between Neuroinflammation and E x c i t o t o x i c i t y .",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"http://dx.doi.org/10.1155/2014/861231 [33] Leonoudakis, D.; Braithwaite, S.P.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neuron Glia Biol., 2004, 1(3), 263-273.http://dx.doi.org/10.1017/S1740925X05000608 [34] Wang, Q.; Wu, J.; Rowan, M.; Anwyl, R. β-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neurosci., 2005, 22(11), 2827-2832.http://dx.doi.org/10.1111/ j.1460-9568.2005.04457.x [35] Viviani, B.; Corsini, E.; Galli, C.L.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Pharmacol., 1998, 150(2), 271-276.http://dx.doi.org/10.1006/taap.1998.8406 [36] Gelbard, H.A.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neurosci., 1993, 15(6), 417-422.http://dx.doi.org/10.1159/000111367 [37] Yu, Z.; Cheng, G.; Wen, X.; W u ,  G .",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Dis., 2002, 11, 199-213.http://dx.doi.org/10.1006/nbdi.2002.0530 [38] Lucin, K.M.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neuron, 2009, 64, 110-122.http://dx.doi.org/10.1016/j.neuron.2009.08.039 [39] Luo, X.G.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neurodegener., 2010, 5, 12.http://dx.doi.org/10.1186/1750-1326-5-12 [40] Conde, J.R.; Streit, W.J.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Aging, 2006, 27, 1451-1461.http://dx.doi.org/10.1016/j.neurobiolaging.2005.07.012 [41] Lambertsen, K.L.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neurosci., 2009, 2 9(5), 1319-1330. http://dx.doi.org/10.1523/ JNEUROSCI.5505-08.2009 [42] Boka, G.; Anglade, P.; Wallach, D.; Javoy-Agid, F.; Agid, Y.; Hirsch, E.C.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Lett., 1994, 172, 151-154.http://dx.doi.org/10.1016/0304-3940(94)90684-X [43] Hofman, F.M.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"1989, 170, 607-612.http://dx.doi.org/10.1084/jem.170.2.607 [44] Perry, R.T.; Collins, J.; Wiener, H.; Acton, R.; Go, R.C.P.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Aging, 2001, 22(6), 873-883.http://dx.doi.org/10.1016/S0197-4580(01) 00291-3 [45] Garnon, J.; Lachance, C.; Di Marco, S.; Hel, Z.; Marion, D.; Ruiz, M.; Newkirk, M.; Khandjian, E. and Radzioch, D. Fragile X-related Protein FXR1P Regulates Proinflammatory Cytokine Tumor Necrosis Factor Expression at the Post-transcriptional Level.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Chem., 2005, 280(7), 5750-5763.http://dx.doi.org/10.1074/ jbc.M401988200 [46] Vezzani, A.;Balosso, S.; Ravizza, T. The role of cytokines in the pathophysiology of epilepsy.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Immun., 2008, 22(6), 797-803.http://dx.doi.org/10.1016/j.bbi.2008.03.009 [47] Rajasekaran, K.; Todorovic, M.; Kapur, J. Calcium-Permeable AMPA Receptors Are Expressed in a Rodent Model of Status Epilepticus.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neurol., 2012, 72, 91-102.http://dx.doi.org/ 10.1002/ana.23570 [48] Selkoe, D.J.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neuron, 1991, 6(4), 487-498.http://dx.doi.org/10.1016/0896-6273(91)90052-2 [49] Meda, L.; Cassatella, M.A.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"N a t u r e , 1994, 374, 647-650.http://dx.doi.org/10.1038/374647a0 [50] Shi, JQ; Wang, BR; Jiang WW; Chen J; Zhu YW; Zhong, L.L; Zhang, Y.D.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Soc., 2011, 59(6), 1142-1144.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"FASEB, 2011, 26(1), 334-345.http://dx.doi.org/10.1096/fj.11-192716 [52] Tobinick, E.; Gross, H.; Weinberger, A.; Cohen, H. TNF-alpha Modulation for Treatment of Alzheimer's Disease: A 6-Month Pilot Study.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neuron, 2009, 62(6), 788-801.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Neuroscience, 2009, 161, 293-300.http://dx.doi.org/10.1016/j.neuroscience.2009.03.005 [55] Huber, K.; Gallagher S.M.",OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"Targets., 2008, 12(8), 921-936.http://dx.doi.org/10.1517/14728222.12.8.921",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/CN-14-474.PMC4983755.pdf
"(Berl)., 2013, 227(4), 7 1 1-725. http://dx.doi.org/10.1007/s00213-013-3005-0 [17] Sławińska, A.; Wierońska, J.M.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Pharmacol., 2013, 169(8), 1824-1839.http://dx.doi.org/10.1111/bph.12254 [18] Wierońska, J.M.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Pharmacol., 2011, 163(5), 1034-1047.http://dx.doi.org/10.1111/j.1476-5381.2011.01301.x [19] Wierońska, J.M.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Psychiatry., 2003, 27(7), 1071-1079.http://dx.doi.org/10.1016/j.pnpbp.2003.09.003 [22] Satow, A.; Suzuki, G.; Maehara, S.; Hikichi, H.; Murai, T.; Murai, T.; Kawagoe-Takaki, H.; Hata, M.; Ito, S.; Ozaki, S.; Kawamoto, H.; Ohta, H. Unique antipsychotic activities of the selective metabotropic glutamate receptor 1 allosteric antagonist 2-cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one.",OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Ther., 2009, 330(1), 179-190.http://dx.doi.org/10.1124/jpet.109.151118 [23] Slattery, D.A.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Ther., 2005, 3 1 2(1), 290-296.http://dx.doi.org/10.1124/jpet.104.073536 [24] Cryan, J.F.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Ther., 2004, 310(3), 952-963.http://dx.doi.org/10.1124/jpet.104.066753 [25] Rorick-Kehn, L.M.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Psychopharmacol (Berl)., 2007, 1 9 3(1), 121-136.http://dx.doi.org/10.1007/s00213-007-0758-3 [26] Rorick-Kehn, L.M.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Ther., 2007, 321(1), 308-317.http://dx.doi.org/10.1124/jpet.106.110809 [27] Noda, Y.; Kamei, H.; Mamiya, T.; Furukawa, H.; Nabeshima, T. Repeated phencyclidine treatment induces negative symptom-like behavior in forced swimming test in mice: imbalance of prefrontal serotonergic and dopaminergic functions.",OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Neuropsychopharmacol., 2000, 23(4), 375-387.http://dx.doi.org/10.1016/S0893-133X(00) 00138-X [28] Noda, Y.; Yamada, K.; Furukawa, H.; Nabeshima, T. Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia.",OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Pharmacol., 1995, 116(5), 2531-2537.http://dx.doi.org/10.1111/ j.1476-5381.1995.tb15106.x [29] Langen, B.; Dost, R.; Egerland, U.; Stange, H,; Hoefgen, N. Effect of PDE10A inhibitors on MK-801-induced immobility in the forced swim test.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Psychopharmacol (Berl)., 2012, 2 2 1(2), 249-259.http://dx.doi.org/10.1007/s00213-011-2567-y [30] Horiguchi, M.; Huang, M.; Meltzer, H.Y.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Ther., 2011, 338(2), 605-614.http://dx.doi.org/10.1124/jpet.111.180638 [31] Horiguchi, M.; Huang, M.; Meltzer, H.Y.",OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Psychopharmacol (Berl)., 2011, 217(1), 13-24.http://dx.doi.org/10.1007/s00213-011-2251-2 [32] Dere, E.; Huston, J.P.; De Souza Silva, M.A.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"FASEB J., 2012, 26(4), 1682-1693. http://dx.doi.org/10.1096/fj.11-195941 [35] Wierońska, J.M.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"2010, 59(7-8), 627-634.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"2013, 5(2),119-123.http://dx.doi.org/10.1021/ ml400338f [37] Snigdha, S.; Horiguchi, M.; Huang, M.; Li, Z.; Shahid, M.; Neill, J.C.; Meltzer, H.Y.",OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Ther., 2010, 332(2), 622-631.http://dx.doi.org/10.1124/jpet.109.156349 [38] Meltzer, H.Y.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Psychopharmacol (Berl)., 2011, 213(2-3), 289-305.http://dx.doi.org/10.1007/s00213-010-2137-8 [39] Horiguchi, M.; Hannaway, K.E.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Neuro- psychopharmacol., 2012, 37(10), 2175-2183.http://dx.doi.org/ 10.1038/npp.2012.64 [40] Meltzer, H.Y.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Neuropsychopharmacol., 2013, 16(10), 2181-2194.http://dx.doi.org/10.1017/S1461145713000928 [41] Guidotti, A.; Auta, J.; Davis, J.M.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Psycho- pharmacol (Berl)., 2005, 180(2), 191-205.http://dx.doi.org/ 10.1007/s00213-005-2212-8 [42] Dong, E.; Agis-Balboa, R.C.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Rev., 2000, 31, 302-312.http://dx.doi.org/10.1016/S0165-0173(99) 00046-6 [44] Kinon, B.J.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Psychopharmacol., 2011, 31(3), 349-355.http://dx.doi.org/10.1097/ JCP.0b013e318218dcd5 [45] Stauffer, V.L., Baygani, S.K.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Psychopharmacol., 2014, 34(5), 552-558. http://dx.doi.org/10.1097/JCP.0000000000000187 [46] Adams, D.H.; Kinon, B.J.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"BMC Psychiatry., 2013, 13(1), 143.http://dx.doi.org/10.1186/1471-244X-13-143 [47] Patil, S.T.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Med., 2007, 13(9), 1102-1107.http://dx.doi.org/10.1038/ nm1632 [48] Sternbach, L.H.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"Chem., 1979, 22(1), 1-7.http://dx.doi.org/10.1021/jm00187a001 [49] Bowery, N.G.",Non-OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
"2006, 6(1), 37-43.http://dx.doi.org/10.1016/ j.coph.2005.10.002",OADS,/arxiv_data1/oa_pdf/bf/47/CN-14-413.PMC4983756.pdf
All ligands were parameterized with CHARMM General Force Field (CGenFF) [56] using the ParamChem webserver (https://cgenff.paramchem.org/).,OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Toxicol., 2010, 50, 295-322. http://dx.doi.org/10.1146/annurev.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Neurosci., 2010, 1(1), 4-12. http://dx.doi.org/10.1021/cn900006n",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Neuropharmacology, 2011, 60(7-8), 1017-1041.http://dx.doi.org/ 10.1016/j.neuropharm.2010.10.022 [4] Dingledine, R.; Borges, K.; Bowie, D.; Traynelis, S.F.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Nature, 1987, 325(6104), 531-533.http://dx.doi.org/10.1038/325531a0 [6] Schoepp, D.D.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Neuro- pharmacology, 1999, 38(10), 1431-1476.http://dx.doi.org/10.1016/ S0028-3908(99)00092-1 [7] Rondard, P.; Pin, J.P. Dynamics a n d  m o d u l a t i o n  o f  m e t a b o t r o p i c  glutamate receptors.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Pharmacol., 2015, 20, 95-101.http://dx.doi.org/10.1016/j.coph.2014.12.001 [8] Kniazeff, J.; Prezeau, L.; Rondard, P.; Pin, J.P.; Goudet, C. Dimers and beyond: The functional puzzles of class C GPCRs.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Sci., 2009, 30(1), 25-31.http://dx.doi.org/10.1016/j.tips.2008.10.006 [10] Swanson, C.J.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Drug Discov., 2005, 4(2), 131-144.http://dx.doi.org/10.1038/nrd1630 [11] Palucha, A.; Pilc, A. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Ther., 2007, 115(1), 116-147.http://dx.doi.org/10.1016/j.pharmthera.2007.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Neuropharmacology, 2001, 40(1), 1-9.http://dx.doi.org/10.1016/ S0028-3908(00)00113-1 [13] Chiechio, S.; Nicoletti, F., Metabotropic glutamate receptors and the control of chronic pain.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Pharmacol., 2012, 12(1), 28-34.http://dx.doi.org/10.1016/j.coph.2011.10.010 [14] Palazzo, E.; Marabese, I.; de Novellis, V.; Rossi, F.; Maione, S., Supraspinal metabotropic glutamate receptors: a target for pain relief and beyond.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Nature, 2000, 407(6807), 971-977.http://dx.doi.org/ 10.1038/35039564 [16] Tsuchiya, D.; Kunishima, N.; Kamiya, N.; Jingami, H.; Morikawa, K. Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Pharmacol., 2012, 84(4), 414-424. http://dx.doi.org/10.1016/j.bcp.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Drug Discov., 2009, 8(1), 41-54.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Chem., 2012, 7(3), 440-451.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Pharmacol., 2013, 83(5), 991-1006.http://dx.doi.org/10.1124/mol.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Model., 2014, 54(5), 1476-1487. http://dx.doi.org/10.1021/ci500127c [24] Dore, A.S.; Okrasa, K.; Patel, J.C.; Serrano-Vega, M.; Bennett, K.; Cooke, R.M.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Nature, 2014, 511(7511), 557-562.http://dx.doi.org/10.1038/nature13396 [25] Wu, H.; Wang, C.; Gregory, K.J.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Science, 2014, 344(6179), 58-64.http://dx.doi.org/10.1126/science.1249489 [26] Micheli, F., Methylphenylethynylpyridine (MPEP) Novartis.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Pharmacol., 2000, 131(7), 1429-1437. http://dx.doi.org/10.1038/sj.bjp.0703715 [28] Molck, C.; Harpsoe, K.; Gloriam, D.E.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Pharmacol., 2012, 82(5), 929-937.http://dx.doi.org/10.1124/mol.112.078808 [29] Pittolo, S.; Gomez-Santacana, X.; Eckelt, K.; Rovira, X.; Dalton, J.; Goudet, C.; Pin, J.P.; Llobet, A.; Giraldo, J.; Llebaria, A.; Gorostiza, P. An allosteric modulator to control endogenous G protein-coupled receptors with light.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Biol., 2014, 10(10), 813-815.http://dx.doi.org/10.1038/nchembio.1612 [30] Emmitte, K.A.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Comm., 2014, 5(10), 1548-1554.http://dx.doi.org/10.1039/ C4MD00208C [32] Sali, A.; Blundell, T.L.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Biol., 1993, 234(3), 779-815.http://dx.doi.org/10.1006/jmbi.1993.1626 [33] Pettersen, E.F.; Goddard, T.D.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Chem., 2004, 25(13), 1605-1612.http://dx.doi.org/ 10.1002/jcc.20084 [34] Morris, G.M.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Chem., 2009, 30(16), 2785-2791.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Chem., 2000, 275(43), 33750-33758.http://dx.doi.org/ 10.1074/jbc.M006230200 [36] Wood, M.R.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Biochemistry, 2011, 50(13), 2403-2410.http://dx.doi.org/10.1021/bi200129s [37] Bennett, K.A.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Pharmacol., 2003, 64(4), 823-832.http://dx.doi.org/ 10.1124/mol.64.4.823 [39] Craveur, P.; Joseph, A.P.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Amino Acids, 2013, 45(2), 279-289.http://dx.doi.org/ 10.1007/s00726-013-1511-3 [40] Forbes, C. C.; Beatty, A. M.; Smith, B.D.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"lett., 2001, 3(22), 3595-3598.http://dx.doi.org/10.1021/ ol016733l [41] Gregory, K.J.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Neurosci., 2014, 5(4), 282-295. http://dx.doi.org/10.1021/ cn400225x [42] Frisch, M.J.; Trucks, G.W.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"toxicol., 2013, 53, 531-56.http://dx.doi.org/10.1146/annurev-pharmtox-032112-135923 [44] Durrant, J.D.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Model., 2011, 29(5), 773-776.http://dx.doi.org/10.1016/j.jmgm.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Biol., 1977, 112(3), 535-542.http://dx.doi.org/10.1016/S0022-2836(77)80200-3 [47] Giraldo, J. Agonist induction, conformational selection, and mutant receptors.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"FEBS Lett., 2004, 556(1-3), 13-18.http://dx.doi.org/ 10.1016/S0014-5793(03)01404-2 [48] Trinquet, E.; Fink, M.; Bazin, H.; Grillet, F.; Maurin, F.; Bourrier, E.; Ansanay, H.; Leroy, C.; Michaud, A.; Durroux, T.; Maurel, D.; Malhaire, F.; Goudet, C.; Pin, J.P.; Naval, M.; Hernout, O.; Chretien, F.; Chapleur, Y.; Mathis, G. D-myo-inositol 1-phosphate as a surrogate of D-myo-inositol 1, 4, 5-tris phosphate to monitor G protein-coupled receptor activation.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Biochem., 2006, 358(1), 126-135. http://dx.doi.org/10.1016/j.ab.2006.08.002 [49] Lomize, M.A.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Bioinformatics, 2006, 22(5), 623-625.http://dx.doi.org/10.1093/ bioinformatics/btk023 [50] Schrödinger Release 2014-2: Maestro, version 9.8, Schrödinger, LLC, New York, NY, 2014.",Non-OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Chem., 2005, 26(16), 1781-1802.http://dx.doi.org/10.1002/jcc.20289 [54] Best, R. B.; Zhu, X.; Shim, J.; Lopes, P. E.; Mittal, J.; Feig, M.; Mackerell, A.D. Jr., Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone phi, psi and side-chain chi(1) and chi(2) dihedral angles.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"heory Comput., 2012, 8(9), 3257-3273.http://dx.doi.org/ 10.1021/ct300400x [55] Humphrey, W.; Dalke, A.; Schulten, K. VMD: visual molecular dynamics.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Sci., 2004, 44(6), 2133-44.http://dx.doi.org/10.1021/ci049780b [58] Golovin, A.; Oldfield, T.J.; Tate, J.G.",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Nucleic Acids Res., 2004, 32(Database issue), D211-216.http://dx.doi.org/10.1093/nar/ gkh078",OADS,/arxiv_data1/oa_pdf/25/1c/CN-14-441.PMC4983757.pdf
"Neurosci., 2009, 10, 272-282. http://dx.doi.org/10.1038/nrn2614 [2] Cull-Candy, S.; Brickley, S.; Farrant, M. NMDA receptor subunits: diversity, development and disease.",OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"Neurobiol., 2001, 11, 327-335. http://dx.doi.org/10.1016/S0959-4388(00)00215-4 [3] Collingridge, G.L.",OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"Physiol., 1983, 334, 33-46. http://dx.doi.org/10.1113/jphysiol.1983.sp014478 [4] Groc, L.; Heine, M.; Cognet, L.; Brickley, K.; Stephenson, F.A.",Non-OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"Neurosci., 2004, 7, 696-696. http://dx.doi.org/10.1038/nn1270 [5] Bashir, Z.I.",Non-OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"Nature, 1991, 3 4 9, 156-158. http://dx.doi.org/10.1038/349156a0 [6] Selig, D.K.",OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"BMC Neurosci., 2005, 6, 48. http://dx.doi.org/10.1186/1471-2202-6-48 [8] Harney, S.C.; Rowan, M.; Anwyl, R. Long-term depression of NMDA receptor-mediated synaptic transmission is dependent on activation of metabotropic glutamate receptors and is altered to long-term potentiation by low intracellular calcium buffering.",Non-OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"Neuron, 2002, 34, 255-264. http://dx.doi.org/10.1016/ S0896-6273(02)00658-X [11] Bellone, C.; Nicoll, R.A.",OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"Neuron, 2007, 55, 779-785. http://dx.doi.org/ 10.1016/j.neuron.2007.07.035 [12] Yashiro K; Philpot, B.D.",OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"Neuropharmacology, 2008, 55, 1081-1094. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"Neurosci., 2014, 34, 12223-12229. http://dx.doi.org/10.1523/ JNEUROSCI.0753-14.2014 [14] Snyder, E.M.; Philpot, B.D.",Non-OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"Neurosci., 2001, 4, 1079-1085. http://dx.doi.org/10.1038/nn746 [15] Anderson, W.W.; Collingridge, G.L.",Non-OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"Methods, 2007, 1 6 2, 346-56. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"Neuropharmacology, 2001, 40, 2 0-27. http://dx.doi.org/10.1016/S0028-3908(00)00118-0 [18] Ireland, D.R.",Non-OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"Neurophysiol., 2009, 101, 1375-1385. http://dx.doi.org/10.1152/jn.90643.2008 [19] Xu, J.Y.",Non-OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"http://dx.doi.org/ 10.1371/journal.pone.0010306 [20] Cull-Candy, S.G.; Leszkiewicz, D.N.",Non-OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
http://dx.doi.org/10.1126/stke.2552004re16,Non-OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"Neuron, 2011, 70, 339-351. http://dx.doi.org/10.1016/ j.neuron.2011.02.045 [22] Gladding, C.M.",OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"Rev., 2009, 61, 3 9 5-412. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"Neurosci., 2008, 9, 387. http://dx.doi.org/ 10.1038/nrn2356",Non-OADS,/arxiv_data1/oa_pdf/45/8d/CN-14-435.PMC4983758.pdf
"Sexual  orientation and health among U.S. adults: national health interview survey, 2013 (National Health Statistics Reports),  2014, http://www.cdc.gov/nchs/data/nhsr/nhsr077.pdf  20.",Non-OADS,/arxiv_data1/oa_pdf/d7/e5/10.1177_0269216316634601.PMC4984311.pdf
http://www.stonewall.org.uk/at_home/sexual_orien- tation_faqs/2694.asp (accessed 13 August 2015)  71.,Non-OADS,/arxiv_data1/oa_pdf/d7/e5/10.1177_0269216316634601.PMC4984311.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/94/fd/10.1177_2058460116653630.PMC4984313.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/2c/6d/10.1177_2325967116660068.PMC4984316.pdf
"This maneuver allowed us to establish stable backup and obtain a Department of Diagnostic and Interventional Radiology, Gunma University Hospital, Maebashi, Japan Corresponding author: Kei Shibuya, Department of Diagnostic and Interventional Radiology, Gunma University Hospital, 3-39-22 Showa-machi, Maebashi, Gunma371-8511, Japan.Email: shibukei@gunma-u.ac.jpActa Radiologica Open 5(8) 1–3 !The Foundation Acta Radiologica 2016Reprints and permissions:sagepub.co.uk/journalsPermissions.navDOI: 10.1177/2058460116651900 arr.sagepub.com Creative Commons CC-BY -NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (h ttp:// www.creativecommons.org/licenses/by-nc-nd/3.0/) which permits non-commercial use, reproduction and distribution of the work as published wit hout adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub .com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/93/cf/10.1177_2058460116651900.PMC4984317.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/a1/0e/10.1177_2058460116649799.PMC4984319.pdf
"If the AF volume is less than expected, it is referred to as oligohydramnios.1Radiology Unit, New Hope Hospital, Onitsha Anambra State, Nigeria 2Department of Radiography and Radiological Sciences, Faculty of Health Sciences and T echnology, Nnamdi Azikiwe University Nnewi Campus, Nigeria 3Radiology Department, State Hospital, Gombe, Nigeria 4Department of Radiography and Radiological Sciences, College of Health Sciences, Bayero University, Kano, Nigeria Corresponding author: JE Agwu, Radiology Unit, New Hope Hospital, Onitsha Anambra State,Nigeria.Email: emmypromi4general@gmail.comActa Radiologica Open 5(8) 1–5 !The Foundation Acta Radiologica 2016Reprints and permissions:sagepub.co.uk/journalsPermissions.navDOI: 10.1177/2058460116652651 arr.sagepub.com Creative Commons CC-BY -NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (h ttp:// www.creativecommons.org/licenses/by-nc-nd/3.0/) which permits non-commercial use, reproduction and distribution of the work as published wit hout adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub .com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/b5/71/10.1177_2058460116652651.PMC4984320.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/eb/4a/10.1177_2058460116655833.PMC4984322.pdf
"722 http://tag.sagepub.com Ther Adv Gastroenterol 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/ba/7e/10.1177_1756283X16651855.PMC4984330.pdf
Reprints and permissions:   http://www.sagepub.co.uk/ journalsPermissions.nav Therapeutic Advances in Gastroenterology Introduction Pancreatic stenting using a plastic stent is widely performed for pancreatic stricture due to chronic pancreatitis [Levy et  al.,Non-OADS,/arxiv_data1/oa_pdf/ba/7e/10.1177_1756283X16651855.PMC4984330.pdf
"http://tag.sagepub.com 723 stricture in the main pancreatic duct using an  uncovered self-expandable metal stent have been reported [Eisendrath and Deviere, 1991; Shin et al.",Non-OADS,/arxiv_data1/oa_pdf/ba/7e/10.1177_1756283X16651855.PMC4984330.pdf
Therapeutic Advances in Gastroenterology 9(5) 724 http://tag.sagepub.com characteristics of these patients.,Non-OADS,/arxiv_data1/oa_pdf/ba/7e/10.1177_1756283X16651855.PMC4984330.pdf
http://tag.sagepub.com 725 placement has been reported.,Non-OADS,/arxiv_data1/oa_pdf/ba/7e/10.1177_1756283X16651855.PMC4984330.pdf
Therapeutic Advances in Gastroenterology 9(5) 726 http://tag.sagepub.com 94% of patients during a mean follow up of 3  years [Cremer et  al.,Non-OADS,/arxiv_data1/oa_pdf/ba/7e/10.1177_1756283X16651855.PMC4984330.pdf
http://tag.sagepub.com 727 stent migration was not seen in any patients.,Non-OADS,/arxiv_data1/oa_pdf/ba/7e/10.1177_1756283X16651855.PMC4984330.pdf
Supplemental material The online videos are available at http://tag.sage-pub.com/supplemental.,Non-OADS,/arxiv_data1/oa_pdf/ba/7e/10.1177_1756283X16651855.PMC4984330.pdf
"Therapeutic Advances in Gastroenterology 9(5) 728 http://tag.sagepub.com Park, D., Kim, M., Moon, S., Lee, S., Seo, D. and  Lee, S. (2008) Feasibility and safety of placement of a newly designed, fully covered self-expandable metal  stent for refractory benign pancreatic ductal strictures:  A pilot study (with video).",Non-OADS,/arxiv_data1/oa_pdf/ba/7e/10.1177_1756283X16651855.PMC4984330.pdf
Visit SAGE journals online  http://tag.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/ba/7e/10.1177_1756283X16651855.PMC4984330.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Therapeutic Advances in Gastroenterology http://tag.sagepub.com 713 Introduction Standard endoclips were introduced in the 1980s and have been successfully used to treat bleeding, GI tract perforation, leak and fistula closure [Raju and Gajula, 2004].",Non-OADS,/arxiv_data1/oa_pdf/5e/f9/10.1177_1756283X16652325.PMC4984331.pdf
Therapeutic Advances in Gastroenterology 9(5) 714 http://tag.sagepub.com tissue grasp and compression without inducing  ischemia or laceration.,Non-OADS,/arxiv_data1/oa_pdf/5e/f9/10.1177_1756283X16652325.PMC4984331.pdf
http://tag.sagepub.com 715 procedures were performed under fluoroscopic  guidance with CO2 insufflation.,Non-OADS,/arxiv_data1/oa_pdf/5e/f9/10.1177_1756283X16652325.PMC4984331.pdf
"Therapeutic Advances in Gastroenterology 9(5) 716 http://tag.sagepub.com Out of 51 OTSCs, 45 clips were deployed in the  upper GI (36 of 11/6t, 7 of 12/6t and 2 of 14/6t), while 6 OTSCs were used in the lower GI tract (2 of 11/6t, 2 of 12/6t and 2 of 14/6t).",Non-OADS,/arxiv_data1/oa_pdf/5e/f9/10.1177_1756283X16652325.PMC4984331.pdf
http://tag.sagepub.com 717 The chronic setting group comprised 30  patients treated for fistula following GI surgery with the deployment of 35 OTSCs (Figure 3).,Non-OADS,/arxiv_data1/oa_pdf/5e/f9/10.1177_1756283X16652325.PMC4984331.pdf
"Therapeutic Advances in Gastroenterology 9(5) 718 http://tag.sagepub.com Among the 15 patients in whom technical suc- cess was achieved, 11 (73.3%) achieved long-term clinical success with a mean follow up of 23 months (range, 1–34 months).",Non-OADS,/arxiv_data1/oa_pdf/5e/f9/10.1177_1756283X16652325.PMC4984331.pdf
http://tag.sagepub.com 719 time; such a timespan is usually sufficient to cure  pathologies like bleeding and acute GI perfora-tion; however it might not be adequate for chronic pathologies like fistula or GI leaks.,Non-OADS,/arxiv_data1/oa_pdf/5e/f9/10.1177_1756283X16652325.PMC4984331.pdf
"Therapeutic Advances in Gastroenterology 9(5) 720 http://tag.sagepub.com closure; however, we recommend their use only  in selected cases after a careful evaluation.",Non-OADS,/arxiv_data1/oa_pdf/5e/f9/10.1177_1756283X16652325.PMC4984331.pdf
"http://tag.sagepub.com 721 Raju, G. and Gajula, L. (2004) Endoclips for GI  endoscopy.",Non-OADS,/arxiv_data1/oa_pdf/5e/f9/10.1177_1756283X16652325.PMC4984331.pdf
Visit SAGE journals online  http://tag.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/5e/f9/10.1177_1756283X16652325.PMC4984331.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Therapeutic Advances in Gastroenterology http://tag.sagepub.com 749 A 34-month-old boy of Caribbean/Hispanic  descent, born abroad and raised in a Houston suburb, following 2 weeks in the Caribbean pre-sented with new-onset painless gagging and vom-iting multiple times per day.",Non-OADS,/arxiv_data1/oa_pdf/53/49/10.1177_1756283X16653582.PMC4984332.pdf
"Therapeutic Advances in Gastroenterology 9(5) 750 http://tag.sagepub.com From this repeat endoscopy, with informed con- sent, bacterial DNA was isolated from gastric fluid and brushings, mucosal biopsies from fun-dus, corpus, and antrum, and stool and was sequenced using recently described methods [Schloss et  al.",Non-OADS,/arxiv_data1/oa_pdf/53/49/10.1177_1756283X16653582.PMC4984332.pdf
http://tag.sagepub.com 751 This report is the first characterization of the gas- tric mucosal microbiota in a child.,Non-OADS,/arxiv_data1/oa_pdf/53/49/10.1177_1756283X16653582.PMC4984332.pdf
Visit SAGE journals online  http://tag.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/53/49/10.1177_1756283X16653582.PMC4984332.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Therapeutic Advances in Gastroenterology http://tag.sagepub.com 747 Dear Editor, Helicobacter pylori infection is the most common  infectious disease worldwide and is thought to be a cause of gastric cancer [Park et al.",Non-OADS,/arxiv_data1/oa_pdf/44/64/10.1177_1756283X16654499.PMC4984333.pdf
Therapeutic Advances in Gastroenterology 9(5) 748 http://tag.sagepub.com Company Limited in 2015.,Non-OADS,/arxiv_data1/oa_pdf/44/64/10.1177_1756283X16654499.PMC4984333.pdf
Available from: http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk8/index.php.,Non-OADS,/arxiv_data1/oa_pdf/44/64/10.1177_1756283X16654499.PMC4984333.pdf
Visit SAGE journals online  http://tag.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/44/64/10.1177_1756283X16654499.PMC4984333.pdf
"702 http://tag.sagepub.com Ther Adv Gastroenterol 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/8b/d4/10.1177_1756283X16656690.PMC4984334.pdf
Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Therapeutic Advances in Gastroenterology Introduction Combined-modality treatment comprising con-current chemoradiotherapy (CCRT) followed by total mesorectal excision (TME) is the standard of care for patients with locally advanced rectal can-cer (LARC).,Non-OADS,/arxiv_data1/oa_pdf/8b/d4/10.1177_1756283X16656690.PMC4984334.pdf
"http://tag.sagepub.com 703 patients with rectal cancer receiving standard  CCRT with 5-fluorouracil (5-FU) achieve a path-ologic complete response (pCR), which has been associated with improved local control and dis-ease-free survival (DFS) [Garcia-Aguilar et  al.",Non-OADS,/arxiv_data1/oa_pdf/8b/d4/10.1177_1756283X16656690.PMC4984334.pdf
Therapeutic Advances in Gastroenterology 9(5) 704 http://tag.sagepub.com double-stapled technique.,Non-OADS,/arxiv_data1/oa_pdf/8b/d4/10.1177_1756283X16656690.PMC4984334.pdf
"Toxicity and efficacy During CCRT and postoperative follow up, adverse events were scored and recorded at each visit according to the Common Terminology Criteria for Adverse Events, Version 3.0 (availa-ble at: http://ctep.cancer.gov).",Non-OADS,/arxiv_data1/oa_pdf/8b/d4/10.1177_1756283X16656690.PMC4984334.pdf
http://tag.sagepub.com 705 patients with tumors located less than 5 cm from  the anal verge.,Non-OADS,/arxiv_data1/oa_pdf/8b/d4/10.1177_1756283X16656690.PMC4984334.pdf
"Therapeutic Advances in Gastroenterology 9(5) 706 http://tag.sagepub.com was discontinued in five patients because of grade  3 gastrointestinal toxicity and in two patients because of grade 3 leukopenia.Postoperative complicationsSurgical complications comprised three (3.9%) anastomotic leakages, two instances of delayed wound healing in coloanal anastomosis, one rec-tovesical fistula and one intestinal obstruction.",Non-OADS,/arxiv_data1/oa_pdf/8b/d4/10.1177_1756283X16656690.PMC4984334.pdf
http://tag.sagepub.com 707 involving oxaliplatin added to neoadjuvant CCRT  [Aschele et  al.,Non-OADS,/arxiv_data1/oa_pdf/8b/d4/10.1177_1756283X16656690.PMC4984334.pdf
"Therapeutic Advances in Gastroenterology 9(5) 708 http://tag.sagepub.com treatment, nonoperative treatment has been sug- gested as management for such patients [Sauer et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/d4/10.1177_1756283X16656690.PMC4984334.pdf
http://tag.sagepub.com 709 create much difficulty in surgical resection and  postoperative complications.,Non-OADS,/arxiv_data1/oa_pdf/8b/d4/10.1177_1756283X16656690.PMC4984334.pdf
"Therapeutic Advances in Gastroenterology 9(5) 710 http://tag.sagepub.com the follow-up time was not long enough; there- fore, long-term oncologic outcomes and late adverse events could not be fully addressed.",Non-OADS,/arxiv_data1/oa_pdf/8b/d4/10.1177_1756283X16656690.PMC4984334.pdf
http://tag.sagepub.com 711 and surgery on downstaging and on the rate of  sphincter-sparing surgery for rectal cancer: the Lyon R90–01 Randomized Trial.,Non-OADS,/arxiv_data1/oa_pdf/8b/d4/10.1177_1756283X16656690.PMC4984334.pdf
"Therapeutic Advances in Gastroenterology 9(5) 712 http://tag.sagepub.com O’Connell, M., Colangelo, L., Beart, R., Petrelli,  N., Allegra, C., Sharif, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/d4/10.1177_1756283X16656690.PMC4984334.pdf
Visit SAGE journals online  http://tag.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/8b/d4/10.1177_1756283X16656690.PMC4984334.pdf
"Dr.F.M.Bickelha upt Depar tment ofTheoretical Chem istry and Amste rdam Cent erforMultiscale Modeling (ACMM ) VUUniv ersity Amst erdam, DeBoelela an1083 1081 HVAms terdam (The Netherla nds) E-mail :F.M.Bic kelhaupt@ vu.nl [b]Prof. Dr.F.M.Bickelha upt Institute ofMolec ules and Mate rials Radbo udUniv ersity Nijmeg en,Heyen daalse weg 135 6525 AJNijm egen (The Netherl ands) Supp orting informa tionandtheORCIDidentification numb er(s) forthe autho r(s)ofthisarticle canbefoundunde rhttp://dx.doi.org/ 10.1002 / open.20150020 8.",Non-OADS,/arxiv_data1/oa_pdf/a7/72/OPEN-5-247.PMC4984409.pdf
"820 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/56/pnv004.PMC4984427.pdf
"Available at: http://www.fda.gov/Drugs/DrugSafety/ucm239821.htm (accessed August20, 2014).",Non-OADS,/arxiv_data1/oa_pdf/b0/56/pnv004.PMC4984427.pdf
"Available at:http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/rx_abuse_plan.pdf (accessedFebruary 16, 2015).",Non-OADS,/arxiv_data1/oa_pdf/b0/56/pnv004.PMC4984427.pdf
"Available at:http://www.deadiversion.usdoj.gov/drug_chem_info/hydrocodone.pdf (accessed February 16, 2015).",OADS,/arxiv_data1/oa_pdf/b0/56/pnv004.PMC4984427.pdf
"Available at: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm334807.htm (accessedOctober 13, 2015).",Non-OADS,/arxiv_data1/oa_pdf/b0/56/pnv004.PMC4984427.pdf
Available at: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm334743.pdf.[http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm334807.htm.,Non-OADS,/arxiv_data1/oa_pdf/b0/56/pnv004.PMC4984427.pdf
1email Lynn.J.Rothschild@nasa.gov[http://phys.org/news/2013-06-spider-silk-nature-stronger- steel.html#jCp].,Non-OADS,/arxiv_data1/oa_pdf/f7/1a/bst0441158.PMC4984444.pdf
B. subtilis spore image courtesy of the 2015 Stanford-Brown iGEM team (http://2015.igem.org/Team:Stanford-Brown/BioHYDRA).,Non-OADS,/arxiv_data1/oa_pdf/f7/1a/bst0441158.PMC4984444.pdf
"The 2011 Brown-Stanford iGEM team [http://2011.igem.org/Team:Brown-Stanford/REGObricks/Biocementation], under our direction, pioneered the concept of using this approach to agglutinate the Martian regolith (surface material) to produce a brick.",Non-OADS,/arxiv_data1/oa_pdf/f7/1a/bst0441158.PMC4984444.pdf
"In 2011 the Brown- Stanford iGEM team suggested that this cyanobacterium would function as the metabolic power centre for the biological infrastructure, thus providing the inspirationfor its name, PowerCell (http://2011.igem.org/Team:Brown- Stanford/PowerCell/Introduction).",Non-OADS,/arxiv_data1/oa_pdf/f7/1a/bst0441158.PMC4984444.pdf
"The PowerCellexperiment will test the ability of the diazotrophic cyanobacterium Anabaena to feed a production bacterium, Bacillus subtilis , which will act as a reporter system as originally conceived by the 2013 Stanford-Brown iGEM team (http://2013.igem.org/Team:Stanford-Brown/Projects/EuCROPIS).",Non-OADS,/arxiv_data1/oa_pdf/f7/1a/bst0441158.PMC4984444.pdf
Wound closure was evaluated in scramble control and GALNT3 knockdown cells using Image J software (https://imagej.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/40/ad/bjc2016116a.PMC4984453.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Loss of GALNT3 in pancreatic cancer 1386 www.bjcancer.com | DOI:10.1038/bjc.2016.116,Non-OADS,/arxiv_data1/oa_pdf/40/ad/bjc2016116a.PMC4984453.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)CTCs as a biomarker in pancreatic cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.121 1375,Non-OADS,/arxiv_data1/oa_pdf/43/b9/bjc2016121a.PMC4984454.pdf
using DAVID online annotation tool (http://david.abcc.ncifcrf.,Non-OADS,/arxiv_data1/oa_pdf/10/4a/bjc2016124a.PMC4984456.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Prognosis signature for rare ovarian cancers 1420 www.bjcancer.com | DOI:10.1038/bjc.2016.124",Non-OADS,/arxiv_data1/oa_pdf/10/4a/bjc2016124a.PMC4984456.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Tumour necrosis in colorectal cancer 1342 www.bjcancer.com | DOI:10.1038/bjc.2016.128,Non-OADS,/arxiv_data1/oa_pdf/5a/74/bjc2016128a.PMC4984458.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)MED12 andFHin uterine leiomyomas BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.130 1411,Non-OADS,/arxiv_data1/oa_pdf/93/20/bjc2016130a.PMC4984459.pdf
"HPV L1 amplicons from HPV16-, 18- and 33-negative samples were sequenced by Sanger method with GP6 þprimer and HPV type identification was performed by alignment of the sequence with HPV sequence references, using the nucleotide blast program from NCBI (http://blast.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/36/8d/bjc2016144a.PMC4984471.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Prognostic value of PIK3CA mutation in anal cancer 1394 www.bjcancer.com | DOI:10.1038/bjc.2016.144,Non-OADS,/arxiv_data1/oa_pdf/36/8d/bjc2016144a.PMC4984471.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Risk factors of proteinuria BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.147 1317,Non-OADS,/arxiv_data1/oa_pdf/8f/6d/bjc2016147a.PMC4984472.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Circulating miRNAs for prostate cancer screening 1366 www.bjcancer.com | DOI:10.1038/bjc.2016.151,Non-OADS,/arxiv_data1/oa_pdf/90/09/bjc2016151a.PMC4984473.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/BRITISH JOURNAL OF CANCER Cancer stem cell metabolism 1312 www.bjcancer.com | DOI:10.1038/bjc.2016.152",Non-OADS,/arxiv_data1/oa_pdf/6b/39/bjc2016152a.PMC4984474.pdf
Available at https://searchworks.stanford.edu/view/9100287.,Non-OADS,/arxiv_data1/oa_pdf/7a/bb/bjc2016160a.PMC4984476.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Ghrelin attenuates CDDP-related renal dysfunction BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.160 1325,Non-OADS,/arxiv_data1/oa_pdf/7a/bb/bjc2016160a.PMC4984476.pdf
"Two additional cohorts of patients with stages II–IV colon or rectal adenocarcinoma were analysed from data generated by TCGA Research Network (http://cancergenome.nih.gov/): one cohort, ‘TCGA27’ ( n¼218), had gene expression analysed by the Custom Agilent 244 K gene expression microarray (Agilent Technologies) and expressed as z-scores, and had methylation profiling performed using the Illumina Infinium HumanMethyla- tion27 BeadChip as described (The Cancer Genome Atlas Network, 2012); and the second cohort, ‘TCGA450’ ( n¼356), had gene expression analysed by RNA sequencing (The Cancer Genome Atlas Network, 2012) and expressed as log 2-transformed values, and also had methylation profiling performed using the Illumina Infinium HumanMethylation450 BeadChip.",Non-OADS,/arxiv_data1/oa_pdf/a7/b4/bjc201687a.PMC4984478.pdf
"A search for the corresponding sequence within the human genome was undertaken using BiSearch (http://bisearch.enzim.hu/) (Tusnady et al, 2005; Aranyi et al, 2006), and the identity of the sequence was verified by ensuring that the sequencing primer was located within the identified region.",OADS,/arxiv_data1/oa_pdf/a7/b4/bjc201687a.PMC4984478.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)CIMP status and EREG level in colorectal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.87 1361,Non-OADS,/arxiv_data1/oa_pdf/a7/b4/bjc201687a.PMC4984478.pdf
There are eight known cases of overdoses in the US FDA clinical trials iloperidone database (Table 1) (product package insert: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022192lbl.pdf).,Non-OADS,/arxiv_data1/oa_pdf/c6/6f/10.1177_2050313X16660485.PMC4984480.pdf
"ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562015000000065ABSTRACT Objective:  Post-infectious bronchiolitis obliterans (PIBO) is a clinical entity that has been  classified as constrictive, fixed obstruction of the lumen by fibrotic tissue.",Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
2014;103(9):913-21.  http://dx.doi.org/10.1111/apa.12689 2.,Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
2010;11(4):233-9. http://dx.doi.org/10.1016/j.prrv.2010.07.005 3.,OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
2006;61(6):503-6. http://dx.doi.org/10.1136/thx.2005.044909 4.,Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
2000;76(3):185-92. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
2002;33(6):466-74. http://dx.doi.org/10.1002/ppul.100976.,Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
2008;84(4):337-43. http://dx.doi.org/10.2223/jped.1807 8.,Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
2006;41(10):947-53. http://dx.doi.org/10.1002/ppul.20472 9.,Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
2008;43(4):381- 90. http://dx.doi.org/10.1002/ppul.20784Table 3.,Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
2005;26(2):319-38.  http://dx.doi.org/10.1183/09031936.05.00034805 11.,Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
2009;180(6):547-52. http://dx.doi.org/10.1164/rccm.200903-0323OC 12.,Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
2000;161(2 Pt 1):353-9.  http://dx.doi.org/10.1164/ajrccm.161.2.9903026 13.,Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
2005;26(5):948-68. http://dx.doi.org/10.1183/09031936.05.00035205 14.,Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
2000;30(4):330-44. http://dx.doi.org/10.1002/1099- 0496(200010)30:4<330::AID-PPUL10>3.0.CO;2-D 15.,Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
2005;60(1):13-6. http://dx.doi.org/10.1136/thx.2004.02993416.,Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
1999;134(6):730-3. http://dx.doi.org/10.1016/ S0022-3476(99)70289-1 17.,Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
1992;47(6):429- 36. http://dx.doi.org/10.1136/thx.47.6.429 19.,Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
http://dx.doi.org/10.1378/chest.117.2_suppl.42S 20.,Non-OADS,/arxiv_data1/oa_pdf/2b/10/1806-3713-jbpneu-42-03-00174.PMC4984543.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562015000000337ABSTRACT Objective:  The objective of this study was to describe the results of anatomic  pulmonary resections performed by video-assisted thoracoscopy in Brazil.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2013;44(4):591-7.  http://dx.doi.org/10.1093/ejcts/ezt051 2.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2012;1(1):16-23. http://dx.doi.org/ 10.3978/j.issn.2225- 319X.2012.04.18 3.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2007;25(31):4993-7. http://dx.doi.org/10.1200/ JCO.2007.12.6649 4.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2009;138(1):11-8. http://dx.doi.org/10.1016/j.jtcvs.2009.03.030 5.,OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2008;18(3):263-8. http://dx.doi.org/10.1016/j.thorsurg.2008.04.001 7.,OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2014;45(5):779-86. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2012;94(4):1060-4. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2012;67(6):557-64. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
http://dx.doi.org/10.1378/chest.117.6.1787 11.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2006;81(2):421-5; discussion 425-6. http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2010;139(2):366-78. http://dx.doi.org/10.1016/j.jtcvs.2009.08.026 13.,OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2014;147(3):929-37. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2007;335(7625):879-83. http://dx.doi.org/10.1136/ bmj.39346.495880.AE 19.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2015;372(17):1629-38. http://dx.doi.org/10.1056/NEJMoa1415236 20.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2012;14(6):797-800.  http://dx.doi.org/10.1093/icvts/ivr098 22.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2013;8(4):334-41. http://dx.doi.org/10.5114/ wiitm.2011.35633 23.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
Available  from: http://who.int/tb/country/data/profiles/en/ 25.,OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2006;32(6):495-504. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2003;121(3):107-10. http://dx.doi.org/10.1590/S1516- 31802003000300004 28.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
2014;45(4):633-9.  http://dx.doi.org/10.1093/ejcts/ezt463 221 J Bras Pneumol.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/1806-3713-jbpneu-42-03-00215.PMC4984544.pdf
ISSN 1806-3713 © 2016 Sociedade Brasileira de Pneumologia e Tisiologiahttp://dx.doi.org/10.1590/S1806-37562016000000043ABSTRACT Post-infectious bronchiolitis obliterans (PIBO) is a small airways disease characterized  by fixed airflow limitation.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
Thorax 1953;8(2):133-6. http://dx.doi.org/10.1136/thx.8.2.133 2.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
AJR  Am J Roentgenol 1992;158(6):1211-5. http://dx.doi.org/10.2214/ ajr.158.6.1590109 3.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
2013;61(4):355-6. http://dx.doi.org/10.5578/tt.6131 4.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
J Med Case Rep.  2011;5:2. http://dx.doi.org/10.1186/1752-1947-5-2 5.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
http://dx.doi.org/10.1136/bcr.05.2011.4191 7.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
http://dx.doi.org/10.1016/j.jtcvs.2013.01.035 8.,OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
2013;31(1):10-6. http://dx.doi.org/10.1590/S0103- 05822013000100003 10.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
2011;87(3):187-98. http://dx.doi.org/10.2223/ jped.2083 11.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
1998;28(1):23-9. http://dx.doi.org/10.1007/ s002470050286 12.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
1999;134(6):730-3. http://dx.doi.org/10.1016/ S0022-3476(99)70289-1 13.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
2011;139(3):633-9.  http://dx.doi.org/10.1378/chest.10-1442 14.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
2013;144(3):974-80. http://dx.doi.org/10.1378/ chest.12-2280 15.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
2006;27(1):36-41.  http://dx.doi.org/10.1183/09031936.06.00019605 16.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
2008;84(4):337-43. http://dx.doi.org/10.2223/jped.1807 17.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
2008;43(4):381- 90. http://dx.doi.org/10.1002/ppul.20784 18.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
2015;11:1563- 72. http://dx.doi.org/10.2147/TCRM.S84151 19.,Non-OADS,/arxiv_data1/oa_pdf/66/dd/1806-3713-jbpneu-42-03-00228.PMC4984545.pdf
"Nati onal End of Life Care Pro- gramme, 2010. http://www.nhsiq .nhs.uk/media/2574509/end-  of-life-care-in-heart-failure-framework-for-implementation.pdf (accessed Nov 7, 2015).",Non-OADS,/arxiv_data1/oa_pdf/25/75/jgc-13-05-420.PMC4984566.pdf
"http://www.healthy-heart-china.com/Website/default/index.aspx (accessed June 24, 2015).",Non-OADS,/arxiv_data1/oa_pdf/b1/08/jgc-13-05-401.PMC4984567.pdf
"https://clinicaltrials.gov/ct2/show/NCT01456481 (accessed Nov 7, 2015).",Non-OADS,/arxiv_data1/oa_pdf/16/49/jgc-13-05-380.PMC4984568.pdf
https://www.ha.org.hk/upload/publication_15/491.,Non-OADS,/arxiv_data1/oa_pdf/92/eb/jgc-13-05-425.PMC4984573.pdf
http://app2.sfda.gov.cn/ datasearchp/index1.do?table Id=27&tableName=TABLE27&  tableView (accessed Mar 2016).,OADS,/arxiv_data1/oa_pdf/92/eb/jgc-13-05-425.PMC4984573.pdf
http://www.moh.gov.,Non-OADS,/arxiv_data1/oa_pdf/92/eb/jgc-13-05-425.PMC4984573.pdf
"Heart transplantati on and ventricular assist device,  2013. http://www.ha.org.hk/haconvention/hac2013/proceed-ings/downloads/MC2.2.pdf (accessed March 4, 2016).",Non-OADS,/arxiv_data1/oa_pdf/92/eb/jgc-13-05-425.PMC4984573.pdf
"At las of heart disease and stroke,  2004. http://www.who.in t/cardiovascular_diseases/resources/  atlas/en/ (accessed April 22, 2014).",Non-OADS,/arxiv_data1/oa_pdf/57/52/jgc-13-05-393.PMC4984575.pdf
"Th e top 10 causes of death, 2013.  http://www.who.int/mediacentre/ factsheets/fs310/en/ (accessed  April 19, 2014).",Non-OADS,/arxiv_data1/oa_pdf/57/52/jgc-13-05-393.PMC4984575.pdf
http://www.bhf.org.uk/publica tions/view-publication.aspx?,Non-OADS,/arxiv_data1/oa_pdf/57/52/jgc-13-05-393.PMC4984575.pdf
"16  Langley T. Non-ischaemic chest pain following coronary  stenting, 2003.  http://exwwwsvh.stvincents .com.au/assets/files/  pdf/NRI/Monograph2003.pdf (accessed May 27, 2014).",Non-OADS,/arxiv_data1/oa_pdf/57/52/jgc-13-05-393.PMC4984575.pdf
"Na- tional report of percutaneous coronary interventional proce-dures report 2011.  http://www.ucl.ac.uk/silva/nicor/audits/  adultcardiacintervention/publ icreports/documents/pcire-  Port 2012 (accessed June 15, 2014).",Non-OADS,/arxiv_data1/oa_pdf/57/52/jgc-13-05-393.PMC4984575.pdf
"28  Pell J, Slack R. The Scottish Coronary Revascularisation  Register Annual Report 2009-201 0. http://www.scotlandcard- iac.org/images/PDF/scrr%200910%20final.pdf ( accessed April  14, 2013).",Non-OADS,/arxiv_data1/oa_pdf/57/52/jgc-13-05-393.PMC4984575.pdf
"http://news.scotland.gov.uk/News /Prescription-charges-42f.as px (accessed February 15, 2014).",Non-OADS,/arxiv_data1/oa_pdf/57/52/jgc-13-05-393.PMC4984575.pdf
"NHS 11 1 public sector equality duty  (PSED) analysis of impact on equality, 2012. https://www.gov.",Non-OADS,/arxiv_data1/oa_pdf/57/52/jgc-13-05-393.PMC4984575.pdf
"Improving car- diac care, 2013. https://www.cardiosmart.org/Heart-Conditions/ Heart-Attack/New-Measure-Hel ps-Hospitals-Focus-on-Read missions-after-PCI (accessed June 2, 2014).",Non-OADS,/arxiv_data1/oa_pdf/57/52/jgc-13-05-393.PMC4984575.pdf
The original Chinese version of the document is available at the official government website: http://www.gov.cn/zhengce/content/2015-06/18/content_9860.htm.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
"2016; 28(1): 4-17. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.216012]Shanghai Archives of Psychiatry, 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
The Chinese version of this previous plan is available on the website of the Zhejiang Centers for Disease Control at: http://www.cdc.zj.cn/bornwcms/Html/zcfg43/2009-03/05/8aac82101fcb0b45011fd43b 61400e09.html.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
"To help support the implementation of the 2002-2010 work plan, in 2008 seventeen different government ministries, commissions, and organizations jointly issued a follow-up document entitled ‘Directives  for Development of the National Mental Health Work System (2008-2015)’, which is available (in Chinese) at:  http://www.nhfpc.gov.cn/jkj/s5888/200805/81047a30f3c34141b12481de35930d78.shtml.",Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
"The official structure of the State Council is listed at: http://www.gov.cn/guowuyuan/gwy_zzjg.htm, and a description in English can be found on Wikipedia at: https:// en.wikipedia.org/wiki/State_Council_of_the_People%27s_Republic_of_China.",Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
"Its official website is http://www.chinapeace.gov.cn/, and a brief  description in English is available on Wikipedia at: https://en.wikipedia.org/wiki/Central_Public_Security_ Comprehensive_Management_Commission.",Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
"Its official website is http://www.ndrc.gov.cn/ , and a description in English is available on Wikipedia at: https://en.wikipedia.org/wiki/National_ Development_and_Reform_Commission#cite_note- 6.",Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
"Its official website is http://www.mca.gov.cn/ and a description in  English is available on Wikipedia at: https://en.wikipedia.org/wiki/Ministry_of_Civil_Affairs• 12 • Shanghai Archives of Psychiatry, 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
"Its official website is http://www.cdpf.org.cn/, and a description in English is available on Wikipedia at: https://en.wikipedia.org/wiki/ China_Disabled_Persons%27_Federation 8.",Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
The Chinese version of the law is available at the official government website: http://www.gov.cn/jrzg/2012-10/26/content_2252122.htm.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
An English translation with annotations  was previously published in Shanghai Archives of Psychiatry and is available at: http://dx.doi.org/10.3969/ j.issn.1002-0829.2012.06.001.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
"The full text of China’s 12 th Five-Year Plan (2011-2015) is available at: http:// www.gov.cn/2011lh/content_1825838.htm, and an English translation prepared by the Delegation of the European Union in China is available at: http://www.britishchamber.cn/content/chinas-twelfth-five-year-plan- 2011-2015-full-english-version 11.",Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
The Chinese version of the plan can be downloaded at: http://www.mca.gov.cn/article/zwgk/fvfg/shflhshsw/200901/20090100025874.shtml 12.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
The report is available at: http://www.moh.gov.cn/jkj/s7915v/201504/d5f3f871e02e4d6e912def7ced719353.shtml   (in Chinese) 15.,OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
The announcement for 2015 is available at: http://www.moh.gov.cn/jws/ zcwj/201506/61340494c00e4ae4bca0ad8411a724a9.shtml (in Chinese) 17.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
Official documents related to different types of the medical insurance and aid services are available on the website of the Ministry of Human Resources and Social Security: http://www.mohrss.gov.cn/gkml/index3.htm (in Chinese) 19.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
The ‘Criminal Procedure Law  of the People’s Republic of China’ released in 1979 (http://www.npc.gov.cn/huiyi/lfzt/xsssfxg/2011-08/23/content_1666668.htm [in English]) includes articles related to the evaluation of persons with possible mental  disorders (Article 120) and the determination of the level of responsibility of persons with mental disorders  (Article 176).,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
"More details about the evaluation process, assessment of the level of responsibility, and subsequent management of such individuals are provided in the  ‘Temporary Regulations for the Forensic Evaluation of Persons with Mental Disorders’ (http://www.chinacourt.",Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
An article published in Shanghai Archives of Psychiatry  provides  an overview of this project: http://dx.doi.org/10.3969/j.issn.1002-0829.2012.03.007 22.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
"‘Causing incidents’ ( 肇事 ) is a violation of the Public Security Administration  Punishments Law of the People’s Republic of China (available at: http://www.mps.gov.cn/n16/n1282/n3493/ n3763/n4168/434718.html, in Chinese), while ‘causing troubles’ ( 肇祸 ) is a violation of the Criminal Law of the  People’s Republic of China (available at:  http://www.mps.gov.cn/n16/n1282/n3493/n3763/n493954/494322.",Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
The digital  versions of the Health Statistics Yearbook of China since 2004 can be accessed at: http://www.moh.gov.cn/ zwgkzt/tjnj/list.shtml  (in Chinese).,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
The WHO country profile for China is available at: http://www.who.int/mental_health/evidence/atlas/profiles/ chn_mh_profile.pdf?ua=1 27.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
The Mental Health Action Plan for 2013-2020 of the World Health Organization is available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
Brief English-language overviews of these theoretical principles are available at: http://english.cpc.people.com.cn/206972/206981/8188424.html; and https:// en.wikipedia.org/wiki/Scientific_Outlook_on_Development  31.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
The governance of civil services in China is explained on Wikipedia at: https://en.wikipedia.org/wiki/Civil_Service_of_the_People%27s_Republic_ of_China.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
A brief description of the National Office of Aging is available at:  http://www.mca.gov.cn/article/zwgk/jggl/ jgzn/200712/20071200006546.shtml (in Chinese).,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
"The examination and certification of physicians is organized by Health and Family Planning Commission and regulated by the Law on Practicing Doctors of the People’s Republic of China (available at: http://www.gov.cn/ banshi/2005-08/01/content_18970.htm, in Chinese).",Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
In 2008 the Ministry of Health (now the Health and Family Planning Commission) issued the first announcement to establish psychological first-aid hotlines: http://www.moh.gov.cn/mohbgt/pw10809/200808/37479.shtml (in  Chinese) 42.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
Policies related to this system are described at: http://www.moh.gov.cn/jkj/ s5888/201204/16ebc49bfe504f979eb31070fc3ac5bf.shtml (in Chinese) 44.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
(http://www.nhfpc.gov.cn/jws/s3577/201409/acaeab089ac44d7a87d38393ccec4a78.shtml in Chinese) 45.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
The official website of the hotline is: http://www.12320.gov.cn/ (in Chinese) 49.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
"The 13 th Five-Year Plan runs from 2016 to 2020 (https://en.wikipedia.org/wiki/Five-year_plans_of_ China).• 16 • Shanghai Archives of Psychiatry, 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
The main policy document on the Informatics Project is available at: http://www.nhfpc.gov.cn/guihuaxxs/ s10741/201312/09bce5f480e84747aa130428ca7fc8ad.shtml (in Chinese) 51.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
Their structures and roles are available at: https://en.wikipedia.org/wiki/ Chinese_People%27s_Political_Consultative_Conference (in Chinese) 52.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
"It should be included within the field of occupational health, but mental health is not mentioned in the Code of Occupational Disease  Prevention of People’s Republic of China  (available at: http://www.nhfpc.gov.cn/zhjcj/s3576/201305/ bcb8d4336e8f470e85a30859fd2bd95a.shtml, in Chinese).",Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
The Comprehensive Management of Public Security Commission was established in 1991 after a series of decisions to strengthen societal stability: http://www.npc.gov.cn/wxzl/wxzl/2000-12/05/content_4548.htm  (in  Chinese).,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
The full text of the Law of the People’s Republic of China on the Protection of Disabled Persons is available at: http://www.gov.cn/jrzg/2008-04/24/content_953439.htm (in Chinese) 56.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
It is available at:  http://www.cdpf.org.cn/ghjh/syfzgh/sew/201106/t20110609_77997.shtml (in Chinese) 57.,Non-OADS,/arxiv_data1/oa_pdf/0e/33/sap-28-01-4.PMC4984605.pdf
"E-mail: changyong_feng@urmc.rochester.edu A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.216031 on May 25, 2016.Summary:  The relative risk, risk difference, and odds ratio are the three most commonly used measures  for comparing the risk of disease between different groups.",Non-OADS,/arxiv_data1/oa_pdf/98/fb/sap-28-01-56.PMC4984606.pdf
2016; 28(1): 56-60. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.216031] 1.,Non-OADS,/arxiv_data1/oa_pdf/98/fb/sap-28-01-56.PMC4984606.pdf
"概 述： 相对危险度  (relative risk) 、危险差  (risk  difference)  和比值比  (odds ratio) 是最常用的三种比较不 同群体之间疾病风险的方法。虽然它们在生物医学和 社会心理学研究中广泛流行，但是尚无文献明确这三种方法之间的关系。许多研究人员误以为它们之间的关系是单调变化的， 即某种测量方式中较高 （或较低）的值与其它测量方式中的较高（或较低）的值相关。本文中，我们讨论了三个定理，并提供例子解释之前大部分研究人员所认为这三种方法之间的关系是不对的；这些测量方法相互之间并没有逻辑关系。研究人员在说明不同种测量方法之间的相关性时或结合使用不同种风险测量方法所得的研究结果时必须非常谨慎。 关键词： 比值比；相对危险度；危险差 本文全文中文版从 2016 年5月25日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.216031 可供免费阅览下载三种常用危险度测量方法之间的关系：相对危险度、危险差和比值比 Feng CY , Wang HY , Wang BK, Lu X, Sun H, Tu XM References 1.",Non-OADS,/arxiv_data1/oa_pdf/98/fb/sap-28-01-56.PMC4984606.pdf
1979; 66 : 403-411. doi:   http://dx.doi.org/10.1093/biomet/66.3.403 3.,Non-OADS,/arxiv_data1/oa_pdf/98/fb/sap-28-01-56.PMC4984606.pdf
1994; 23(1): 201-203. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/fb/sap-28-01-56.PMC4984606.pdf
2009; 10(4): 264-269. doi:  http://dx.doi.org/10.1038/nrg2516measures have not been made clear in the literature.,Non-OADS,/arxiv_data1/oa_pdf/98/fb/sap-28-01-56.PMC4984606.pdf
2016; 28(1): 1-3. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.216036],Non-OADS,/arxiv_data1/oa_pdf/85/58/sap-28-01-1.PMC4984607.pdf
2016; 28(1): 4-17. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.216012 2.,Non-OADS,/arxiv_data1/oa_pdf/85/58/sap-28-01-1.PMC4984607.pdf
Available  at: http://www.gov.cn/zhengce/content/2015-06/18/ content_9860.htm.,Non-OADS,/arxiv_data1/oa_pdf/85/58/sap-28-01-1.PMC4984607.pdf
Shanghai Arch Psychiatry   2012; 24(6): 305-321. doi: http://dx.doi.org/ 10.3969/ j.issn.1002-0829.2012.06.001 4.,Non-OADS,/arxiv_data1/oa_pdf/85/58/sap-28-01-1.PMC4984607.pdf
2012; 24(3): 172-174. doi: http://dx.doi.org/10.3969/ j.issn.1002-0829.2012.03.007 5.,Non-OADS,/arxiv_data1/oa_pdf/85/58/sap-28-01-1.PMC4984607.pdf
2016; 28(1): 28-34. doi:  http://dx.doi.org/10.11919/j.issn.1002-0829.215124 7.,Non-OADS,/arxiv_data1/oa_pdf/85/58/sap-28-01-1.PMC4984607.pdf
1979; 9(1): 139-145.  doi:  http://dx.doi.org/10.1017/S0033291700021644 8.,Non-OADS,/arxiv_data1/oa_pdf/85/58/sap-28-01-1.PMC4984607.pdf
2016; 28(1): 35-41.  doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215127 11.,Non-OADS,/arxiv_data1/oa_pdf/85/58/sap-28-01-1.PMC4984607.pdf
2016; 28(1): 45-47. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/58/sap-28-01-1.PMC4984607.pdf
2016; 28(1): 48-51. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.215112 15.,Non-OADS,/arxiv_data1/oa_pdf/85/58/sap-28-01-1.PMC4984607.pdf
2016; 28(1): 56-60. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/58/sap-28-01-1.PMC4984607.pdf
"E-mail: manbhatia1@rediffmail.com A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215077 on  May 25, 2016..M.S.",Non-OADS,/arxiv_data1/oa_pdf/b2/dc/sap-28-01-52.PMC4984608.pdf
2016; 28(1): 52-55. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215077] 1.,Non-OADS,/arxiv_data1/oa_pdf/b2/dc/sap-28-01-52.PMC4984608.pdf
"概述： 地震是世界上许多地区比较常见的自然灾害， 但地震对心理健康影响的研究还很有限。经历地震的 人往往遭受重大损失，患精神障碍的风险增加。然而，规模不大、非破坏性地震现象所致精神障碍的患病率还是未知的。本文报告了一名就诊于精神科门诊的 10 岁女孩，她出现严重影响功能的焦虑症状已 2周， 其诱因是经历了一场较远地区的地震，而在当地仅有非破坏性震感，媒体却过度报道。她的情况不符合任何特定的焦虑相关障碍，因此最合适的诊断是精神障碍诊断与统计手册第五版  (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, DSM-5) 非特 异性分类中的 “其它特定焦虑障碍 ”。经过一种苯二 氮䓬类药物和一种选择性 5-羟色胺再摄取抑制剂的治 疗，患者的症状 4周后消失。 关键词： 地震；新闻报道；自然灾害；其他焦虑障碍； 选择性 5-羟色胺再摄取抑制剂；儿童 ;  印度 本文全文中文版从 2016 年5月25日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215077 可供免费阅览下载当地新闻对远距离地震所致非破坏性震感的过度报道促发儿童焦虑障碍的病例报告 Bhatia MS, Gautam P References 1.",Non-OADS,/arxiv_data1/oa_pdf/b2/dc/sap-28-01-52.PMC4984608.pdf
2011; 185(1-2): 161-166. doi : http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b2/dc/sap-28-01-52.PMC4984608.pdf
2008; 32(2): 280-291. doi:  http://dx.doi.org/10.1111/j.1467-7717.2008.01039.x 4.,Non-OADS,/arxiv_data1/oa_pdf/b2/dc/sap-28-01-52.PMC4984608.pdf
Epub 2007 Mar 21. doi: http://dx.doi.org/10.1016/ j.comppsych.2006.12.0035.,OADS,/arxiv_data1/oa_pdf/b2/dc/sap-28-01-52.PMC4984608.pdf
Epub 2012 Oct 19. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b2/dc/sap-28-01-52.PMC4984608.pdf
"E-mail: manyucc@126.com A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.216032 on May 25, 2016.Mental illnesses are the result of cerebral dysfunctions  of unknown etiology which manifest as cognitive,  affective, motivational, and behavioral impairments.",Non-OADS,/arxiv_data1/oa_pdf/5a/97/sap-28-01-45.PMC4984609.pdf
"概述：许多跨病种研究逐渐发现在不同的常见精神疾 病之间——包括精神分裂症、 双相情感障碍、 和抑郁症， 存在共同的遗传变异，而目前诊断系统中已经将这些疾病分为独立的精神障碍。这些跨病种研究对基于临床症状的精神障碍诊断传统系统是一种挑战，但是这否能够成为精神疾病分类的一种改进方法从而改善这些承受痛苦的患者的预后仍有待观察。 关键词： 跨障碍分析；精神疾病；遗传学；诊断 本文全文中文版从 2016年5月25日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.216032 可供免费阅览下载跨病种研究对精神疾病诊断标准的影响 王媺媞，崔东红Shanghai Archives of Psychiatry, 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/5a/97/sap-28-01-45.PMC4984609.pdf
2014; 157(1): 201-214. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/97/sap-28-01-45.PMC4984609.pdf
2013; 381(9875): 1371-1379. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/97/sap-28-01-45.PMC4984609.pdf
2016; 73(3): 275-283. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/97/sap-28-01-45.PMC4984609.pdf
2013; 499(7458): 341-345. doi: http://dx.doi.org/10.1038/ nature123487.,Non-OADS,/arxiv_data1/oa_pdf/5a/97/sap-28-01-45.PMC4984609.pdf
2011; 57(1): 40-47. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/97/sap-28-01-45.PMC4984609.pdf
doi: http://dx.doi.org/10.1126/ scisignal.aac7538 9.,Non-OADS,/arxiv_data1/oa_pdf/5a/97/sap-28-01-45.PMC4984609.pdf
2013; 56(2):  340-349. doi: http://dx.doi.org/10.1007/s00125-012-2758-z 10.,Non-OADS,/arxiv_data1/oa_pdf/5a/97/sap-28-01-45.PMC4984609.pdf
2015; 6:  8271. doi: http://dx.doi.org/10.1038/ncomms9271 Dr. Meiti Wang graduated from Chongqing Medical University in 2013 with a bachelor’s degree.,Non-OADS,/arxiv_data1/oa_pdf/5a/97/sap-28-01-45.PMC4984609.pdf
"E-mail: 13661598481@163.com A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215116 on May 25, 2016.Boyuan ZHANG1, Xuefan DING1, Weihong LU2, Jing ZHAO2, Qinyu LV2, Zhenghui YI2, Shaoping ZHANG1,  Yindi CHEN1,*Effect of group cognitive-behavioral therapy on the quality of  life and social functioning of patients with mild depression•Original research article • Background: Several studies of moderate-to-severe depression have shown that combined treatment with  individual cognitive behavioral therapy (CBT) and antidepressant medication is better than either CBT or  antidepressants alone.",Non-OADS,/arxiv_data1/oa_pdf/f5/af/sap-28-01-18.PMC4984610.pdf
"2016; 28(1): 18-27. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215116]Shanghai Archives of Psychiatry, 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/f5/af/sap-28-01-18.PMC4984610.pdf
2008; 50(4): 428-436. doi:   http://dx.doi.org/10.1097/JOM.0b013e31816b5034 3.,Non-OADS,/arxiv_data1/oa_pdf/f5/af/sap-28-01-18.PMC4984610.pdf
2004; 61(7): 714-719.  doi: http://dx.doi.org/10.1001/archpsyc.61.7.714 5.,Non-OADS,/arxiv_data1/oa_pdf/f5/af/sap-28-01-18.PMC4984610.pdf
doi:  http://dx.doi.org/10.1177/0004867415569799  6.,Non-OADS,/arxiv_data1/oa_pdf/f5/af/sap-28-01-18.PMC4984610.pdf
"1988; 52(1): 30-41. doi: http://dx.doi.org/10.1207/ s15327752jpa5201_2背景：有关中度至重度抑郁症的一些研究表明，联合 使用认知行为治疗  (cognitive behavioral therapy, CBT) 与 抗抑郁药物的效果优于单独使用 CBT或抗抑郁药物。 很少研究关注团体 CBT治疗和药物治疗对轻度抑郁症 患者的效果。 目标：评估联合使用团体 CBT治疗与抗抑郁药物对轻 度抑郁患者生活质量及社会功能的影响。 方法：我们将 62例轻度抑郁症患者随机分为对照组   (n=30) 与干预组  (n=32) ，对照组予以抗抑郁药物治疗 12周， 干预组予以抗抑郁药物合并团体 CBT治疗 12周； 此后，两组均持续药物治疗 1年。在治疗后 12周和一 年随访结束时，对所有被试采用盲法进行汉密顿抑郁 量表中文版  (Chinese versions of the Hamilton Depression  Rating Scale) 、汉密顿焦虑量表  (Hamilton Anxiety Rating  Scale) 、社会功能缺陷筛选量表  (Social Disability Screen- ing Schedule) 、生活满意度评定量表  (Life Satisfaction  Rating) 、多维社会支持感知  (Multidimensional Scale of  Perceived Social Support) 和简明健康调查量表  (Short  Form Health Survey) 的评估。结果：重复测量的方差分析显示，治疗期间两组的 抑郁和焦虑症状均明显改善，联合 CBT与抗抑郁药物 治疗的干预组的改善更大。几乎所有的社会功能、社会支持和生活质量评估同时表明 CBT合并抗抑郁药物 组比单用抗抑郁药物组的改善显著更多。此外，即使采用的协方差分析调整了基线时的人口学差异和临床特征以及随时间推移的抑郁和焦虑严重程度的变化差异， CBT合并抗抑郁药物组在团体治疗后 12周和团体 治疗结束后的一年后都比单用抗抑郁药物组的改善更为明显，且有统计学差异。 结论：单用抗抑郁药物或联合抗抑郁药治疗和团体 CBT治疗都可以有效地改善轻度抑郁症患者的社会功 能、生活质量和健康功能。然而，合并药物治疗和团体CBT治疗优于单用抗抑郁药物治疗，而且这些效益 可以在 CBT疗程结束后持续至少长达 1年。 关键词：团体治疗 ； 认知行为治疗 ； 抑郁症 ； 生活质量 ； 社会功能；中国 本文全文中文版从 2016 年5月25日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215116 可供免费阅览下载团体认知行为治疗对轻度抑郁症患者生活质量及社会功能的作用 张博元，丁雪凡，卢卫红，赵静，吕钦谕，易正辉，张少平，陈银娣Shanghai Archives of Psychiatry, 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/f5/af/sap-28-01-18.PMC4984610.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/af/sap-28-01-18.PMC4984610.pdf
doi: http://dx.doi.org/10.1016/j.jad.2008.03.01823.,OADS,/arxiv_data1/oa_pdf/f5/af/sap-28-01-18.PMC4984610.pdf
2006; 20(3 Suppl): 19- 28. doi: http://dx.doi.org/10.1177/1359786806064314 24.,Non-OADS,/arxiv_data1/oa_pdf/f5/af/sap-28-01-18.PMC4984610.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/af/sap-28-01-18.PMC4984610.pdf
"E-mail: amirmemari@farabi.tums.ac.ir A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215124 on May 25, 2016.Negin PAAST1,2, Zohreh KHOSRAVI2, Amir Hossein MEMARI1,*, Monir SHAYESTEHFAR1,  Mohammad ARBABI3Comparison of cognitive flexibility and planning ability in  patients with obsessive compulsive disorder, patients with obsessive compulsive personality disorder, and healthy controls•Original research article • Background: Cognitive functioning in individuals with Obsessive Compulsive Disorder(OCD) and with  Obsessive Compulsive Personality Disorder (OCPD) has not been adequately studied.",Non-OADS,/arxiv_data1/oa_pdf/86/22/sap-28-01-28.PMC4984611.pdf
2016; 28(1): 28-34. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215124]  1.,Non-OADS,/arxiv_data1/oa_pdf/86/22/sap-28-01-28.PMC4984611.pdf
"背 景： 强迫症患者  (Obsessive Compulsive Disorder,  OCD) 与强迫型人格障碍患者  (Obsessive Compulsive  Personality Disorder, OCPD) 的认知功能还没有得到充分 的研究。 目标： 验证 OCD 和OCPD 患者的认知灵活性和计划能 力。 方法： 本研究在德黑兰心理咨询门诊选定了 25例 OCD 患者和 20例OCPD 患者，他们在既往两周都没 有服药，并且从大学工作人员和当地社区居民中选 定了 25名健康对照者。对所有参与者均进行 28项 一般健康问卷  (28-item version of the General Health  Questionnaire, GHQ-28) 、威斯康星卡片分类测验   (Wisconsin Card Sorting Test, WCST) 、和伦敦塔试验   (Tower of London test, TOL) ）。本研究运用 WCTS 的两 个测量指标（持续错误数和完成分类数）评估认知灵活性以及 TOL的三个测量指标（ 12个试验总共的移动 次数、总应答时和计划时间）评估计划能力。 结果： 2组患者的当前心理困扰程度显著高于对照组。 在控制人口学因素和心理困扰水平后， OCD 患者和OCPD 患者在 WCST 测试中比对照组更容易出现持续性 错误，而 OCD 患者（不包括 OCPD 患者）的完成分类 数比对照组显著减少。 OCD 患者和 OCDP 患者都比对 照组需要更多的移动次数来完成 12项TOL任务，并 且OCD 患者比 OCPD 患者和对照组需要花更长的时间 来完成任务。 结论： 与健康对照组相比， OCD 和OCPD 患者的认知 灵活性和计划能力都有所受损，并且 OCD 和OCPD 患 者之间的认知功能测试也存在一些差异。我们需要对 OCD 和OCPD 患者进行长期随访研究评估在强迫症状 严重性加重与减轻时认知功能的改变，从而决定此类 认知评估指标对于强迫症是否有诊断或临床关联性。 关键词： 强迫症；强迫型人格障碍；执行功能；神经 心理学；伊朗 本文全文中文版从 2016 年5月25日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215124 可供免费阅览下载强迫症患者、强迫型人格障碍患者和健康对照者之间的认知灵活性和计划能力比较   Paast N, Khosravi Z, Memari A, Shayestehfar M, Arbabi M References 1.",Non-OADS,/arxiv_data1/oa_pdf/86/22/sap-28-01-28.PMC4984611.pdf
"2010; 177(1-2): 156- 160. doi: http://dx.doi.org/10.1016/j.psychres.2010.01.006Shanghai Archives of Psychiatry, 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/86/22/sap-28-01-28.PMC4984611.pdf
2012; 53(2): 167-175. doi:  http://dx.doi.org/10.1016/j.comppsych.2011.03.007 7.,OADS,/arxiv_data1/oa_pdf/86/22/sap-28-01-28.PMC4984611.pdf
2013; 54(5):533-540.doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/22/sap-28-01-28.PMC4984611.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/22/sap-28-01-28.PMC4984611.pdf
2011; 35(8): 1969- 1976. doi: http://dx.doi.org/10.1016/j.pnpbp.2011.09.009 10.,Non-OADS,/arxiv_data1/oa_pdf/86/22/sap-28-01-28.PMC4984611.pdf
2013; 29 (3): 418-430. doi:  http://dx.doi.org/10.1521/pedi_2013_27_101 11.,Non-OADS,/arxiv_data1/oa_pdf/86/22/sap-28-01-28.PMC4984611.pdf
1979; 9(1): 139-145.  doi: http://dx.doi.org/10.1017/S0033291700021644 21.,Non-OADS,/arxiv_data1/oa_pdf/86/22/sap-28-01-28.PMC4984611.pdf
2011; 57(4): 259. doi: http://dx.doi.org/10.1016/ S1836-9553(11)70060-1 22.,OADS,/arxiv_data1/oa_pdf/86/22/sap-28-01-28.PMC4984611.pdf
2015; 20(5): 490-499. doi: http://dx.doi.org/10.1017/ S1092852914000662  23.,Non-OADS,/arxiv_data1/oa_pdf/86/22/sap-28-01-28.PMC4984611.pdf
2005; 33(2): 185-197.doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/22/sap-28-01-28.PMC4984611.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/22/sap-28-01-28.PMC4984611.pdf
"Second People’s Hospital of Dali, Yunnan *correspondence: Dr. Yingfeng Zhang, Department of Judicial Authentication, Second People's Hospital, 300 Yangbi Road, Dali, Yunnan 671003, China     E-mail: zyfzyfdl@163.com A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215112 on  May 25, 2016.Yingfeng ZHANG*, Hongxia MA, Yanbin WANG  Case report of body dysmorphic disorder in a suicidal patient •Case report • Summary: Few reports exist about the treatment of body dysmorphic disorder (BDD) in patients who  are suicidal.",Non-OADS,/arxiv_data1/oa_pdf/0a/d8/sap-28-01-48.PMC4984612.pdf
2016; 28(1): 48-51. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215112] 1.,Non-OADS,/arxiv_data1/oa_pdf/0a/d8/sap-28-01-48.PMC4984612.pdf
"概述： 对治疗伴自杀行为的躯体变形障碍  (body  dysmorphic disorder, BDD) 的病例报道较少。本文报道 了一位患有 BDD 的19岁男性患者，两年来认为自己 面部变丑， 这一信念逐渐加重， 几乎达妄想程度。 然而， 他最初被误诊为抑郁障碍，部分原因是他企图自杀，当时存在抑郁症状和社会退缩。后来经证实，这些症状是继发于 BDD 的。经过 8周住院治疗，采用氟西汀 和认知行为治疗相结合，患者的症状彻底改善，社会功能也恢复正常。这一病例提醒我们，自杀行为和意念有多方面原因；为了避免误诊和不恰当的治疗，临床医生只有在排除其它可能的原因后才能推断自杀行为和意念是抑郁症的直接结果。本文也讨论了自 1886年Enrico Morselli 首度报道 BDD 后 ，在理解 BDD 和 BDD 的诊断标准上的诸多变化。 关键词： 躯体变形障碍；抑郁症；自杀行为；误诊； 中国 本文全文中文版从 2016 年5月25日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215112 可供免费阅览下载因自杀行为而就诊的躯体变形障碍 1 例报告 张迎锋 , 马红霞 , 王彦兵 References 1.",Non-OADS,/arxiv_data1/oa_pdf/0a/d8/sap-28-01-48.PMC4984612.pdf
165(9): 1111-1118. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/d8/sap-28-01-48.PMC4984612.pdf
2000; 23(3): 617-628. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/d8/sap-28-01-48.PMC4984612.pdf
doi: http://dx.chinadoi.,Non-OADS,/arxiv_data1/oa_pdf/0a/d8/sap-28-01-48.PMC4984612.pdf
2001; 21(6): 949-970. doi:  http://dx.doi.org/10.1016/S0272-7358(00)00075-1 11.,OADS,/arxiv_data1/oa_pdf/0a/d8/sap-28-01-48.PMC4984612.pdf
1997; 32(1):  24-29. doi: http://dx.doi.org/10.1007/BF0080066412.,Non-OADS,/arxiv_data1/oa_pdf/0a/d8/sap-28-01-48.PMC4984612.pdf
2006; 36(6): 877-885. doi:  http://dx.doi.org/ 10.1017/S0033291706007264 13.,Non-OADS,/arxiv_data1/oa_pdf/0a/d8/sap-28-01-48.PMC4984612.pdf
2000; 23(3): 617-628. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/d8/sap-28-01-48.PMC4984612.pdf
"doi: http://dx.chinadoi.cn/10.3969/ j.issn.1671-6264.2013.02.031 (received, 2015-10-20; accepted, 2015-12-29) Dr. Yingfeng Zhang graduated from Dali University with bachelor’s degree in clinical medicine in 2003.",Non-OADS,/arxiv_data1/oa_pdf/0a/d8/sap-28-01-48.PMC4984612.pdf
"E-mail: zhangchen645@gmail.com A full-text Chinese translation of this article will be available at  http://dx.doi.org/10.11919/j.issn.1002-0829.216015 on May 25, 2016.Summary: The present diagnostic classification of mental illnesses is primarily based on symptomatology.",Non-OADS,/arxiv_data1/oa_pdf/2a/82/sap-28-01-42.PMC4984613.pdf
2016; 28(1): 42-44. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.216015] Mental illnesses are a group of complex conditions  that affect populations.,Non-OADS,/arxiv_data1/oa_pdf/2a/82/sap-28-01-42.PMC4984613.pdf
"For example, based on data collected by the Schizophrenia Research Forum (http://www.schizophreniaforum.org/whatsnew.asp), there were 1727 genetic studies about 1008 different genes among patients with schizophrenia reported before 29 January 2016, but many of the positive results (and findings from meta-analyses) could not be  replicated.",OADS,/arxiv_data1/oa_pdf/2a/82/sap-28-01-42.PMC4984613.pdf
概述： 现有的精神疾病诊断系统主要是依据症状学来 分类的。 最近一项跨病种全基因组关联分析研究显示， 在临床诊断为精神分裂症、双相障碍、抑郁症、注意缺陷多动障碍以及孤独症谱系障碍等疾病的患者中，染色体 3p21 和10q24 区域内的基因具有相似性， 两条 L- 型电压门控钙离子通道亚基基因 CACNA1C 和CACNB2 的单核苷酸多态性也相似。这些研究结果表明这五种看似独立的疾病其病理机制存在着某种关联。这种跨遗传学研究结果对以症状为基础的精神障碍诊断分类系统的挑战 张晨 病种研究对现有以症状为基础的精神疾病诊断分类系统提出了挑战。研究人员需要找出创造性方法，消除这两种不同方法对精神障碍理解、分类间的差异。 关键词： 诊断分类；跨病种；遗传学 本文全文中文版从 2016 年5月25日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.216015 可供免费阅览下载 References 1.,Non-OADS,/arxiv_data1/oa_pdf/2a/82/sap-28-01-42.PMC4984613.pdf
2015; 76(6): 675-683. doi: http://dx.doi.org/10.4088/ JCP .14nr095992.,Non-OADS,/arxiv_data1/oa_pdf/2a/82/sap-28-01-42.PMC4984613.pdf
doi:  http://dx.doi.org/10.1038/tp.2015.199 4.,Non-OADS,/arxiv_data1/oa_pdf/2a/82/sap-28-01-42.PMC4984613.pdf
2013; 12(4): 406-414.  doi: http://dx.doi.org/10.1016/S1474-4422(13)70011-5 5.,Non-OADS,/arxiv_data1/oa_pdf/2a/82/sap-28-01-42.PMC4984613.pdf
2013; 381(9875): 1371-1379. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/82/sap-28-01-42.PMC4984613.pdf
2013; 9(4):  181. doi: http://dx.doi.org/10.1038/nrneurol.2013.547.,Non-OADS,/arxiv_data1/oa_pdf/2a/82/sap-28-01-42.PMC4984613.pdf
2015;  11: 2801-2810. doi: http://dx.doi.org/10.2147/NDT.S63470 9.,Non-OADS,/arxiv_data1/oa_pdf/2a/82/sap-28-01-42.PMC4984613.pdf
2015; 134: 36-54. doi: http://dx.doi.org/10.1016/ j.pneurobio.2015.09.002 10.,Non-OADS,/arxiv_data1/oa_pdf/2a/82/sap-28-01-42.PMC4984613.pdf
"E-mail: zhiminliu@bjmu.edu.cn A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215127  on May 25, 2016.Yafei WU1, Shiyan YAN3, Yanping BAO2, Zhi LIAN2, Zhi QU2, Zhimin LIU2,*Cross-sectional study of the severity of self-reported depressive  symptoms in heroin users who participate in a methadone  maintenance treatment program •Original research article • Background: Methadone maintenance treatment (MMT) is widely recognized as an effective method of  combatting narcotic addiction.",Non-OADS,/arxiv_data1/oa_pdf/fe/c8/sap-28-01-35.PMC4984614.pdf
2016; 28(1): 35-41. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215127] 1.,Non-OADS,/arxiv_data1/oa_pdf/fe/c8/sap-28-01-35.PMC4984614.pdf
"背景： 美沙酮维持治疗  (methadone maintenance  treatment, MMT) 是一种公认的有效降低毒瘾的措施。 美沙酮维持治疗可以减少海洛因成瘾戒断症状，并因 此可以提供心理和社会支持，对吸毒者的康复至关重要。 目标：比较目前正在接受 MMT的海洛因成瘾者和没 有接受 MMT的海洛因成瘾者之间的抑郁症状严重程 度。 方法：本研究运用了 Beck-13 (13-item version of the  Beck Depression Inventory, BDI-13) 抑郁自评量表和人口 学历史资料调查表，对中国三个城市 9个美沙酮治疗 中心的 929例正在接受 MMT的海洛因成瘾患者（平 均已接受 9个月 MMT治疗）和已经在中心注册参加 MMT治疗但尚未开始的 238例海洛因成瘾患者进行评 估。 结果：与正在接受 MMT的成瘾者中有 68% (628 / 929)  报告抑郁症状相比， 79% (188/238) 的未治疗成瘾者报 告有抑郁症状  (X2=11.69, p<0.001)。未经治疗组的 BDI 评分中位数（四分位区间）是 10.4 (7.9-11.4) ，而 MMT组BDI评分中位数是 8.0 (5.7-11.6) ，两者有显著差异   (Z=2.75, p=0.006)。在 MMT组内，自我报告的抑郁症状 严重程度与参加 MMT时间呈负相关  (rs=-0.24, Z=2.88,  p=0.004)。多元线性回归分析发现，在控制所有人口 学变量后，治疗组的抑郁症状严重程度仍然轻于非治疗组。在控制 MMT疗效后，自我报告家庭关系较差   ( β= 0.118, t=6.56,  p<0.001) 以及离异  (β= 0.120, t=3.73,  p<0.001) 的海洛因成瘾患者抑郁症状较严重。 结论：中度至重度抑郁症状常见于海洛因成瘾患者。 MMT治疗与海洛因成瘾患者抑郁症状较轻相关，但需 要采用前瞻性随机对照试验来确定 MMT是否确实改 善了海洛因成瘾患者的抑郁症状。与家庭成员的关系较差也与海洛因成瘾患者的抑郁症状有关，这表明对海洛因成瘾患者的治疗需要纳入一些方法来帮助海洛因成瘾患者修复由于他们成瘾造成的社会关系割裂。 关键词： 美沙酮维持治疗；海洛因滥用；抑郁；中国 本文全文中文版从 2016年5月25日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215127 可供免费阅览下载参与美沙酮维持治疗的海洛因成瘾者自我报告的抑郁症状严重程度：一项横断面调查 吴亚飞，闫世艳，鲍艳萍，连智，曲直，刘志民Shanghai Archives of Psychiatry, 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/fe/c8/sap-28-01-35.PMC4984614.pdf
2001;  158(10): 1706-1713. doi: http://dx.doi.org/10.1176/appi.,Non-OADS,/arxiv_data1/oa_pdf/fe/c8/sap-28-01-35.PMC4984614.pdf
1976; 133(12):  1434-1438. doi: http://dx.doi.org/10.1176/ajp.133.12.1434 4.,Non-OADS,/arxiv_data1/oa_pdf/fe/c8/sap-28-01-35.PMC4984614.pdf
doi:  http://dx.doi.org/10.1016/j.drugalcdep.2008.05.005 13.,OADS,/arxiv_data1/oa_pdf/fe/c8/sap-28-01-35.PMC4984614.pdf
doi: http://dx.doi.org/10.1111/j.1360- 0443.2007.02118.x 14.,Non-OADS,/arxiv_data1/oa_pdf/fe/c8/sap-28-01-35.PMC4984614.pdf
2000; 18(4): 331-337. doi: http://dx.doi.org/10.1016/s0740- 5472(99)00084-7 16.,Non-OADS,/arxiv_data1/oa_pdf/fe/c8/sap-28-01-35.PMC4984614.pdf
2006; 30(4): 355-362. doi: http://dx.doi.org/10.1016/ j.jsat.2006.03.012  17.,OADS,/arxiv_data1/oa_pdf/fe/c8/sap-28-01-35.PMC4984614.pdf
"doi: http://dx.chinadoi.cn/10.3969/j.issn.1006- 902X.2003.03.017 (received, 2015-12-04; accepted, 2015-01-15) Dr. Yafei Wu received a bachelor’s degree in 1998 and a master’s degree in public health in 2008 from  Xi’an Jiao Tong University Health Science Center.",Non-OADS,/arxiv_data1/oa_pdf/fe/c8/sap-28-01-35.PMC4984614.pdf
"The Sasang constitutional types represent different  Original articleISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[4]:032-037 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.035    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/90/2093-6966-v18-n04-032.PMC4984615.pdf
"Department of Physiology, College of Korean Medicine, Sangji University,83 Sangjidae-gil, Wonju, Gangwon-do, Korea.Tel: +82-33-730-0673    Fax: +82-33-730-0653E-mail: jinlee@sangji.ac.kr ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1Department of Physiology, College of Korean Medicine, Sangji University, Wonju, Korea 2Department of Sasang Constitutional Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 3Korea Institute of Oriental Medicine, Daejeon, Korea Received: Oct 21, 2015    Reviewed: Nov 06, 2015    Accepted: Nov 12, 2015Key Words body mass index, Braverman nature assessment, QSCC  II, Sasang constitutional medicine",Non-OADS,/arxiv_data1/oa_pdf/58/90/2093-6966-v18-n04-032.PMC4984615.pdf
"http://www.journal.ac033 personalities, temperaments, functions and structures of  organs, body shapes, susceptibilities to particular diseas - es, and drug responses [2].",Non-OADS,/arxiv_data1/oa_pdf/58/90/2093-6966-v18-n04-032.PMC4984615.pdf
034  http://www.journal.ac Journal of Pharmacopuncture 2015;18(4):032-037 there were no significant differences in age or gender  among the Sasang constitutional types (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/58/90/2093-6966-v18-n04-032.PMC4984615.pdf
http://www.journal.ac035  Journal of Pharmacopuncture 2015;18(4):032-037 Table 3 Braverman temperament types according to Yin and Yang constitutions Table 4 Body mass index according to Sasang constitutions Table 5 Body mass index according to Braverman temperament typesDopamine type* Acetylcholine  type* GABA type*Serotonin type*N (%) Yang constitution 16 (43.2%) 7 (18.9%) 9 (24.3%) 5 (13.5%) 37 (100%) Yin constitution 23 (25.3%) 11 (12.1%) 50 (54.9%) 7 (7.7%) 91 (100%)    29.962 - P-value 0.017 - BMI (kg/m2)*Distribution of obesity# N (%)LBW Normal Overweight Obese Soyangin 21.06 ± 1.91 5 (11.6%) 31 (72.1%) 7 (16.3%) 0 (0.0%) 43 (30%) Taeeumin 23.96 ± 2.70 0 (0.0%) 15 (48.4%) 2 (6.5%) 14 (45.2%) 31 (22%) Soeumin 20.33 ± 1.93 13 (19.1%) 50 (73.5%) 4 (5.9%) 1 (1.5%) 68 (48%) F or    231.888 45.214 - P-value < 0.001†< 0.001‡- BMI (kg/m2)*Distribution of obesity# N (%)LBW Normal Overweight Obese Dopamine type 21.73 ± 2.67 4 (10.3%) 26 (66.7%) 5 (12.8%) 4 (10.3%) 39 (30%) Acetylcholine type 20.49 ± 2.13 4 (22.2%) 12 (66.7%) 2 (11.1%) 0 (0.0%) 18 (14%) GABA 20.33 ± 1.93 13 (19.1%) 50 (73.5%) 4 (5.9%) 1 (1.5%) 68 (48%) type 21.38 ± 2.17 5 (8.5%) 43 (72.9%) 5 (8.5%) 6 (10.2%) 59 (46%) Serotonin type 22.35 ± 3.67 2 (16.7%) 5 (41.7%) 1 (8.3%) 4 (33.3%) 12 (9%) F or   21.598 10.998 - P-value 0.193†0.216‡-*number (%).,Non-OADS,/arxiv_data1/oa_pdf/58/90/2093-6966-v18-n04-032.PMC4984615.pdf
http://www.journal.ac036 physical health.,Non-OADS,/arxiv_data1/oa_pdf/58/90/2093-6966-v18-n04-032.PMC4984615.pdf
http://orcid.org/0000-0002-5362-1199.Journal of Pharmacopuncture 2015;18(4):032-037,Non-OADS,/arxiv_data1/oa_pdf/58/90/2093-6966-v18-n04-032.PMC4984615.pdf
"http://www.journal.ac037 Sung JH, Korea BMTI Laboratory.",OADS,/arxiv_data1/oa_pdf/58/90/2093-6966-v18-n04-032.PMC4984615.pdf
WHO Western pacific regional office; c2000 [cited 2015  May 10] Available from: http://www.wpro.who.int/nu- trition/documents/Redefining_obesity/en/.,Non-OADS,/arxiv_data1/oa_pdf/58/90/2093-6966-v18-n04-032.PMC4984615.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/e2/94/amep-7-433.PMC4984665.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e2/94/amep-7-433.PMC4984665.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e2/94/amep-7-433.PMC4984665.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice Advances in Medical Education and Practice 2016:7 433–441Dovepress submit your manuscript | www.dovepress.com Dovepress ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article 433 http: //10.2147/AMEP .S78385A simple heuristic for Internet-based   evidence search in primary care: a randomized  controlled trial Andreas Eberbach1 Annette Becker1 Justine Rochon2 Holger Finkemeler1 Achim Wagner3 Norbert Donner-Banzhoff1 1Department of Family and  Community Medicine,    Philipp University of Marburg,   Marburg, Germany; 2Institute of  Medical Biometry and Informatics,  University of Heidelberg, Heidelberg,  Germany;  3Department of Sport  Medicine, Justus-Liebig-University of Giessen, Giessen, GermanyBackground: General practitioners (GPs) are confronted with a wide variety of clinical ques- tions, many of which remain unanswered.",Non-OADS,/arxiv_data1/oa_pdf/e2/94/amep-7-433.PMC4984665.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/e2/94/amep-7-433.PMC4984665.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 441 Heuristic for Internet-based evidence search  4.,Non-OADS,/arxiv_data1/oa_pdf/e2/94/amep-7-433.PMC4984665.pdf
Available from: http://www.allgemein- medizin-projekte.de/index.php?id=22.,Non-OADS,/arxiv_data1/oa_pdf/e2/94/amep-7-433.PMC4984665.pdf
"4, 127 –132 http://dx.doi.org/10.1080/21541264.2016.1203628",Non-OADS,/arxiv_data1/oa_pdf/81/1d/ktrn-07-04-1203628.PMC4984676.pdf
"3, 69 –74 http://dx.doi.org/10.1080/21541264.2016.1170252",Non-OADS,/arxiv_data1/oa_pdf/87/50/ktrn-07-03-1170252.PMC4984684.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/66/46/amep-7-475.PMC4984689.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/66/46/amep-7-475.PMC4984689.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/66/46/amep-7-475.PMC4984689.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 475–482Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 475 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S111026 Self-assessment of nursing competency among final  year nursing students in Thailand: a comparison  between public and private nursing institutions  Krisada Sawaengdee1,2 Kanang Kantamaturapoj3 Parinda Seneerattanaprayul1 Weerasak Putthasri1 Rapeepong  Suphanchaimat1,4 1International Health Policy Program  (IHPP), 2Praboromrajchanok  Institute for Health Workforce  Development, Ministry of Public Health, Nonthaburi,  3Banphai Hospital,   Khon Kaen, 4Department of Social  Sciences, Faculty of Social Sciences and Humanities, Mahidol University,  Nakhon Pathom, ThailandIntroduction and objectives: Nurses play a major role in Thailand’ s health care system.",Non-OADS,/arxiv_data1/oa_pdf/66/46/amep-7-475.PMC4984689.pdf
"4Correspondence: Rapeepong  SuphanchaimatIHPP, Ministry of Public Health, Tiwanon Road, Nonthaburi,   Thailand 11000   Tel +66 2 590 2381Fax +66 2 590 2385 Email rapeepong@ihpp.thaigov.netJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Sawaengdee et alsRunning head recto: Self-assessment of nursing competency among final year nursing studentsDOI: http://dx.doi.org/10.2147/AMEP .S111026",Non-OADS,/arxiv_data1/oa_pdf/66/46/amep-7-475.PMC4984689.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/66/46/amep-7-475.PMC4984689.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 482 Sawaengdee et als Author contributions All authors contributed toward data analysis, drafting and  revising the paper and agree to be accountable for all aspects of the work.",Non-OADS,/arxiv_data1/oa_pdf/66/46/amep-7-475.PMC4984689.pdf
Available from: http://www.rsu.ac.th/academic/tqf/file_upload/20140829104104.docx.,Non-OADS,/arxiv_data1/oa_pdf/66/46/amep-7-475.PMC4984689.pdf
Available from: http://graduateschool.bu.ac.th/tqf/images/pdf/tqf_th.pdf.,Non-OADS,/arxiv_data1/oa_pdf/66/46/amep-7-475.PMC4984689.pdf
Available from: http://www.tnc.or.th/files/2010/12/page-448/__ 66735.pdf.,Non-OADS,/arxiv_data1/oa_pdf/66/46/amep-7-475.PMC4984689.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Ang-2 as a biomarker in gastric cancer 862 www.bjcancer.com | DOI:10.1038/bjc.2016.30,Non-OADS,/arxiv_data1/oa_pdf/c9/17/bjc201630a.PMC4984795.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER AdCD40L treatment of melanoma patients 880 www.bjcancer.com | DOI:10.1038/bjc.2016.42,Non-OADS,/arxiv_data1/oa_pdf/df/0b/bjc201642a.PMC4984796.pdf
"For external validation of MYC mRNA expression, bc-GenExMiner v3.0 (Breast Cancer Gene- Expression Miner v3.2) online data set (http://bcgenex.centregau- ducheau.fr) was used.",OADS,/arxiv_data1/oa_pdf/53/57/bjc201646a.PMC4984797.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER MYC in breast cancer subtypes 928 www.bjcancer.com | DOI:10.1038/bjc.2016.46,Non-OADS,/arxiv_data1/oa_pdf/53/57/bjc201646a.PMC4984797.pdf
"Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc).BRITISH JOURNAL OF CANCER apoC-III, a novel biomarker for gastric adenocarcinoma 938 www.bjcancer.com | DOI:10.1038/bjc.2016.52",Non-OADS,/arxiv_data1/oa_pdf/a8/37/bjc201652a.PMC4984799.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Sex hormones and prostate cancer by ERG expression 944 www.bjcancer.com | DOI:10.1038/bjc.2016.61,Non-OADS,/arxiv_data1/oa_pdf/3c/17/bjc201661a.PMC4984801.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Oncamex as antitumour agent in breast cancer 916 www.bjcancer.com | DOI:10.1038/bjc.2016.6",Non-OADS,/arxiv_data1/oa_pdf/ab/b8/bjc20166a.PMC4984802.pdf
Available from http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/UCM071590.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7b/af/bjc201682a.PMC4984804.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/70/7f/mder-9-277.PMC4984822.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/70/7f/mder-9-277.PMC4984822.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/70/7f/mder-9-277.PMC4984822.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 277–283Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 277 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S110756 D3D augmented reality imaging system: proof of  concept in mammography David B Douglas1 Emanuel F Petricoin2 Lance Liotta2 Eugene Wilson3 1Department of Radiology, Stanford  University, Palo Alto, CA, 2Center for  Applied Proteomics and Molecular  Medicine, George Mason University,  Manassas, VA,  3Department of  Radiology, Fort Benning, Columbus,  GA, USAPurpose: The purpose of this article is to present images from simulated breast microcalci- fications and assess the pattern of the microcalcifications with a technical development called  “depth 3-dimensional (D3D) augmented reality”.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/mder-9-277.PMC4984822.pdf
"While D3D technology can be applied to multiple types of radiological imaging, the  specific focus in the article will be related to viewing of microcalcifications in mammog-Correspondence: David B Douglas Department of Radiology, Stanford University, 300 Pasteur Drive, Room S047, Stanford, CA 94305-5105, USATel +1 650 723 4000 ext 14257Email ddouglas@stanford.eduJournal name: Medical Devices: Evidence and Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Douglas et alRunning head recto: D3D augmented realityDOI: http://dx.doi.org/10.2147/MDER.S110756",Non-OADS,/arxiv_data1/oa_pdf/70/7f/mder-9-277.PMC4984822.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/mder-9-277.PMC4984822.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/56/99/tcrm-12-1231.PMC4984823.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1231–1237Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1231ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10978 5 Prognostic indicators for failed nonsurgical  reduction of intussusception Jiraporn Khorana1 Jesda singhavejsakul1 nuthapong Ukarapol2 Mongkol laohapensang3 Jakraphan siriwongmongkol1 Jayanton Patumanond4 1Division of Pediatric surgery,   Department of surgery, 2Division  of gastroenterology, Department  of Pediatrics, Chiang Mai University  hospital, Chiang Mai, 3Division of  Pediatric surgery, Department of  surgery, siriraj hospital, Mahidol  University, Bangkok, 4Center of  excellence in applied epidemiology,   Thammasat University hospital,   Pathumthani, ThailandPurpose:  To identify the risk factors for failure of nonsurgical reduction of intussusception.",Non-OADS,/arxiv_data1/oa_pdf/56/99/tcrm-12-1231.PMC4984823.pdf
"The success rate of the nonsurgical reduction has Correspondence: Jesda singhavejsakul Division of Pediatric surgery, Department  of surgery, Chiang Mai University  hospital, Chiang Mai 50200, Thailand Tel +66 8 1992 9767 Fax +66 53 93 6139 email pedsurgerycmu@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Khorana et al Running head recto: Prognostic factors for intussusception reduction failure DOI: http://dx.doi.org/10.2147/TCRM.S109785",Non-OADS,/arxiv_data1/oa_pdf/56/99/tcrm-12-1231.PMC4984823.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/56/99/tcrm-12-1231.PMC4984823.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/99/tcrm-12-1231.PMC4984823.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/08/0f/ppa-10-1529.PMC4984824.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1529–1537Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1529Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S4540 1 Schizophrenia relapse, patient considerations,  and potential role of lurasidone Leslie Citrome Department of Psychiatry and  Behavioral Sciences, New York  Medical College, valhalla, NY, USAAbstract:  When treating persons with schizophrenia, delaying time to relapse is a main goal.",Non-OADS,/arxiv_data1/oa_pdf/08/0f/ppa-10-1529.PMC4984824.pdf
"Unfortunately, relapse is common, with an  estimate of 80% of patients experiencing a relapse in their first 5 years of treatment.1  Delaying time to relapse is a primary goal when using antipsychotic medication, and  may mitigate against further decline.2 Lifelong use of antipsychotic medication is thus  required.3 Unfortunately, antipsychotic medications are associated with a myriad of  adverse effects.4,5 Demonstrated differences in tolerability profiles among the different  choices of antipsychotics6 make it possible to attempt to match up an individual patient  to the best choice for such patient based on past history of tolerability, comorbidities,  and personal preferences.7,8 Lurasidone is a second-generation (atypical) antipsychotic agent that has demon - strated efficacy in the treatment of patients with schizophrenia, and it is approved as  such in the United States, Canada, the European Union, Switzerland, and Australia;  it is also approved in the United States and Canada for the treatment of major depres - sive episodes associated with bipolar I disorder as either a monotherapy or adjunc - tive therapy with lithium or valproate.9 Lurasidone’s pharmacodynamic profile is  distinguished by its relatively high affinity for serotonin 5-HT7 receptors and its  partial agonist activity at 5-HT1A receptors, together with being a full antagonist at Correspondence: Leslie Citrome 11 Medical Park Drive, Suite 106,  Pomona, NY 10970, USA Tel +1 845 362 2081 Fax +1 845 362 8745 email citrome@cnsconsultant.co m Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Citrome Running head recto: Lurasidone and relapse prevention DOI: http://dx.doi.org/10.2147/PPA.S45401",Non-OADS,/arxiv_data1/oa_pdf/08/0f/ppa-10-1529.PMC4984824.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/08/0f/ppa-10-1529.PMC4984824.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/19/d6/imcrj-9-231.PMC4984825.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/19/d6/imcrj-9-231.PMC4984825.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/19/d6/imcrj-9-231.PMC4984825.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 231–235International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 231 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S113377Arterial stiffness, as monitored by cardio–ankle  vascular index, is affected by obstructive sleep  apnea, blood glucose control, and body weight –   a case with 8 years follow up Kazuhiro Shimizu1 T omoyuki Yamamoto2,3 Kohji Shirai2,4 1Department of Internal Medicine,   T oho University Sakura Medical  Center, Chiba, Japan; 2Department   of Vascular Function, T oho University Sakura Medical Center, Chiba, Japan;   3Biological Information Analysis  Section, Fukuda Denshi Co., Ltd.,  T okyo, Japan;  4Department of  Internal Medicine, Mihama Hospital,  Chiba,  JapanAbstract:  The cardio–ankle vascular index (CA VI) is an indicator of arterial stiffness from the  heart to the ankles.",Non-OADS,/arxiv_data1/oa_pdf/19/d6/imcrj-9-231.PMC4984825.pdf
"For the  assessment of stiffness of long arteries, Bramwell-Hill’ s equation was adapted, which Correspondence: Kazuhiro Shimizu Department of Internal Medicine, Toho University Sakura Medical Center, 564-1 Shimoshizu, Sakura-shi, Chiba 285-8741, JapanTel +81 43 462 8811Fax +81 43 462 8820Email k432@sakura.med.toho-u.ac.jpJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Shimizu et alRunning head recto: Arterial stiffness affected by OSA, blood glucose control, and body weightDOI: http://dx.doi.org/10.2147/IMCRJ.S113377",OADS,/arxiv_data1/oa_pdf/19/d6/imcrj-9-231.PMC4984825.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/19/d6/imcrj-9-231.PMC4984825.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 235 Arterial stiffness affected by OSA, blood glucose control, and body weight",Non-OADS,/arxiv_data1/oa_pdf/19/d6/imcrj-9-231.PMC4984825.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/31/24/ndt-12-1993.PMC4984826.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1993–1998Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1993OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11016 2 association of depression with sleep quality might  be greater than that of pain intensity among  outpatients with chronic low back pain hsin-Yu Wang1,2,* Tsai-sheng Fu2,3,* shih-chieh hsu1,2 ching-i hung1,2 1Department of Psychiatry, chang  gung Memorial hospital at linkou,   Taoyuan, 2chang gung University  college of Medicine, Taoyuan,   3Department of Orthopedics, chang  gung Memorial hospital at Keelung,   Taiwan, republic of china *These authors contributed equally  to this workPurpose:  No study to date has compared the associations of pain intensity, depression, and  anxiety with insomnia among outpatients with chronic low back pain (CLBP).",Non-OADS,/arxiv_data1/oa_pdf/31/24/ndt-12-1993.PMC4984826.pdf
"It has been estimated  that 90% of patients with depression complain of sleep disturbance.8,9 People with  insomnia are ten times more likely to suffer from clinical depression.10 In fact, sleep  disturbance is one of the diagnostic criteria for major depressive disorder (MDD).11 correspondence: ching-i hung Department of Psychiatry, chang  gung Memorial hospital at linkou,  5 Fu-shing street, Kweishan,  Taoyuan 333, Taiwan, republic of china Tel +886 3 328 1200 ext 2439 Fax +886 3 328 0267 email a36250@cgmh.org.t w Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Wang et al Running head recto: Depression is associated with insomnia DOI: http://dx.doi.org/10.2147/NDT.S110162",Non-OADS,/arxiv_data1/oa_pdf/31/24/ndt-12-1993.PMC4984826.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/31/24/ndt-12-1993.PMC4984826.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/24/ndt-12-1993.PMC4984826.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/6e/36/clep-8-273.PMC4984827.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6e/36/clep-8-273.PMC4984827.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6e/36/clep-8-273.PMC4984827.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 273–283Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 273 METHODOLOGY open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S108307 Algorithm linking patients and general practices  in Denmark using the Danish National Health  Service Register Maiken Ina Siegismund  Kjaersgaard1 Peter Vedsted2 Erik Thorlund Parner1 Bodil Hammer Bech3 Mogens Vestergaard2,4 Kaare Rud Flarup2 Morten Fenger-Grøn2 1Section for Biostatistics, 2Research  Unit for General Practice, 3Section  for Epidemiology, 4Section for General  Medical Practice, Department of  Public Health, Aarhus University,  Aarhus, DenmarkBackground: The patient list system in Denmark assigns virtually all residents to a general  practice.",Non-OADS,/arxiv_data1/oa_pdf/6e/36/clep-8-273.PMC4984827.pdf
"The patient lists make up the patient Correspondence: Maiken Ina Siegismund  KjaersgaardSection for Biostatistics, Department of Public Health, Aarhus University, Bartholins Allé 2, Aarhus C 8000, DenmarkTel +45 8716 7998Email maiken@ph.au.dkJournal name: Clinical Epidemiology Article Designation: METHODOLOGYY ear: 2016V olume: 8Running head verso: Kjaersgaard et alRunning head recto: Algorithm linking patients and general practices in DenmarkDOI: http://dx.doi.org/10.2147/CLEP .S108307",OADS,/arxiv_data1/oa_pdf/6e/36/clep-8-273.PMC4984827.pdf
Available from: http://sundhedsdatastyrelsen.dk/da/registre-og-services.,OADS,/arxiv_data1/oa_pdf/6e/36/clep-8-273.PMC4984827.pdf
Available from: http://cap.au.dk/fileadmin/cap.au.dk/Documents/Boernemarkering_v20160115.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6e/36/clep-8-273.PMC4984827.pdf
Available from: http://cap.au.dk/fileadmin/cap.au.dk/Docu- ments/Patientgruppe_v20160115.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6e/36/clep-8-273.PMC4984827.pdf
Available from: http://cap.au.dk/fileadmin/cap.au.dk/Documents/Honorering_og_afregning_v20160115.pdf.,OADS,/arxiv_data1/oa_pdf/6e/36/clep-8-273.PMC4984827.pdf
Available from: http://cap.au.dk/fileadmin/cap.au.dk/Docu- ments/Honoraruge_v20160209.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6e/36/clep-8-273.PMC4984827.pdf
Available from: http://cap.au.dk/fileadmin/cap.au.dk/Documents/Tidskode_v20160209.pdf.,OADS,/arxiv_data1/oa_pdf/6e/36/clep-8-273.PMC4984827.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/6e/36/clep-8-273.PMC4984827.pdf
Available from: http://cap.au.dk/fileadmin/cap.au.dk/Documents/ Grundydelser_v20160209.pdf.,OADS,/arxiv_data1/oa_pdf/6e/36/clep-8-273.PMC4984827.pdf
Available from: http://cap.au.dk/fileadmin/cap.au.dk/Documents/Samtaleterapi_v20160209.pdf.,OADS,/arxiv_data1/oa_pdf/6e/36/clep-8-273.PMC4984827.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/12/3f/ott-9-4859.PMC4984828.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4859–4866OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4859Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9786 1Oncogenic nanogP8 expression regulates cell  proliferation and migration through the akt/mTO r  signaling pathway in human gastric cancer – sgc- 7901cell line Zheng Jiang Yao liu chuan Wang Department of gastroenterology,   The First affiliated hospital of  chongqing Medical University,   Yuzhong District,  chongqing, People’s  republic of chinaBackground:  Although elevated expression of NanogP8 has been detected in many human  tumor tissues, its role in gastric tumorigenesis remains unclear.",Non-OADS,/arxiv_data1/oa_pdf/12/3f/ott-9-4859.PMC4984828.pdf
"Given that only one amino correspondence: Zheng Jiang Department of gastroenterology,  The First Affiliated Hospital of Chongqing  Medical University, Yuzhong District,  chongqing 400016, People’s republic of  china email jiangzhdr@yeah.ne t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Jiang et al Running head recto: NanogP8 regulates human gastric cancer cell proliferation DOI: http://dx.doi.org/10.2147/OTT.S97861",Non-OADS,/arxiv_data1/oa_pdf/12/3f/ott-9-4859.PMC4984828.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/12/3f/ott-9-4859.PMC4984828.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/3f/ott-9-4859.PMC4984828.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4f/7c/opth-10-1479.PMC4984829.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1479–1486Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1479Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10696 9 retinal vascular occlusion: a window to diagnosis  of familial and acquired thrombophilia and  hypofibrinolysis, with important ramifications  for pregnancy outcomes stephan g Dixon1 Carl T Bruce1 Charles J glueck1 robert a sisk2,3 robert K hutchins2,3 Vybhav Jetty1 Ping Wang1 1Cholesterol, Metabolism, and  Thrombosis Center, Jewish Hospital  of Cincinnati, 2Cincinnati Eye Institute,   3Department of Ophthalmology,   University of Cincinnati College  of Medicine, Cincinnati, OH, USAAim:  Our specific aim was to document the pathoetiologic importance of thrombophilia among  females presenting with severe ischemic retinal vein (RVO) or retinal artery (RAO) occlusion,  without typical risk factors, and to emphasize that the ophthalmologists’ diagnosis of throm - bophilia has important diagnostic and therapeutic downstream ramifications for nonocular  thrombosis, including reproductive outcomes.",Non-OADS,/arxiv_data1/oa_pdf/4f/7c/opth-10-1479.PMC4984829.pdf
"Keywords:  thrombophilia, retinal vascular occlusion, retinal vein occlusion, retinal artery  occlusion Introduction Widely recognized, but neither sensitive nor specific risk factors for ocular vascular  occlusion (OVO) include age, history of smoking, hypertension, hyperlipidemia, and  diabetes mellitus.1–11 Rare systemic risk factors for OVO include hyperviscosity, myelo - proliferative disorders, retro-orbital mass effect, and vasculitis such as Behcet’s.12,13 Correspondence: Charles J glueck Cholesterol, Metabolism, and  Thrombosis Center, Jewish Hospital  of Cincinnati, Suite 430, 2135 Dana  Avenue, Cincinnati, OH 45207, USA Tel +1 513 924 8250 Fax +1 513 924 8273 email cjglueck@mercy.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Dixon et al Running head recto: Retinal vascular occlusion DOI: http://dx.doi.org/10.2147/OPTH.S106969",Non-OADS,/arxiv_data1/oa_pdf/4f/7c/opth-10-1479.PMC4984829.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/4f/7c/opth-10-1479.PMC4984829.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/7c/opth-10-1479.PMC4984829.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/39/34/ott-9-4929.PMC4984830.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4929–4935OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4929Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10896 8 antihormonal treatment associated  musculoskeletal pain in women with breast  cancer in the adjuvant setting selcuk seber1 Dilek solmaz2 Tarkan Yetisyigit1 1Medical Oncology Department,   2rheumatology Department,   namik Kemal University hospital,   T ekirdag, T urkeyPurpose:  Antihormonal treatment is an effective therapy in the adjuvant setting.",Non-OADS,/arxiv_data1/oa_pdf/39/34/ott-9-4929.PMC4984830.pdf
"In an analysis of BIG 1-98 trial, which incorporated more than 8,000 post - menopausal breast cancer patients, nearly 20% of women randomized to letrozole  therapy experienced arthralgia while the incidence was 13.4% in women who received  tamoxifen.1 The incidence of bone and joint pain in patients receiving additional correspondence: selcuk seber Medical Oncology Department,  namik Kemal University hospital,  University street, suleymanpasa,  Tekirdag 59000, Turkey Tel +90 282 250 5411 Fax +90 282 250 9928 email selcukseber@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Seber et al Running head recto: Musculoskeletal pain in women with breast cancer DOI: http://dx.doi.org/10.2147/OTT.S108968",Non-OADS,/arxiv_data1/oa_pdf/39/34/ott-9-4929.PMC4984830.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/39/34/ott-9-4929.PMC4984830.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/34/ott-9-4929.PMC4984830.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7b/95/ott-9-4923.PMC4984831.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4923–4928OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4923Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10800 0 a rare case report of primary bone lymphoma  and a brief review of the literature Jia Wang1,2 shouren Fan1,3 Jie Liu2 Bao song4 1school of Medicine and Life sciences,   University of Jinan- shandong academy  of Medical sciences, 2Department of  Oncology, shandong Cancer Hospital  affiliated to shandong University,   3Department of Intervention, Qihe  people’s Hospital, 4elementary  Laboratory, shandong Cancer Hospital  affiliated to shandong University, Jinan,   people’s republic of ChinaAbstract:  Primary bone lymphoma is a rare and peculiar extranodal presentation of non-Hodgkin’s  lymphoma, which threatens human health.",Non-OADS,/arxiv_data1/oa_pdf/7b/95/ott-9-4923.PMC4984831.pdf
"After 1 month, with aggravated pain, swelling Correspondence: Jie Liu Department of Oncology, shandong  Cancer Hospital affiliated to Shandong  University, No 440 Jiyan road, Huaiyin  District, Jinan, shandong province  250000, people’s republic of China email lj691012@126.co m Bao song elementary Laboratory, shandong Cancer  Hospital affiliated to Shandong University,  No 440 Jiyan road, Huaiyin District,  Jinan, shandong province 250000,  people’s republic of China email songbaojn@126.co m Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Primary bone lymphoma DOI: http://dx.doi.org/10.2147/OTT.S108000",Non-OADS,/arxiv_data1/oa_pdf/7b/95/ott-9-4923.PMC4984831.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7b/95/ott-9-4923.PMC4984831.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/95/ott-9-4923.PMC4984831.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3d/aa/oajsm-7-075.PMC4984832.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Shoulder injuries in soccer goalkeepers: review  and development of a FIFA 11 + shoulder injury  prevention program Benno Ejnisman1 Gisele Barbosa1 Carlos V Andreoli1 A de Castro Pochini1 Thiago Lobo2 Rodrigo Zogaib2 Moises Cohen1 Mario Bizzini3 Jiri Dvorak3 1Department of Orthopaedics,   Federal University of São Paulo,   2Sports Medicine Department, Santos  FC, São Paulo, Brazil; 3FIFA-Medical  Assessment and Research Centre,   Schulthess Clinic, Zurich, Switzerland Correspondence: Benno Ejnisman   Department of Orthopaedics, Federal  University of São Paulo, Rua Estado de  Israel 636, Cep 04022-002, São Paulo, SP ,  Brazil   Email bennoale@uol.com.b rAbstract:  In the last years, shoulder injuries have represented an increasing health problem in  soccer players.",Non-OADS,/arxiv_data1/oa_pdf/3d/aa/oajsm-7-075.PMC4984832.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/3d/aa/oajsm-7-075.PMC4984832.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/aa/oajsm-7-075.PMC4984832.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 267–275Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 267 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S113067 Balancing innovation and medical device  regulation: the case of modern metal-on-metal hip  replacements Jason J Howard1,2 1Division of Orthopedic Surgery,   Department of Surgery, Sidra Medical  and Research Center, 2Department  of Orthopedic Surgery, Weill Cornell Medical College, Doha, QatarAbstract: Due to problems with wear particle generation and subsequent loosening using  conventional metal-on-polyethylene total hip replacements, there has been a shift toward  alternative bearing systems, including metal-on-metal (MoM), for younger, more active  patients with degenerative joint disease.",Non-OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
"Since the advent of the concepts of “low-friction arthroplasty” introduced by the British surgeon Sir John Charnley in the early 1960s, the evolution of the THR has led to a device that can successfully reduce or eliminate Correspondence: Jason J Howard Division of Orthopedic Surgery, Department of Surgery, Sidra Medical and Research Center, PO Box 26999, Doha, Qatar Tel +974 4404 2274 Fax +974 4404 1969 Email jason.howard@me.comJournal name: Medical Devices: Evidence and Research Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: HowardRunning head recto: Failure of regulation in metal-on-metal hip replacementDOI: http://dx.doi.org/10.2147/MDER.S113067",Non-OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
Available from: http://www.nytimes.com/2011/06/26/health/26innovate.html?pagewanted= 1&_r= 0.,Non-OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
Available from: http://www.fda.gov/downloads/Advisory Committees/CommitteesMeetingMaterials/MedicalDevices/Medical DevicesAdvisoryCommittee/OrthopaedicandRehabilitation-DevicesPanel/UCM310225.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cftopic/pma/pma.cfm?num=p04003.,OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
Available from: https://www.nice.org.uk/guidance/ta304.,Non-OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
Available from: http://www.nytimes.com/2012/02/15/business/hip-implant-the-fda-rejected-was-marketed-abroad.html?_r= 1&hp= &pagewanted= all.,Non-OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/Orthopaedi-candRehabilitationDevicesPanel/UCM309302.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
Available from: http://www.accessdata.fda.gov/cdrh_docs/pdf8/K080991.pdf.,OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
Available from: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM268141.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
Available from: http://www.accessdata.fda.gov/cdrh_docs/pdf4/p040033a.pdf.,OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
Available from: http://www.fda.gov/medicaldevices/   productsandmedicalprocedures/implantsandprosthetics/metalonmet-alhipimplants/ucm241769.htm.,Non-OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
Available from: http://www.fda.gov/medicaldevices/productsand-medicalprocedures/implantsandprosthetics/metalonmetalhipimplants/ucm241770.htm.,Non-OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id= 96073.,OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
Available from: https://www.federalregister.gov/articles/2013/01/18/2013-01006/effective-date-of-requirement-for-premarket-approval-for-two-class-iii-preamendments-devices.,Non-OADS,/arxiv_data1/oa_pdf/f1/8e/mder-9-267.PMC4984833.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)UVR and Hodgkin lymphoma in the United States BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.383 831,Non-OADS,/arxiv_data1/oa_pdf/cc/8d/bjc2015383a.PMC4984855.pdf
Statistical analyses were performed by the R (version 3.1.2) statistical software (https://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/e4/07/bjc201631a.PMC4984857.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Liver function in early hepatocellular carcinoma 750 www.bjcancer.com | DOI:10.1038/bjc.2016.33,Non-OADS,/arxiv_data1/oa_pdf/fd/88/bjc201633a.PMC4984858.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Diabetes and cancer 722 www.bjcancer.com | DOI:10.1038/bjc.2016.37",Non-OADS,/arxiv_data1/oa_pdf/45/54/bjc201637a.PMC4984860.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER BRAF-V600E expression in melanoma 808 www.bjcancer.com | DOI:10.1038/bjc.2016.44,Non-OADS,/arxiv_data1/oa_pdf/ea/17/bjc201644a.PMC4984864.pdf
A nomogram was established based on the results of multi- variate analysis and by using the package of rms in R version 2.14.1 (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/48/7c/bjc201647a.PMC4984866.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER IL-35 correlates with HCC aggressiveness and recurrence 776 www.bjcancer.com | DOI:10.1038/bjc.2016.47,Non-OADS,/arxiv_data1/oa_pdf/48/7c/bjc201647a.PMC4984866.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Triapine potentiates platinum combination therapy 786 www.bjcancer.com | DOI:10.1038/bjc.2016.54,Non-OADS,/arxiv_data1/oa_pdf/b6/ea/bjc201654a.PMC4984868.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Tonsillectomy and oropharyngeal cancer 838 www.bjcancer.com | DOI:10.1038/bjc.2016.63,Non-OADS,/arxiv_data1/oa_pdf/95/2f/bjc201663a.PMC4984870.pdf
"Before screening, 131 373 were mailed information about the Predicting Risk of Cancer At Screening (PROCAS) study, a consent form and questionnaire (http://www.uhsm.nhs.uk/ research/Documents/PROCAS%20Questionnaire.pdf).",Non-OADS,/arxiv_data1/oa_pdf/ab/43/bjc201656a.PMC4984905.pdf
Cancer Research UK (2014) http://www.cancerresearchuk.org/health- professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/mortality#ref-2 (accessed July 2015).,Non-OADS,/arxiv_data1/oa_pdf/ab/43/bjc201656a.PMC4984905.pdf
"Educational level and employment status were extracted from the 2007 Employment Survey, a quarterly household survey on employment outcomes in which 75 000 people are surveyed each year (for further information, please go to http://www.insee.fr/en/methodes/default.asp?page=- sources/ope-enq-emploi-continu.htm).",OADS,/arxiv_data1/oa_pdf/55/b3/bjc201662a.PMC4984908.pdf
Please go to http://www.insee.fr/en/methodes/default.asp?page=sources/ ope-rp.htm for more information on the French census.,OADS,/arxiv_data1/oa_pdf/55/b3/bjc201662a.PMC4984908.pdf
"In the latest edition (2003), almost 40 000 people were surveyed (http://www.insee.fr/en/methodes/ default.asp?page=sources/ope-enq-fqp.htm).",OADS,/arxiv_data1/oa_pdf/55/b3/bjc201662a.PMC4984908.pdf
"Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Quality of life, long-term survivors and long-term outcome: the ABC-02 study BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.64 971",Non-OADS,/arxiv_data1/oa_pdf/77/09/bjc201664a.PMC4984909.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Effect of aspirin/NSAIDs on survival of oesophageal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.65 1059,Non-OADS,/arxiv_data1/oa_pdf/28/0e/bjc201665a.PMC4984910.pdf
The Mass Screening Registry (2014) Available at: http://www.cancer.fi/ syoparekisteri/en/mass-screening-registry/statistics/koko-maa/ (lastaccessed 18 August 2014).,Non-OADS,/arxiv_data1/oa_pdf/14/4b/bjc201668a.PMC4984912.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Screening and mortality from breast cancer 1044 www.bjcancer.com | DOI:10.1038/bjc.2016.68,Non-OADS,/arxiv_data1/oa_pdf/14/4b/bjc201668a.PMC4984912.pdf
"Objective cognitive function was measured with the CogState computerised test battery (CogState Ltd; http://www.cogstate.com); a brief test designed specifically for repeated application and free from practice effects (Falleti et al, 2003; Silbert et al, 2004; Vardy et al, 2006).",OADS,/arxiv_data1/oa_pdf/73/19/bjc201671a.PMC4984913.pdf
"Available at https://www.caring.com/blogs/caring-currents/ chemo-brain-can-be-a-serious-concern-for-cancer-patients.Hermelink K, Henschel V, Untch M, Bauerfeind I, Lux MP, Munzel K (2008) Short-term effects of treatment-induced hormonal changes on cognitivefunction in breast cancer patients: results of a multicenter, prospective, longitudinal study.",Non-OADS,/arxiv_data1/oa_pdf/73/19/bjc201671a.PMC4984913.pdf
"Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Prognostic role of ERBB2 ,MET andVEGFA BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.74 1011",Non-OADS,/arxiv_data1/oa_pdf/17/c7/bjc201674a.PMC4984915.pdf
The P-values for the individual questions were adjusted for mult iple comparisons using the false- discovery rate approach (calculated using the p.adjust function of the stats library in R (http://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/cf/8d/bjc201676a.PMC4984916.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Hickman catheters and implantable ports in chemotherapy BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.76 985,Non-OADS,/arxiv_data1/oa_pdf/cf/8d/bjc201676a.PMC4984916.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER sTNF-RII and survival in colorectal cancer 1002 www.bjcancer.com | DOI:10.1038/bjc.2016.85,Non-OADS,/arxiv_data1/oa_pdf/dd/d4/bjc201685a.PMC4984918.pdf
Weight loss intervention  has been suggested as an effective cancer prevention strategy and is supported by reductions  in cancer incidence and mortality of patients who have had bariatric surgery and dramatic  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/d4/emss-69219.PMC4984953.pdf
Available from: http://ntp.niehs.nih.gov/ntp/ohat/lead/final/monographhealtheffectslowlevellead_newissn_508.pdf  11  California Department of Public Health; Occupational Lead Poisoning  Prevention Program.,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
Available from: https://www.cdph.,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
Available from: https://www.cdph.ca.gov/programs/olppp/Documents/LeadStdPELRec.pdf  13  EPA.,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
Available from: http://cfpub.epa.gov/ncea/isa/ recordisplay.cfm?deid=255721  14  National Institute of Occupational Safety and Health.,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
Available from: http://www.cdc.gov/ niosh/topics/ables/description.html  15  Kerr P. Vast amount of fraud discovered in workers’ compensation  system.,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
Available from: http://kff.org/health-costs/report/how-much- is-enough-out-of-pocket-spending-among-medicare-beneficiaries-a-chartbook/ .,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
"Available from: http://www.healthpocket.com/healthcare-research/infostat/2015-obamacare-out-of-pocket-preview#.VU5S7U0rjcu  41  MEPS (Medical Expenditure Panel Survey), Department of Health  and Human Services, AHRQ.",Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi:http://dx.doi.org/10.1289/ehp.9784 .,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
Available  from: http://www.bls.gov/opub/ted/2015/occupational-employment- wages-2014.htm (visited 2015 Jul 19).,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi:  http://dx.doi.org/10.1177/1403494814542263.,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
"Available from: http://www.cdc.gov/nchs/ data/databriefs/db07.htm#ref08  50  Welch CA, Czerwinski D, Ghimire B, Bertsimas D. Depression and  costs of health care.",OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi:   http://dx.doi.org/10.1016/j.janxdis.2013.09.009.,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi:   http://dx.doi.org/10.1016/j.jad.2014.04.039 .,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi:http://dx.doi.org/10.1002/ajim.22247.,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
Available from: http://yosemite.epa.,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
Available from: http://www.ksg.harvard.edu/m- rcbg/hcdp/numbers/Deconstructing%20the%20Costs%20Summary.,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi:  http://dx.doi.org/10.1016/j.jval.2010.10.006 .,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
16. http://www.hschange.com/CONTENT/1162/.,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
"Available from: http://www.ajmc.com/publications/issue/2014/2014-vol20-n11/variation-in-hospital-inpatient-prices-across-small-geographic-areas/3#sthash.fBdrffzR.dpuf  35  Maeda JL, Mosher Henke R, Marder WD, Karaca Z, Friedman  BS, Wong, HS.",Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
"http://www.ajmc.com/publications/issue/2014/2014-vol20-n11/variation-in-hospital-inpatient-prices-across-small-geographic-areas/2#sthash.YRib7Bzx.dpuf  36  Coughlin TA, Holahan J, Caswell K, McGrath M. Uncompensated  care for the uninsured in 2013: a detailed examination.",Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
Available from: http://www3.epa.gov/ ozonepollution/pdfs/20151001ria.pdf  82  OSHA.,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
"Available from: https://www.osha.gov/dcsp/smallbusiness/ safetypays/background.html  83  Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch  W. Health, absence, disability, and presenteeism cost estimates  of certain physical and mental health conditions affecting U.S. employers.",OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi:  http://dx.doi.org/10.1016/j.janxdis.2014.03.001.,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi:   http://dx.doi.org/10.1016/j.fertnstert.2013.01.145 .,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
"Available from: http://www.cdc.gov/niosh/ docs/2004-146/ch2/ch2-6.asp.htm  92  Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC.",OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi:   http://dx.doi.org/10.4088/JCP.14m09298.,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi:http://dx.doi.org/10.1093/aje/kwp248.,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi: http://dx.doi.org/10.1039/c2em30652b .,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
"Available from: http://www.alz.org/alzheimers_disease_ stages_of_alzheimers.asp  58  Neumann PJ, Gharib SD, Weinstein MC.",Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi: http://dx.doi.org/10.1016/j.juro.2013.08.083 .,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
Available from: http://www.usrds.org/adr.aspx  63  US Renal Data System.,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
http://kidney.niddk.nih.gov/KUDiseases/pubs/kustats/  65  EPA.,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
"Available from: http://yosemite.epa.gov/ee/epa/eed.nsf/   1acac3896fc46b38852575a6006ab36a/a344d66cad70b0fb852575a   7005e2c9f!opendocument  66  Van Houtven G, Honeycutt AA, Gilman B, McCall NT, Throneburg  WW, Sykes KE.",Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
Available  from: http://www.epa.gov/research/aging/docs/2004-coi-paper.pdf  67  American Heart Association.,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi:  http://dx.doi.org/10.1161/CIRCOUTCOMES.114.000927.,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi:   http://dx.doi.org/10.1002/clc.22341 .,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi: http://dx.doi.org/10.3399/bjgp13X665242.,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi:  http://dx.doi.org/10.1111/j.1468-0009.2011.00648.x.,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
Available from: http://www.census.gov/ prod/2014pubs/p25-1140.pdf 110  US Census Bureau.,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
Available from: http://www.nchh.org/Portals/0/ Contents/EPA-HQ-OPPT-2005-0049-0916_Final_Economic_ Analysis_3-08.pdf 112  EPA.,OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
"Accessed from: https://cfext.epa.gov/flpp/ 113  Keogh JP, Nuwayhid I, Gordon JL, Gucer PW.",OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
2012.  http://www.cdc.gov/dhdsp/pubs/docs/SIB_Hypertension_Workers.,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
doi:   http://dx.doi.org/10.1002/ajim.22362 .,Non-OADS,/arxiv_data1/oa_pdf/25/db/yjoh-22-107.PMC4984972.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d5/3e/ijn-11-3849.PMC4984987.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3849–3857International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3849OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10756 1 The intrinsic antimicrobial activity of citric acid- coated manganese ferrite nanoparticles is enhanced  after conjugation with the antifungal peptide cm-p5 carlos lopez-abarrategui,1  Viviana Figueroa-espi,2 Maria  B  lugo-alvarez,1 caroline D  Pereira,3 hilda garay,4 João  arg Barbosa,5 rosana Falcão,6  linnavel Jiménez-hernández,2  Osvaldo estévez-hernández,2,7  edilso reguera,8 Octavio l  Franco,3,9 simoni c Dias,3  anselmo J Otero-gonzalez1 1Faculty of Biology, center for Protein  studies, 2lab of structural analysis, Institute  of Materials science and T echnology,   havana University, la habana, havana,   cuba; 3center for Biochemical and  Proteomics analyses, catholic University  of Brasilia, Brasilia, Brazil; 4laboratory of  Peptide analysis and synthesis, center of  genetic engineering and Biotechnology,   la habana, havana, cuba; 5Department of  cellular Biology, laboratory of Biophysics,   Institute of Biological science, University  of Brasilia, 6Brazilian agricultural research  corporation ( eMBraPa), center of  genetic resources and Biotechnology  (ceN argeN), Brasilia DF , Brazil; 7Instituto  de ciencia y Tecnología de Materiales  (IMre), Universidad de la habana, cuba;   8research center for applied science and  advanced Technology ( cIcaTa), National  Polytechnic Institute (IPN), lagaria Unit,    Mexico DF , Mexico; 9s-Inova Biotech, Post- graduate in Biotechnology, Universidade  catolica Dom Bosco, campo grande, BrazilAbstract:  Diseases caused by bacterial and fungal pathogens are among the major health  problems in the world.",Non-OADS,/arxiv_data1/oa_pdf/d5/3e/ijn-11-3849.PMC4984987.pdf
"Their use as anti-infective tools represents a novel approach for  the development of antimicrobial therapies.4,5 Even though such peptides have been  shown to be both broad spectrum (having antimicrobial, anticancer, immunomodula - tory, wound healing and angiogenesis properties) and significantly potent in preclinical  studies, this success has not been transmitted to clinical practice yet.6 The major  disadvantages of AMPs have been low stability, cytotoxicity, biodistribution, and  high production costs.4,7correspondence: simoni c Dias center for Biochemical and Proteomics  analyses, catholic University of Brasilia,  sgaN 916, avenue W5, Brasilia, DF, Brazil,   ceP 70790-160 email simoni@ucb.b r anselmo J Otero-gonzalez center for Protein studies, Faculty of Biology,  havana University, 25 street x J street,   Vedado, 10400 havana city, cuba email aotero@fbio.uh.c uJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lopez-Abarrategui et al Running head recto: Antimicrobial activity of citric acid-coated MNPs DOI: http://dx.doi.org/10.2147/IJN.S107561",Non-OADS,/arxiv_data1/oa_pdf/d5/3e/ijn-11-3849.PMC4984987.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d5/3e/ijn-11-3849.PMC4984987.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/3e/ijn-11-3849.PMC4984987.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/05/80/ijn-11-3825.PMC4984988.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3825–3831International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3825OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10825 3 Decreased Pseudomonas aeruginosa  biofilm  formation on nanomodified endotracheal tubes:  a dynamic lung model Mary C Machado1 Thomas J Webster2 1center for Biomedical engineering,   Division of engineering Brown  University, rI, Usa; 2Department of  Orthopaedics, Division of Engineering  Brown University, rI, UsaAbstract:  Ventilator-associated pneumonia (VAP) is a serious complication of mechanical venti - lation that has been shown to be associated with increased mortality rates and medical costs in the  pediatric intensive care unit.",Non-OADS,/arxiv_data1/oa_pdf/05/80/ijn-11-3825.PMC4984988.pdf
"VAP is the second most common nosocomial  infection in the PICU and affects 3%–10% of all children on mechanical ventilation.1,2  Infants and children from 2 months to 12 months of age have the highest age-specific  rate of VAP.3 Infections such as VAP lead to increased mortality4 and morbidity.2,5,6  Additionally, VAP has been shown to increase the duration of mechanical ventila - tion by up to 11 days,2 increasing stays in the PICU6 and hospital costs by as much  as $55,882.7 Two of the pathogens most commonly associated with all VAP in the  pediatric population are Staphylococcus aureus and Pseudomonas  aeruginosa .3,8 VAP presents a difficult problem to the PICU, because it is often hard to distinguish  pneumonia from tracheal colonization or other conditions common in mechanically Correspondence: Thomas J Webster Department of Chemical Engineering,  Northeastern University, 360 Huntington  avenue, Boston, Ma 02115, Usa Tel +1 617 373 6585 email th.webster@neu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Machado and Webster Running head recto: Decreased P. aeruginosa  biofilm formation on nanomodified ETTs DOI: http://dx.doi.org/10.2147/IJN.S108253",Non-OADS,/arxiv_data1/oa_pdf/05/80/ijn-11-3825.PMC4984988.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/05/80/ijn-11-3825.PMC4984988.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/80/ijn-11-3825.PMC4984988.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0a/c0/dmso-9-243.PMC4984989.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Comparison of efficacy and safety of two starting  insulin regimens in non-Asian, Asian Indian, and  East Asian patients with type 2 diabetes: a post  hoc analysis of the PARADIGM study Linong Ji1 Kyung Wan Min2 Juliana Oliveira3 Thomas Lew4 Ran Duan3 1Department of Endocrinology,   Peking University People’s Hospital,   Beijing, People’s Republic of China;   2Department of Endocrinology, Eulji  Hospital, Seoul, Republic of Korea; 3Eli  Lilly and Company, Indianapolis, IN,   USA; 4Eli Lilly and Company, Taipei,   Songshan District, Taiwan Correspondence: Thomas Lew   Eli Lilly and Company, 11th floor, 365  Fuxing North Road, Taipei 10543,  Songshan District, Taiwan   T el +886 2 3518 2213   Email lew_thomas@lilly.co mObjective:  The objective of this study was to explore the efficacy and safety of insulin lispro  mix 25 (25% insulin lispro and 75% insulin lispro protamine suspension [LM25]) or insulin  glargine plus insulin lispro (G +L) in insulin-naïve patients with type 2 diabetes from different  racial/ethnic groups.",Non-OADS,/arxiv_data1/oa_pdf/0a/c0/dmso-9-243.PMC4984989.pdf
